
<html lang="en"     class="pb-page"  data-request-id="eea544a9-3642-4f8d-a909-0f16bad66cdc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00139;issue:issue:10.1021/jmcmar.2018.61.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925" /></meta><meta name="dc.Creator" content="Sean  Conroy" /></meta><meta name="dc.Creator" content="Nicholas D.  Kindon" /></meta><meta name="dc.Creator" content="Jacqueline  Glenn" /></meta><meta name="dc.Creator" content="Leigh A.  Stoddart" /></meta><meta name="dc.Creator" content="Richard J.  Lewis" /></meta><meta name="dc.Creator" content="Stephen J.  Hill" /></meta><meta name="dc.Creator" content="Barrie  Kellam" /></meta><meta name="dc.Creator" content="Michael J.  Stocks" /></meta><meta name="dc.Description" content="The human P2Y2 receptor (hP2Y2R) is a G-protein-coupled receptor that shows promise as a therapeutic target for many important conditions, including for antimetastatic cancer and more recently for ..." /></meta><meta name="Description" content="The human P2Y2 receptor (hP2Y2R) is a G-protein-coupled receptor that shows promise as a therapeutic target for many important conditions, including for antimetastatic cancer and more recently for ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 20, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00139" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00139" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00139" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00139" /></link>
        
    
    

<title>Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00139" /></meta><meta property="og:title" content="Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0001.jpeg" /></meta><meta property="og:description" content="The human P2Y2 receptor (hP2Y2R) is a G-protein-coupled receptor that shows promise as a therapeutic target for many important conditions, including for antimetastatic cancer and more recently for idiopathic pulmonary fibrosis. As such, there is a need for new hP2Y2R antagonists and molecular probes to study this receptor. Herein, we report the development of a new series of non-nucleotide hP2Y2R antagonists, based on the known, non-nucleotide hP2Y2R antagonist AR-C118925 (1), leading to the discovery of a series of fluorescent ligands containing different linkers and fluorophores. One of these conjugates, 98, displayed micromolar affinity for hP2Y2R (pKd = 6.32 ± 0.10, n = 17) in a bioluminescence-energy-transfer (BRET) assay. Confocal microscopy with this ligand revealed displaceable membrane labeling of astrocytoma cells expressing untagged hP2Y2R. These properties make 98 one of the first tools for studying hP2Y2R distribution and organization." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00139"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00139">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00139&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00139&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00139&amp;href=/doi/10.1021/acs.jmedchem.8b00139" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3089-3113</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00125" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00152" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.8b00606"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y<sub>2</sub> Receptor Based on AR-C118925</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Sean Conroy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sean Conroy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Centre for Biomolecular Sciences, University Park Nottingham, Nottingham NG7 2RD, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Conroy">Sean Conroy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicholas D. Kindon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicholas D. Kindon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Centre for Biomolecular Sciences, University Park Nottingham, Nottingham NG7 2RD, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+D.++Kindon">Nicholas D. Kindon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jacqueline Glenn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacqueline Glenn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Physiology, Pharmacology & Neuroscience, Medical School, University of Nottingham, Nottingham NG7 2UH, U.K.</div><div class="loa-info-affiliations-info">Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, the Midlands NG7 2UH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacqueline++Glenn">Jacqueline Glenn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leigh A. Stoddart</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leigh A. Stoddart</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Physiology, Pharmacology & Neuroscience, Medical School, University of Nottingham, Nottingham NG7 2UH, U.K.</div><div class="loa-info-affiliations-info">Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, the Midlands NG7 2UH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leigh+A.++Stoddart">Leigh A. Stoddart</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard J. Lewis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard J. Lewis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Mölndal, Gothenburg 431 83, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+J.++Lewis">Richard J. Lewis</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen J. Hill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen J. Hill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Physiology, Pharmacology & Neuroscience, Medical School, University of Nottingham, Nottingham NG7 2UH, U.K.</div><div class="loa-info-affiliations-info">Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, the Midlands NG7 2UH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+J.++Hill">Stephen J. Hill</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barrie Kellam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barrie Kellam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Centre for Biomolecular Sciences, University Park Nottingham, Nottingham NG7 2RD, U.K.</div><div class="loa-info-affiliations-info">Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, the Midlands NG7 2UH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barrie++Kellam">Barrie Kellam</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0030-9908" title="Orcid link">http://orcid.org/0000-0003-0030-9908</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Michael J. Stocks</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael J. Stocks</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Centre for Biomolecular Sciences, University Park Nottingham, Nottingham NG7 2RD, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#aac7c3c9c2cbcfc684d9dec5c9c1d9eac4c5dedec3c4cdc2cbc784cbc984dfc1"><span class="__cf_email__" data-cfemail="75181c161d1410195b06011a161e06351b1a01011c1b121d14185b14165b001e">[email protected]</span></a>. Tel.: +44 (0)115 951 5151.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Stocks">Michael J. Stocks</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3046-137X" title="Orcid link">http://orcid.org/0000-0003-3046-137X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00139&amp;href=/doi/10.1021%2Facs.jmedchem.8b00139" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3089–3113</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 20, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 January 2018</li><li><span class="item_label"><b>Published</b> online</span>20 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00139" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00139</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00139"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2217</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00139" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Conroy&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;D. Kindon&quot;},{&quot;first_name&quot;:&quot;Jacqueline&quot;,&quot;last_name&quot;:&quot;Glenn&quot;},{&quot;first_name&quot;:&quot;Leigh&quot;,&quot;last_name&quot;:&quot;A. Stoddart&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;J. Lewis&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;J. Hill&quot;},{&quot;first_name&quot;:&quot;Barrie&quot;,&quot;last_name&quot;:&quot;Kellam&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Stocks&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3089-3113&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00139&quot;},&quot;abstract&quot;:&quot;The human P2Y2 receptor (hP2Y2R) is a G-protein-coupled receptor that shows promise as a therapeutic target for many important conditions, including for antimetastatic cancer and more recently for idiopathic pulmonary fibrosis. As such, there is a need for new hP2Y2R antagonists and molecular probes to study this receptor. Herein, we report the development of a new series of non-nucleotide hP2Y2R antagonists, based on the known, non-nucleotide hP2Y2R antagonist AR-C118925 (1), leading to the discovery of a series of fluorescent ligands containing different linkers and fluorophores. One of these conjugates, 98, displayed micromolar affinity for hP2Y2R (pKd = 6.32 ± 0.10, n = 17) in a bioluminescence-energy-transfer (BRET) assay. Confocal microscopy with this ligand revealed displaceable membrane labeling of astrocytoma cells expressing untagged hP2Y2R. These properties make 98 one of the first tools for studying hP2Y2R distribution and organization.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00139&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00139" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00139&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00139" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00139&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00139" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00139&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00139&amp;href=/doi/10.1021/acs.jmedchem.8b00139" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00139" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00139" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00139%26sid%3Dliteratum%253Aachs%26pmid%3D29558126%26genre%3Darticle%26aulast%3DConroy%26date%3D2018%26atitle%3DSynthesis%2Band%2BEvaluation%2Bof%2Bthe%2BFirst%2BFluorescent%2BAntagonists%2Bof%2Bthe%2BHuman%2BP2Y2%2BReceptor%2BBased%2Bon%2BAR-C118925%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D7%26spage%3D3089%26epage%3D3113%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291687" title="Reagents">Reagents</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/jmcmar.2018.61.issue-7/20180412/jmcmar.2018.61.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The human P2Y<sub>2</sub> receptor (<i>h</i>P2Y<sub>2</sub>R) is a G-protein-coupled receptor that shows promise as a therapeutic target for many important conditions, including for antimetastatic cancer and more recently for idiopathic pulmonary fibrosis. As such, there is a need for new <i>h</i>P2Y<sub>2</sub>R antagonists and molecular probes to study this receptor. Herein, we report the development of a new series of non-nucleotide <i>h</i>P2Y<sub>2</sub>R antagonists, based on the known, non-nucleotide <i>h</i>P2Y<sub>2</sub>R antagonist AR-C118925 (<b>1</b>), leading to the discovery of a series of fluorescent ligands containing different linkers and fluorophores. One of these conjugates, <b>98</b>, displayed micromolar affinity for <i>h</i>P2Y<sub>2</sub>R (p<i>K</i><sub>d</sub> = 6.32 ± 0.10, <i>n</i> = 17) in a bioluminescence-energy-transfer (BRET) assay. Confocal microscopy with this ligand revealed displaceable membrane labeling of astrocytoma cells expressing untagged <i>h</i>P2Y<sub>2</sub>R. These properties make <b>98</b> one of the first tools for studying <i>h</i>P2Y<sub>2</sub>R distribution and organization.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">P2Y receptors (P2YRs) are G-protein-coupled receptors (GPCRs) that are activated by extracellular nucleotides. The P2Y family is composed of eight members, encoded by distinct genes, that can be subdivided into two groups on the basis of their primary signaling through specific G proteins<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and sequence homology. The first subgroup includes the P2Y<sub>1,2,4,6,11</sub> receptors, which primarily signal though G<sub>q</sub>, whereas the second subgroup, signaling through G<sub>i</sub>, encompasses the P2Y<sub>12,13,14</sub> receptor subtypes.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Notably, the P2Y<sub>2</sub> receptor (P2Y<sub>2</sub>R) is activated by the endogenous agonists uridine-5′-triphosphate (UTP, <i>h</i>P2Y<sub>2</sub> EC<sub>50</sub> = 140 nM) and adenosine-5′-triphosphate (ATP, <i>h</i>P2Y<sub>2</sub> EC<sub>50</sub> = 230 nM).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> As P2Y<sub>2</sub>R is predominately G<sub>q</sub>-coupled, receptor activation leads to the stimulation of phospholipase C, IP<sub>3</sub> release, and the elevation of the intracellular Ca<sup>2+</sup> concentration, as well as the initiation of protein kinase C and the activation of the mitogen-activated protein-kinase cascade.</div><div class="NLM_p">Defining the clinical role for P2Y<sub>2</sub>R antagonism has been hampered by the lack of high-affinity and druglike receptor antagonists.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, it has been reported that ATP released from tumor-cell-activated platelets induces the opening of the endothelial barrier, leading to the migration of tumor cells and hence cancer proliferation. More importantly, P2Y<sub>2</sub>R was identified as the primary mediator of this effect; a strong reduction of tumor cell metastasis was observed in P2Y<sub>2</sub>R-deficient mice, revealing a therapeutic potential of P2Y<sub>2</sub>R antagonists as antimetastatic agents.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Recently, it has been reported that both inflammation and fibrosis were reduced in P2Y<sub>2</sub>R-deficient mice compared with those in wild-type animals. In addition, mechanistic studies have demonstrated that the recruitment of neutrophils into the lungs, the proliferation and migration of lung fibroblasts, and IL-6 production are all key P2Y<sub>2</sub>R-mediated processes. These studies clearly demonstrate the involvement of P2Y<sub>2</sub>R subtypes in the pathogenesis of fibrotic lung diseases in humans and mice and support the development of selective P2Y<sub>2</sub>R antagonists for the treatment of idiopathic pulmonary fibrosis (IPF).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> To date, the only reported high-affinity P2Y<sub>2</sub>R antagonists were those developed by scientists from AstraZeneca resulting in the non-nucleotide P2Y<sub>2</sub>R antagonist AR-C118925 (<b>1</b>).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0002.gif" alt="" id="fx1" /></img></div><div class="NLM_p">Several in vivo and ex vivo studies using <b>1</b> have been reported that further validate the therapeutic benefits of P2Y<sub>2</sub>R antagonists. Importantly, it was shown that <b>1</b>, which was reported to be inactive at 10 μM against a panel of 37 other receptors, was able to concentration-dependently antagonize ATPγS-induced mucin secretion in an ex vivo model of human bronchial epithelial cells.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In addition, Müller et al. recently demonstrated that <b>1</b> was a selective, high-affinity, reversible antagonist of P2Y<sub>2</sub>R.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p last">We were drawn to the exciting possibility of using <b>1</b> as a chemical template to design new P2Y<sub>2</sub>R antagonists<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and synthesize fluorescently labeled chemical tools to further probe P2Y<sub>2</sub>R function.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Using fluorescence as a means to study GPCRs allows scientists access to a large range of pharmacological techniques that can capture dynamic processes in living cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In particular, fluorescently labeled receptor antagonists have been developed to target GPCRs, allowing the visualization of GPCR function at the cellular level.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> In addition, fluorescent ligands can be used in resonance-energy-transfer (RET) techniques, in particular those that utilize nanoluciferase (NLuc), to quantify ligand–receptor interactions and determine the affinities of unlabeled ligands.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This offers advantages for receptors such as P2Y<sub>2</sub>R for which there are currently no commercially available radio ligands. In addition, as the reported antagonists for P2Y<sub>2</sub>R have mid to high affinities, it is proposed that the fluorescent ligands designed from these might also have affinities in this range. This may prove problematic for techniques which directly monitor fluorescent-ligand binding, but NanoBRET has been shown to display low, nonspecific binding at high fluorescent-ligand concentrations.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis and Evaluation of the <i>h</i>P2Y<sub>2</sub>R Antagonists</h3><div class="NLM_p">The medicinal-chemistry strategy involved an initial exploration of the structure–activity relationship (SAR) around <b>1</b> in order to enable the design of structural analogues with improved predicted physicochemical properties and to guide our design strategy by highlighting suitable linking sites to attach the fluorophore groups (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SARs for the P2Y<sub>2</sub>R antagonists showing the change from the furan in <b>1</b> to thiazole (reduced lipophilicity) and the change from 2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulene to the 7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazole tricyclic ring system.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Estimated Affinity Values for P2Y<sub>2</sub>R Antagonists <b>1</b>–<b>6</b> Obtained from the Calcium-Mobilization Assay</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center"><i>h</i>P2Y<sub>2</sub> p<i>K</i><sub>b</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center"><i>h</i>P2Y<sub>2</sub> p<i>K</i><sub>b</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">7.51 ± 0.09 (12)</td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">IA<a class="ref internalNav" href="#t1fn3" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">6.43 ± 0.08 (3)</td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">6.48 ± 0.10 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">7.11 ± 0.14 (7)</td><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center">5.99 ± 0.03 (7)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The estimated affinity value for each antagonist (p<i>K</i><sub>b</sub>) was calculated using the Gaddum equation from the shift of the UTPγS concentration–response curve brought about by the addition of a single concentration of the antagonist. The data shown are the means ± SEM, and the numbers of separate experiments are given in parentheses.</p></div><div class="footnote" id="t1fn3"><sup><sup>b</sup></sup><p class="last">IA = inactive; i.e., less than a 50% inhibition of the response to 0.1 μM UTPγS in the presence of a 10 μM concentration of the compound. UTPγS EC<sub>50</sub> = 7.9 ± 1.3 nM (<i>n</i> = 25).</p></div><div class="footnote" id="t1fn2"><sup><sup>c</sup></sup><p class="last">The literature value is pA<sub>2</sub> = 5.7.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></p></div></div></div><div class="NLM_p"><b>1</b> has previously been shown to have a high lipophilicity (cLogP = 4.2)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and poor physicochemical properties for oral delivery.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> We therefore synthesized the thiazole analogue, <b>3</b> (cLogP = 3.8), with little loss of affinity for P2Y<sub>2</sub>R. Replacement of the 2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulene with a 7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazole tricyclic ring gave <b>5</b> (p<i>K</i><sub>b</sub> = 6.5, cLogP = 3.4).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition, a nonparallel SAR with P2Y<sub>2</sub>R affinity was observed in the replacement of the <i>N</i>-1 thiouracil substituent with a methyl group, which gave compound <b>6</b>, whereas the corresponding analogue, <b>4</b>, proved inactive. In order to explore this intriguing finding and study this SAR, we synthesized a range of analogues of <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Calcium-Mobilization Activities for the P2Y<sub>2</sub>R Antagonists <b>6</b>–<b>19</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0019.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center"><i>h</i>P2Y<sub>2</sub> p<i>K</i><sub>b</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">6.56 ± 0.14 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">PhNH</td><td class="colsep0 rowsep0" align="center">IA<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="center">IA (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub>CH<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="center">IA (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">1-methyl piperazin-4-yl</td><td class="colsep0 rowsep0" align="center">IA (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">morpholinyl</td><td class="colsep0 rowsep0" align="center">IA (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">piperidinyl</td><td class="colsep0 rowsep0" align="center">IA (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">2-methoxyethan-1-aminyl</td><td class="colsep0 rowsep0" align="center">6.60 ± 0.21 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">2-methoxypropan-1-aminyl</td><td class="colsep0 rowsep0" align="center">6.56 ± 0.09 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">2-ethoxyethan-1-aminyl</td><td class="colsep0 rowsep0" align="center">6.73 ± 0.05 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">2-isopropoxyethan-1-aminyl</td><td class="colsep0 rowsep0" align="center">6.49 ± 0.09 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">2-phenoxyethan-1-aminyl</td><td class="colsep0 rowsep0" align="center">IA (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="center">IA (3)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The estimated affinity value for each antagonist (p<i>K</i><sub>b</sub>) was calculated using the Gaddum equation from the shift of the UTPγS concentration–response curve brought about by the addition of a single concentration of the antagonist. The data shown are the means ± SEM, and the numbers of separate experiments are given in parentheses.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IA = inactive; i.e., less than a 50% inhibition of the response to 0.1 μM UTPγS in the presence of a 10 μM concentration of the compound (<i>n</i> = 3).</p></div></div></div><div class="NLM_p">From the SAR study of <b>6</b>, it was shown that replacing the thiazole 2-methyl substituent with an amino group increased <i>h</i>P2Y<sub>2</sub>R affinity (compare <b>6</b> with <b>7</b>), whereas a sterically demanding substituent, such as that in <b>19</b>, resulted in a complete loss of affinity for <i>h</i>P2Y<sub>2</sub>R. We therefore explored the substitution of the amino group and showed that both compounds with sterically demanding amino groups (<b>8</b>, <b>9</b>, and <b>10</b>) and compounds with cyclic tertiary amines (<b>11</b>, <b>12</b>, and <b>13</b>) were inactive. However, the linear, less sterically demanding alkyl amino groups, such as those in <b>14</b>, <b>15</b>, <b>16</b>, and <b>17</b>, increased <i>h</i>P2Y<sub>2</sub>R affinity, although the bulkier 2-phenoxyethan-1-amino substituent in <b>18</b> resulted in the compound being inactive.</div><div class="NLM_p">Thus far, all of the compounds synthesized were tested as racemic mixtures. To try and determine whether the activity resided in one enantiomer, the resolution of <b>14</b> and <b>16</b> was achieved through semipreparative chiral HPLC, and the biology of each of the resolved enantiomers was independently assessed (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Calcium-Mobilization Activities for the Resolved Enantiomers of <b>14</b> and <b>16</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center">racemic compound</th><th class="colsep0 rowsep0" align="center">enantiomeric excess (ee)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>h</i>P2Y<sub>2</sub> p<i>K</i><sub>b</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" rowspan="2" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">99%</td><td class="colsep0 rowsep0" align="center">6.63 ± 0.11 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="center">78%</td><td class="colsep0 rowsep0" align="center">5.82 ± 0.05 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" rowspan="2" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">95%</td><td class="colsep0 rowsep0" align="center">IA<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center">96%</td><td class="colsep0 rowsep0" align="center">6.78 ± 0.05 (6)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The compounds were separated using Phenomenex’s Lux 5 μm amylose-2 stationary phase.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">The estimated affinity value for each antagonist (p<i>K</i><sub>b</sub>) was calculated using the Gaddum equation from the shift of the UTPγS concentration–response curve brought about by the addition of a single concentration of the antagonist. The data shown are the means ± SEM, and the numbers of separate experiments are given in parentheses.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">IA = inactive; i.e., less than a 50% inhibition of the response to 0.1 μM UTPγS in the presence of a 10 μM concentration of the compound (<i>n</i> = 3).</p></div></div></div><div class="NLM_p">From these results, it is possible to see that the <i>h</i>P2Y<sub>2</sub>R-antagonist affinities observed for the racemic compounds <b>14</b> and <b>16</b> reside largely in enantiomers <b>20</b> and <b>23</b>, respectively. Although some antagonist activity is observed for <b>21</b>, this may be attributed to residual active enantiomer <b>20</b>, which constitutes 11% of the sample. Unfortunately, the resolved enantiomers proved to be amorphous powders, and so single-crystal X-ray determination of their absolute chiralities could not be used for structural determination. However, vibrational circular dichroism was used for <b>22</b> and <b>23</b>, from which spectra were acquired for both samples and fitted to the calculated spectra.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> The results (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_002.pdf" class="ext-link">Supporting Information</a>) showed that there was a good match between the spectrum of <b>22</b> and the calculated spectrum for the (<i>S</i>)-enantiomer; therefore, <b>23</b> was assigned as the active (<i>R</i>)-enantiomer (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chiral resolution of <b>16</b> and structural assignment made by vibrational circular dichroism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In an attempt to increase affinity within the new series of compounds, we the incorporated key structural features of <b>14</b> and <b>5</b> to generate compound <b>24</b>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0003.gif" alt="" id="fx3" /></img></div><div class="NLM_p">However, <b>24</b> did not demonstrate the expected increase in affinity from the combination of features from <b>14</b> and <b>5</b> and instead showed a level of <i>h</i>P2Y<sub>2</sub>R affinity ( p<i>K</i><sub>d</sub> = 7.02 ± 0.05, <i>n</i> = 4) similar to those of <b>1</b> and <b>3</b>, demonstrating that the SARs within the series of compounds were nonadditive.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">The synthesis of compounds <b>2</b>–<b>4</b> is illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The alkylation of 5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> with ethyl 2-(bromomethyl)thiazole-4-carboxylate followed by a treatment with Lawesson’s reagent and saponification gave <b>2</b>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> which was reacted with 2-amino tetrazole via benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate activation to afford <b>3</b>. In a similar manner, alkylation with methyl iodide followed by a conversion to the thiouracil gave <b>4</b> in a good overall yield.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) ethyl 2-(bromomethyl)thiazole-4-carboxylate, 50 °C, 24 h (55%). (b) Lawesson’s reagent, <b>1</b>, 4-dioxane, 100 °C, 18 h (85%). (c) NaOH, methanol/H<sub>2</sub>O, reflux, 1 h (91%). (d) 5-Aminotetrazole, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, DIPEA, rt, 1 h (49%). (e) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) iodomethane, 50 °C, 24 h (61%). (f) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (40%).</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> shows the synthetic route to compounds <b>5</b> and <b>6</b>. The first step involved performing a Heck reaction coupling 3-chloroiodobeneze, <b>25</b>, to allyl alcohol, and this successfully isomerized in situ yielding the desired aldehyde, <b>26</b>. This compound was reacted with ethyl dichloroacetate in a Darzens condensation<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> to generate an α-chloro epoxide, which was reacted directly with thioacetamide to afford the desired 2-methylthiazole, <b>27</b>, with moderate yields achieved over two steps. Freshly prepared sodium ethoxide, generated from sodium metal in dried ethanol, was found to be the optimal base for the Darzens condensation. Saponification gave the carboxylic acid, <b>28</b>, and treatment with oxalyl chloride generated the acyl chloride, which was immediately cyclized to give the tricyclic ketone, <b>29</b>, as a single regioisomer. Lithiation of the di-<i>tert</i>-butyl ether-protected uracil, <b>30</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> was readily achieved with <i>n</i>-butyllithium, and this compound underwent a 1,2-addition to the ketone, <b>29</b>, to give the tertiary alcohol, <b>32</b>. Concomitant deprotection and dehydration resulted in uracil, <b>33</b>, via heating in trifluoroacetic acid. Although the yield for this reaction was poor, other acidic conditions were ineffective. Alkylation at the <i>N</i>1-position of the uracil was achieved in a one-pot process of silylation with <i>N</i>,<i>O</i>-bis(trimethylsilyl)trifluoroacetamide (BSTFA), alkylation with iodomethane, and subsequent desilylation, which give <b>34</b>. Finally, a reaction with Lawesson’s reagent gave <b>6</b>. From the uracil intermediate, <b>33</b>, alkylation with ethyl 2-(bromomethyl) thiazole-4-carboxylate<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> gave <b>35</b>, which was subsequently reacted with Lawesson’s reagent to give <b>36</b>. Hydrolysis was followed by a reaction of the resulting carboxylic acid with 5-aminotetrazole and benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate to give <b>5</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Allyl alcohol, tetrabutylammonium chloride, DMF, 3 mol % palladium(II)acetate, NaHCO<sub>3</sub>, 50 °C, 18 h (92%). (b) (i) Ethyl dichloroacetate, sodium ethoxide, diethyl ether, 30 min, 0–40 °C; (ii) thioacetamide, ethanol, reflux, 3 h (30% over two steps). (c) NaOH, H<sub>2</sub>O/THF (1:1), rt, 18 h (99%). (d) (i) Oxalyl chloride, catalytic DMF, DCM, rt, 3 h; (ii) aluminum(III)chloride, DCM, rt, 18 h (39% over two steps). (e) Sodium <i>tert</i>-butoxide, THF, 0 °C to rt, 18 h (61%). (f) (i) <i>n</i>-Butyllithium, THF, −78 °C, 30 min; (ii) <b>29</b>, −78 °C to rt, 1 h (65%). (g) Trifluoroacetic acid, reflux, 72 h (36%). (h) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) iodomethane, 50 °C, 24 h (61%). (i) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (40%). (j) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) ethyl 2-(bromomethyl)thiazole-4-carboxylate, 50 °C, 24 h (57%). (k) Lawesson’s reagent, 1,4-dioxane, 100 °C, 18 h (89%). (l) (i) NaOH, methanol/H<sub>2</sub>O, reflux, 1 h (91%); (ii) 5-aminotetrazole, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, DIPEA, rt, 1 h (30%).</p></p></figure><div class="NLM_p">In a similar sequence to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, aldehyde <b>26</b> was reacted with ethyl dichloroacetate, and the resulting crude α-chloro epoxide reacted with thiourea to afford the 2-aminothiazole, <b>37</b>, which was converted to the 2-chlorothiazole, <b>38</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The ethyl ester was hydrolyzed to afford the carboxylic acid, <b>39</b>, which was converted to the acid chloride and cyclized to the tricyclic ketone, <b>40</b>. Lithiation of the <i>tert</i>-butyl ether-protected uracil, <b>31</b>, and a reaction with <b>40</b> gave the tertiary alcohol, <b>41</b>. After screening a range of milder acidic conditions, heating to 140 °C with microwave irradiation in acetic acid/1,4-dioxane (1:1) for 10 min was found to be optimal for the formation of the desired uracil intermediate, <b>42</b>, which was subsequently methylated to give <b>43</b>. The chlorine atom in compound <b>43</b> was readily displaced through a nucleophilic aromatic substitution with a range of primary and secondary amines upon heating under basic conditions. These conditions were unsuccessful when aniline was used, and in this instance, heating in the microwave with hydrochloric acid (catalytic) proved successful in giving <b>46</b>. Microwave-based conditions were employed for the substitution with ammonia in the synthesis of <b>45</b>. A Suzuki reaction with phenylboronic acid gave <b>44</b>. Through the use of Lawesson’s reagent, it was then possible to convert these uracil derivatives (<b>44</b>–<b>54</b>) to the respective 4-thiouracil derivatives (<b>6</b>–<b>19</b>). Through a route analogous to the synthesis of compound <b>7</b>, it was possible to generate the desired tetrazole analogue, <b>24</b>. Uracil intermediate <b>42</b> was alkylated at the <i>N</i>1-position with ethyl 2-(bromomethyl)thiazole-4-carboxylate to give <b>57</b>. This compound was reacted with 2-methoxyethylamine to afford <b>58</b>, which was subsequently reacted with Lawesson’s reagent to give the 4-thiouracil, <b>59</b>. Hydrolysis followed by benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate activation and a reaction with 5-aminotetrazole afforded <b>24</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0015.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) Ethyl dichloroacetate, sodium ethoxide, diethyl ether, 30 min, 0–40 °C; (ii) thiourea, ethanol, reflux, 2.5 h (46% over two steps). (b) Copper(II)chloride, <i>tert</i>-butyl nitrite, acetonitrile, rt, 2 h (65%). (c) NaOH, H<sub>2</sub>O/THF (1:1), rt, 18 h (quant). (d) (i) Oxalyl chloride, catalytic DMF, DCM, rt, 3 h; (ii) AlCl<sub>3</sub>, DCM, rt, 18 h (83% over two steps). (e) (i) <b>31</b>, <i>n</i>-butyllithium, THF, −78 °C, 30 min; (ii) <b>82</b>, −78 °C to rt, 1 h (79%). (f) Acetic acid/1,4-dioxane (1:1), 140 °C, 10 min (58%). (g) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) iodomethane, 50 °C, 24 h (61%). (h) Phenylboronic acid, Na<sub>2</sub>CO<sub>3</sub>, 1 mol % bis(triphenylphosphine) palladium(II)chloride, 1,4-dioxane, water, microwave irradiation, 150 °C, 5 min (68%). (i) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (76%). (j) R<sub>1</sub>R<sub>2</sub>NH, 1,4-dioxane, microwave irradiation, 100 °C, 4 h (51–92%). (k) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (44–88%). (l) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, 1,2-dichloroethane, reflux, 18 h; (ii) ethyl 2-(bromomethyl)thiazole-4-carboxylate, reflux, 48 h (91%). (m) 2-Methoxyethyl amine, triethylamine, 1,4-dioxane, reflux, 72 h (59%). (n) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (81%). (o) (i) NaOH, methanol/H<sub>2</sub>O, reflux, 1 h (91%); (ii) 5-aminotetrazole, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, DIPEA, rt, 2 h (34%).</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthesis of the <i>h</i>P2Y<sub>2</sub>R Fluorescent Ligands</h3><div class="NLM_p">With a view to developing a series of fluorescent conjugates suitable for both a bioluminescence-resonance-energy-transfer (BRET) ligand-binding assay<a onclick="showRef(event, 'ref18 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref18 ref27 ref28 ref29">(18,27−29)</a> and imaging via confocal microscopy, we embarked on a strategy to synthesize BODIPY conjugates, specifically with the dyes BODIPY A (628 nm absorption max, 642 nm emission max) or BODIPY B (503 nm absorption max, 509 nm emission max) as this would allow us the opportunity of ligand choice in future imaging work.</div><div class="NLM_p">Two positions on the P2Y<sub>2</sub>R-antagonist core structure were considered for the attachment of the linker and fluorophore (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). In order to simplify the synthetic chemistry and increase the SARs within the series, we examined the replacement of the furan ring of <b>1</b> and the thiazole ring of <b>2</b> with 1,3,5-trisubstituted phenyl rings. This would allow the attachment of the acyl tetrazole group in addition to providing a second free carboxylic acid group to which the fluorescent conjugates could be attached. Fortunately, the 3,5-dicarboxylic acid on <b>60</b> (<i>h</i>P2Y<sub>2</sub>R p<i>K</i><sub>d</sub> = 6.53 ± 0.04, <i>n</i> = 7) was well tolerated with no loss of affinity for P2Y<sub>2</sub>R compared with the affinity of compound <b>2</b>. Therefore, the first series of compounds had the linker fluorophore attached via the phenyl ring of <b>60</b>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0004.gif" alt="" id="fx4" /></img></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of the fluorescent P2Y<sub>2</sub>R antagonists based on the SARs of <b>1</b>. The figure shows the potential attachment points to which either BODIPY A or BODIPY B could be attached via a suitable linking group. The asterisks (*) represent the attachment points for the fluorophore linkage via a suitable linking group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Having established that alkoxyalkyl amines are tolerated in terms of activity in the 2-position of the thiazole in the 4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl) tricyclic rings of compounds of the type shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, this position was chosen as the second point of attachment of the linker fluorophore. Finally, a third generation of fluorescent ligands were explored that contained the optimal second-generation fluorescent ligand with an incorporated acyl tetrazole functional group.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> First-Generation <i>h</i>P2Y<sub>2</sub>R Fluorescent Ligands</h3><div class="NLM_p">The general synthetic route for the first-generation P2Y<sub>2</sub>R fluorescent antagonists is shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0016.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthetic Route for the First-Generation P2Y<sub>2</sub>R Fluorescent Antagonists<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Dimethyl 5-(bromomethyl)isophthalate, BSTFA, 1,2-dichloroethane, reflux, 16 h. (b) Lawesson’s reagent, 1,4-dioxane, reflux, 16 h. (c) NaOH (2 equiv), MeOH, toluene, H<sub>2</sub>O, 4 h, 65% (three steps). (d) <i>tert</i>-Butyl (2-(2-aminoethoxy)ethyl)carbamate (53%) or <i>tert</i>-butyl (2-aminoethyl)carbamate (63%), <i>N</i>Et<sub>3</sub>, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, rt, 0.5 h. (e) LiOH, MeOH, H<sub>2</sub>O, 16 h, rt, 14–30%. (f) 4-Aminotetrazole, <i>N</i>Et<sub>3</sub>, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, 1 h, rt. (g) HCl (4 M) in 1,4-dioxane, 1 h. (h) BODIPY-SE, DIPEA, DMF, rt, 1–4 h, 15–45%.</p></p></figure><div class="NLM_p">Alkylation of 5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> with dimethyl 5-(bromomethyl)isophthalate followed by a treatment with Lawesson’s reagent and the selective hydrolysis of one of the methyl esters gave <b>61</b>. This carboxylic acid (<b>61</b>) was activated using benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate and coupled to form the appropriate amides (<b>62</b> and <b>63</b>). The second esters of <b>62</b> and <b>63</b> were then hydrolyzed and converted to amidotetrazoles (<b>64</b> and <b>65</b>). Finally, the Boc protecting group was removed, and the resulting amine was coupled to the fluorophore with the appropriate commercially available BODIPY succinimidyl ester to give a small library of four fluorescent conjugates (<b>66</b>–<b>69</b>).</div><div class="NLM_p">To determine whether any of these conjugates had affinities for P2Y<sub>2</sub>R and consequently if they could be used in NanoBRET binding assays, a 1321N1 astrocytoma cell line expressing recombinant P2Y<sub>2</sub>R tagged on its N-terminus with NLuc (NLuc-P2Y<sub>2</sub>R) was generated. The NLuc-tagged P2Y<sub>2</sub> receptors exhibited normal calcium signals (UTPγS EC<sub>50</sub> = 91 ± 12 nM, <i>n</i> = 3). These NLuc-P2Y<sub>2</sub> cells were treated with increasing concentrations of <b>66</b>–<b>69</b> and then treated with the NLuc substrate, furimazine, before the resulting BRET signal was monitored. All four compounds showed moderate to low affinities for the NLuc-P2Y<sub>2</sub>R (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), with conjugates <b>68</b> and <b>69</b> having higher affinities. However, this did illustrate the power of using NanoBRET to monitor ligand binding to low-affinity receptors.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Affinities of <b>66</b>, <b>67</b>, <b>68</b>, and <b>69</b> Determined in 1321N1 Astrocytoma Cells Expressing Recombinant NLuc-P2Y<sub>2</sub>R</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center"><i>n</i><a class="ref internalNav" href="#t4fn2" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">R<a class="ref internalNav" href="#t4fn3" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">NanoBRET p<i>K</i><sub>d</sub><a class="ref internalNav" href="#t4fn1" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">5.56 ± 0.1 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="center">5.78 ± 0.18 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">6.12 ± 0.07 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="center">6.07 ± 0.15 (3)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn2"><div class="footnote" id="t4fn2"><sup><sup>a</sup></sup><p class="last">See <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</p></div><div class="footnote" id="t4fn3"><sup><sup>b</sup></sup><p class="last">A and B correspond to the R groups in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</p></div><div class="footnote" id="t4fn1"><sup><sup>c</sup></sup><p class="last">The p<i>K</i><sub>d</sub> values were derived from saturation binding curves. The data shown are the means ± SEM, and the numbers of separate experiments are given in parentheses.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Second-Generation <i>h</i>P2Y<sub>2</sub>R Fluorescent Ligands</h3><div class="NLM_p">The general synthetic route for the second-generation P2Y<sub>2</sub>R fluorescent antagonists, in which the linker fluorophores are attached to the thiazole rings, is illustrated in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0017.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. General Synthetic Route for the Second-Generation P2Y<sub>2</sub>R Fluorescent Antagonists<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Amine, <i>N</i>Et<sub>3</sub>, 1,4-dioxane, reflux, 72 h, 96–97%. (b) Lawesson’s reagent, 1,4-dioxane, 100 °C, 18 h, 39–74%. (c) TFA, DCM, rt, 30 min. (d) Amine, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, DIPEA, rt, 1 h, 36–58% (two steps). (e) TFA, DCM, rt, 30 min. (f) BODIPY-SE, DIPEA, DMF, rt, 1–4 h, 10–54% (two steps).</p></p></figure><div class="NLM_p">Nucleophilic displacement of the 2-chloro substituent of <b>43</b> by either <i>tert</i>-butyl 3-aminopropanoate or <i>tert</i>-butyl 6-aminohexanoate gave the corresponding <i>tert</i>-butyl esters (<b>70</b> and <b>71</b>). Treatment with Lawesson’s reagent in 1,4-dioxane at 100 °C resulted in the formation of the 4-thiouracils (<b>72</b> and <b>73</b>). The carboxylic acids were generated from the <i>tert</i>-butyl esters via TFA-mediated hydrolysis and subsequently coupled with <i>tert</i>-butyl (2-aminoethyl)carbamate or <i>tert</i>-butyl (2-(2-aminoethoxy)ethyl)carbamate to generate the corresponding amides (<b>74</b>–<b>77</b>). The Boc protecting groups were removed using TFA, and the resulting amines were coupled with the appropriate commercially available BODIPY succinimidyl ester (SE), generating a small library of 14 fluorescent conjugates (<b>78</b>–<b>91</b>). These fluorescent conjugates were initially tested using the aforementioned NanoBRET binding assay at fixed concentrations of 10 μM in the presence or absence of 10 μM <b>1</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_002.pdf" class="ext-link">Figure S1</a> in the Supporting Information). It was found that <b>80</b>, <b>85</b>, <b>86</b>, and <b>87</b> generated the largest specific NanoBRET signals; therefore, their affinities were determined from saturation binding assays, demonstrating the excellent signal-to-noise ratios observed from NanoBRET assays even for low-affinity conjugates (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. NanoBRET saturation binding isotherms, determined in 1321N1 astrocytoma cells expressing recombinant NLuc-P2Y<sub>2</sub>R, for (a) <b>80</b>, (b) <b>85</b>, (c) <b>86</b>, and (d) <b>87</b> in the absence and presence of 10 μM <b>1</b>. The data points are the mean values ± SEM (<i>n</i> = 3 or 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Affinities of <b>85</b>, <b>86</b>, <b>87</b>, and <b>80</b> Determined in 1321N1 Astrocytoma Cells Expressing Recombinant NLuc-P2Y<sub>2</sub>R</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>d</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="center">5.29 ± 0.17 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>85</b></td><td class="colsep0 rowsep0" align="center">4.91 ± 0.14 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="center">5.67 ± 0.10 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b></td><td class="colsep0 rowsep0" align="center">5.38 ± 0.19 (3)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The p<i>K</i><sub>d</sub> values were derived from saturation binding curves. The data shown are the means ± SEM, and the numbers of separate experiments are given in parentheses.</p></div></div></div><div class="NLM_p last">Reassuringly, the affinities determined for the nonfluorescent P2Y<sub>2</sub>R antagonist, <b>1</b>, with either <b>86</b> (p<i>K</i><sub>i</sub> = 7.45 ± 0.13, <i>n</i> = 4) or <b>87</b> (p<i>K</i><sub>i</sub> = 7.32 ± 0.13, <i>n</i> = 4) were consistent with the affinities determined using the P2Y<sub>2</sub>R functional assay (p<i>K</i><sub>b</sub> = 7.51 ± 0.09), demonstrating that the P2Y<sub>2</sub>R fluorescent ligands could be used in a NanoBRET assay for determining the affinities of nonfluorescent P2Y<sub>2</sub>R antagonists. The clear demonstration of the saturable specific binding of these low-affinity fluorescent ligands confirmed the utility of the NanoBRET binding format and the ability to exploit the good signal-to-noise ratio of this proximity-based assay. To explore the opportunity to develop higher-affinity fluorescent conjugates, we embarked on a synthetic strategy to incorporate affinity-enhancing acyl-tetrazole functional groups into the fluorescent compounds.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Third-Generation P2Y<sub>2</sub>R Fluorescent Ligands</h3><div class="NLM_p">The general synthetic route for the third-generation P2Y<sub>2</sub>R fluorescent antagonists is illustrated in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. The displacement of the chlorine atom in compound <b>57</b> with <i>tert</i>-butyl 3-aminopropanoate gave the <i>tert</i>-butyl ester, <b>92</b>. Treatment with TFA afforded the conversion of the <i>tert</i>-butyl ester to the corresponding acid, which was immediately activated and coupled to <i>tert</i>-butyl (2-aminoethyl)carbamate, <b>93</b>, with HATU. Hydrolysis of the ethyl ester, activation of the carboxylic acid by benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, and coupling with 5-aminotetrazole gave the amidotetrazole, <b>94</b>. The Boc protecting group was removed, and the resulting amine was attached to the fluorophore with the appropriate BODIPY succinimidyl ester (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0018.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. General Synthetic Route for the Third-Generation P2Y<sub>2</sub>R Fluorescent Antagonists<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Amine, <i>N</i>Et<sub>3</sub>, 1,4-dioxane, reflux, 72 h (89%). (b) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (48%). (c) TFA, DCM, rt, 30 min (55%). (d) <i>tert</i>-Butyl (2-aminoethyl)carbamate, HATU, DCM, DIPEA, rt, 24 h (63%). (e) (i) NaOH, MeOH, reflux, 4 h; (ii) 5-aminotetrazole, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DIPEA, DMF, rt, 4 h (28% over two steps). (f) (i) TFA, DCM, rt, 30 min; (ii) BODIPY-SE, DIPEA, DMF, rt, 1–4 h (11–18% over two steps). The structures of compounds <b>95</b>–<b>98</b> are assigned in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</p></p></figure><div class="NLM_p">In contrast to the nonfluorophore compounds <b>14</b> and <b>24</b>, whose affinities hardly changed when their uracil <i>N</i>1-substituents were changed, in three of the four compounds (<b>95</b>–<b>98</b>), there were significant increases in their affinities relative to those of the nonamidotetrazole series (compare <b>98</b> with <b>86</b>, <b>96</b> with <b>85</b>, and <b>97</b> with <b>80</b>; <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Affinities of <b>95</b>, <b>96</b>, <b>97</b>, and <b>98</b> Determined in 1321N1 Astrocytoma Cells Expressing Recombinant NLuc-P2Y<sub>2</sub>R</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center"><i>m</i><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">R<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">NanoBRET p<i>K</i><sub>d</sub><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>95</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">6.05 ± 0.12 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>96</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="center">7.05 ± 0.05 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>97</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">6.89 ± 0.06 (7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>98</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="center">6.32 ± 0.10 (17)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">See <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">A and B correspond to the R groups in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">The p<i>K</i><sub>d</sub> values were derived from saturation binding curves. The data shown are the means ± SEM, and the numbers of separate experiments are given in parentheses.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Pharmacological Evaluation of Third-Generation P2Y<sub>2</sub>R Fluorescent Ligands</h3><div class="NLM_p">To further evaluate the utility of the fluorescent ligands in studying the pharmacology of P2Y<sub>2</sub>R, one BODIPY A and one BODIPY B linked fluorescent ligand (<b>97</b> and <b>98</b>, respectively) were chosen for further studies. Initially, we confirmed that <b>97</b> and <b>98</b> still retained the ability to functionally antagonize P2Y<sub>2</sub>R (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). In a Ca<sup>2+</sup>-mobilization assay, modest rightwards shifts of the agonist-dose–response curves were observed for both 10 μM <b>97</b> (p<i>K</i><sub>b</sub> = 5.69 ± 0.05, <i>n</i> = 8) and 10 μM <b>98</b> (p<i>K</i><sub>b</sub> = 5.87 ± 0.05, <i>n</i> = 7).</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacological evaluations of <b>97</b> and <b>98</b> showing the effects on Ca<sup>2+</sup> mobilization in <i>h</i>P2Y<sub>2</sub>R-1321N1 cells induced by 0.1 μM UTPγS (<i>n</i> = 7 or 8).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>97</b> and <b>98</b> bought about clear concentration-dependent increases in BRET ratios in NLuc-tagged-<i>h</i>P2Y<sub>2</sub>R assays (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). These increases were antagonized by <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>c,d), yielding p<i>K</i>i values of 7.66 ± 0.11 (<i>n</i> = 9) and 7.38 ± 0.04 (<i>n</i> = 6) for the antagonism of <b>97</b> and <b>98</b> binding, respectively.</div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacological evaluations of (a) <b>97</b> and (b) <b>98</b> showing BRET saturation binding (<i>n</i> = 7). Displacement of (c) <b>97</b> (100 nM, <i>n</i> = 9) and (d) <b>98</b> (1 μM, <i>n</i> = 6) binding in NLuc-P2Y<sub>2</sub> 1321N1 cells by <b>1</b>. The values shown are the means ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further evaluate the utility of fluorescent conjugate <b>98</b> in the NanoBRET ligand-binding assay, the affinities of a selection of P2Y<sub>2</sub>R antagonists (<b>1</b>, <b>3</b>, <b>6</b>, <b>22</b>, <b>23</b>, <b>60</b>, and <b>86</b>) and the previously reported stabilized-triphosphate P2Y<sub>2</sub>R antagonist, <b>99</b>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> over a range of P2Y<sub>2</sub>R affinities, were determined in competition binding experiments.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0005.gif" alt="" id="fx5" /></img></div><div class="NLM_p">All eight compounds induced concentration-dependent decreases in the specific binding of <b>98</b>, which enabled their affinities to be determined. There was a good correlation between the values obtained in the NanoBRET assay and those determined in the Ca<sup>2+</sup>-mobilization assay (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). In addition to those of the antagonists, the NanoBRET assay was also used to estimate the affinity of UTPγS. As there have been no reports of radio ligands for P2Y<sub>2</sub>R, this measurement has not previously been possible.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Comparison of the Affinity Estimates Obtained in the Ca<sup>2+</sup>-Mobilization and NanoBRET Assays<a class="ref internalNav" href="#t7fn4" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>b</sub> Ca<sup>2+</sup> mobilization<a class="ref internalNav" href="#t7fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>i</sub> NanoBRET (<b>98</b>)<a class="ref internalNav" href="#t7fn2" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">7.51 ± 0.09 (12)</td><td class="colsep0 rowsep0" align="center">7.38 ± 0.04 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">7.11 ± 0.14 (7)</td><td class="colsep0 rowsep0" align="center">6.89 ± 0.05 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center">5.99 ± 0.03 (7)</td><td class="colsep0 rowsep0" align="center">5.81 ± 0.10 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="center"><5.0 (6)</td><td class="colsep0 rowsep0" align="center">5.28 ± 0.05 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center">6.74 ± 0.10 (6)</td><td class="colsep0 rowsep0" align="center">6.56 ± 0.16 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="center">6.53 ± 0.04 (7)</td><td class="colsep0 rowsep0" align="center">6.84 ± 0.02 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="center">6.30 ± 0.05 (6)</td><td class="colsep0 rowsep0" align="center">6.40 ± 0.01 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99</b></td><td class="colsep0 rowsep0" align="center">6.59 ± 0.12 (3)<a class="ref internalNav" href="#t7fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">7.08 ± 0.03 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">UTPγS</td><td class="colsep0 rowsep0" align="center">ND<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">5.46 ± 0.04 (6)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn4"><div class="footnote" id="t7fn4"><sup><sup>a</sup></sup><p class="last">The data shown are the means ± SEM, and the numbers of separate experiments are given in parentheses.</p></div><div class="footnote" id="t7fn1"><sup><sup>b</sup></sup><p class="last">The estimated affinity value for each antagonist (p<i>K</i><sub>b</sub>) was calculated using the Gaddum equation from the shift of the agonist-dose–response curve brought about by the addition of a single concentration of the antagonist.</p></div><div class="footnote" id="t7fn2"><sup><sup>c</sup></sup><p class="last">Measured in competition binding experiments with fluorescent ligand <b>98</b>.</p></div><div class="footnote" id="t7fn3"><sup><sup>d</sup></sup><p class="last">Reported pA<sub>2</sub> = 8.0.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></p></div><div class="footnote" id="t7fn5"><sup><sup>e</sup></sup><p class="last">ND = not determined due to agonist activity.</p></div></div></div><div class="NLM_p">The availability of both green (<b>98</b>) and red (<b>97</b>) fluorescent P2Y<sub>2</sub>R ligands with reasonable affinities for <i>h</i>P2Y<sub>2</sub>R suggested that they may both have utility in imaging the receptor in living cells. Confocal-microscope images of fluorescent ligands <b>97</b> and <b>98</b> with 1321N1 astrocytoma cells expressing <i>h</i>P2Y<sub>2</sub>R (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a,c) showed localized membrane fluorescence and very little intracellular fluorescence. When the cells were pretreated with <b>1</b>, the membrane-specific fluorescence of <b>97</b> and <b>98</b> was substantially reduced (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>b,d), indicating that the majority of the membrane fluorescence observed was specific labeling of P2Y<sub>2</sub>R.</div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Visualization of the binding of (a,b) <b>97</b> and (c,d) <b>98</b> on astrocytoma cells expressing <i>h</i>P2Y<sub>2</sub>R. The images in the left-hand column (a,c) are confocal image with 100 nM concentrations of the fluorescent ligands, whereas the right-hand column (b,d) shows images of the cells with the fluorescent ligands and 10 μM <b>1</b>. In all of the conditions, the cells were incubated for 30 min at 37 °C in the presence or absence of 10 μM <b>1</b>. Single-equatorial confocal images were then obtained in the continued presence of the fluorescent ligand (<b>97</b> or <b>98</b>) and the unlabeled antagonist. The images shown are from a single experiment representative of the four performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have described the synthesis and evaluation of new examples of acidic <i>h</i>P2Y<sub>2</sub>R antagonists based on the known <i>h</i>P2Y<sub>2</sub>R antagonist, <b>1</b>. In addition, we have shown the discovery of a new series of neutral <i>h</i>P2Y<sub>2</sub>R antagonists and demonstrated SAR leading to the identification of potent <i>h</i>P2Y<sub>2</sub>R antagonists (such as <b>20</b> and <b>23</b>). In addition, we have shown a stereochemical preference for biological activity within this series, as typified by the resolved examples of <b>20</b> versus <b>21</b> and <b>22</b> versus <b>23</b>. Vibrational circular dichroism has suggested that in the case of <b>16</b>, all of the <i>h</i>P2Y<sub>2</sub>R biological activity resides in the (<i>R</i>)-enantiomer (<b>23</b>), although single-crystal X-ray work will be required to confirm this initial stereochemical assignment. The SAR studies led to the identification of suitable linking sites for the attachment of the fluorescent ligands, thus generating three distinct series of fluorescently labeled <i>h</i>P2Y<sub>2</sub>R antagonists. From this extensive synthetic work, two examples (<b>97</b> and <b>98</b>) were identified as demonstrating both functional antagonist activities (in Ca<sup>2+</sup>-mobilization assays) and sufficient affinities for <i>h</i>P2Y<sub>2</sub>R through a new bioluminescence-resonance-energy-transfer (BRET) assay. In addition, confocal microscopy revealed clear, displaceable membrane labeling of astrocytoma cells expressing <i>h</i>P2Y<sub>2</sub>R. These excellent imaging properties make <b>97</b> and <b>98</b> ideal tools for studying <i>h</i>P2Y<sub>2</sub>R distribution and organization. Finally, the discovery of the new <i>h</i>P2Y<sub>2</sub>R-antagonist fluorescent ligands (<b>97</b> and <b>98</b>) became realized as a result of an extensive program of synthetic chemistry, in which it proved essential to explore the parallel changes of linker-attachment points, fluorophores, and linking groups.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> From this study, only a few fluorescent conjugates were shown to possess sufficient affinities to enable the establishment of a new NanoBRET-based fluorescent assay for the identification of new <i>h</i>P2Y<sub>2</sub>R fragments and ligands.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry General Methods</h3><div class="NLM_p">Chemicals and solvents were provided by Fisher Scientific UK, Acros Organics, Sigma-Aldrich, Merck Millipore, or Fluorochem. BODIPYFL-X-NHS (D6102) and BODIPY630/650-X-NHS (D10000) were purchased from Molecular Probes (Invitrogen). All reactions were monitored by TLC using Merck Silica Gel 60 Å F254 TLC plates or by LC-MS. Unless otherwise stated, all compounds were dried under high vacuum either at rt or in an oven at 40 °C. LC-MS data was collected on a Shimadzu UFLCXR HPLC system coupled to an Applied Biosystems API 2000 electrospray-ionization (ESI) LC-MS/MS. The column used was a Phenomenex Gemini-NX (3 μm, 110 Å, C18, 50 × 2 mm), and it was operated at 40 °C. The flow rate was 0.5 mL/min, and UV detection was at 220 and 254 nm. LC-MS method 1 was 5% B for 1 min, 5–98% B over 2 min, 98% B for 2 min, 98–5% B over 0.5 min, and then 5% B for 1 min. LC-MS method 2 was 10% B for 1.5 min, 10–98% B over 8 min, 98% B for 2 min, 98–10% B over 0.5 min, and then 10% B for 1 min. Solvent A was 0.1% formic acid in water, and solvent B was acetonitrile. Unless otherwise stated, the compounds reported had purities >95% at the wavelength and method quoted. HRMS data was collected on a Bruker microTOF II mass spectrometer using electrospray ionization (ESI-TOF). Adducts within errors of ±10 ppm were reported. Preparative RP-HPLC was performed on a Waters 2767 sample manager coupled to Waters 2525 binary-gradient module and a Waters 2457 dual-wavelength absorbance detector. The column used was a Phenomenex Gemini-NX (5 μm, 110 Å, C18, 150 × 21 mm) at ambient temperature. The flow rate was 40 mL/min, and UV detection was at 254 nm. Preparative-RP-HPLC method 3 was 10% B for 1 min, 10–35% B over 4 min, 35–40% B over 20 min, 40–90% B over 2 min, 90–10% B over 2 min, and then 10% B for 1 min. Preparative-RP-HPLC method 4 was 10% B for 1 min, 10–45% B over 4 min, 45–50% B over 20 min, 50–90% B over 2 min, 90–10% B over 2 min, and then 10% B for 1 min. Solvent A was 0.1% trifluoroacetic acid in water, and solvent B was 0.1% trifluoroacetic acid in acetonitrile. Chiral-HPLC was performed on a Dionex ICS-3000 SP single pump coupled to a Rheodyne 9725i PEEKinjector with a Dionex UltiMate 3000 Variable Wavelength Detector. The columns used for the analytical and semipreparative runs were 250 × 4.6 mm and 250 × 10 mm Phenomenex Luxes (5 μm, Amylose-2), respectively. These operated at ambient temperature, and unless otherwise stated, the mobile phase was 25% ethanol/hexane with a flow rate of 1 mL/min for the analytical runs and 5 mL/min for the semipreparative runs. UV detection was at 254 nm. NMR spectroscopy was performed with a Bruker AV(III) HD 400 NMR spectrometer equipped with a 5 mm BBFO+ probe, which recorded the <sup>1</sup>H and <sup>13</sup>C NMR at 400.25 and 100.66 MHz, respectively, or with a Bruker AV(III) 500 NMR spectrometer equipped with a 5 mm dual <sup>1</sup>H/<sup>13</sup>C helium-cooled cryoprobe, which recorded the <sup>1</sup>H and <sup>13</sup>C NMR at 500.13 and 125.77 MHz, respectively. The NMR data was processed using iNMR (version 5.5.7), which referenced the spectra to those of the residual solvents. Chemical shifts (δ) are quoted as values in parts per million, and coupling constants (<i>J</i>) are given in hertz. Multiplicities are described using the following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; qi, quintet; sep, septet; m, multiplet; app, apparent; and br, broad.</div><div class="NLM_p last">All compounds submitted for biological screening had purities >95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure 1: Substitution of 2-Chlorothiazole to Generate 2-Aminothiazoles</h3><div class="NLM_p last">A stirred solution of <b>43</b> (0.15–0.50 mmol) dissolved in anhydrous 1,4-dioxane (0.1 M, 1.5–5.0 mL) was treated with a chosen amine (4 equiv, 0.45–2.00 mmol) and triethyl amine (10 equiv, 1.50–5.00 mmol) under N<sub>2</sub> and either heated to reflux for 36–72 h until completion was observed by TLC or LC-MS or heated in a microwave reactor at 100 °C for 4 h. The reaction mixture was concentrated in vacuo directly onto a silica gel and purified by chromatography on a silica gel (2–5% MeOH/DCM with 0.1% 880 NH<sub>3</sub>) to afford the desired 2-aminothiazoles, <b>45</b>–<b>56</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure 2: Thionation of Uracils to 4-Thiouracils Using Lawesson’s Reagent</h3><div class="NLM_p last">Stirred suspensions or solutions of the uracils (0.05–0.25 mmol) and Lawesson’s reagent (2 stoichiometric equiv/1 molar equiv, 0.05–0.25 mmol) in anhydrous 1,4-dioxane (0.05 M, 1–5 mL) were heated to reflux (120 °C) under N<sub>2</sub> for 18 h, generating deep-yellow-orange solutions. These were allowed to cool to room temperature, and the crude reaction mixtures were concentrated in vacuo onto silica gels, and unless otherwise stated, the title compounds were purified by chromatography on silica gels and eluted with 0–5% MeOH/DCM to afford the desired 4-thiouracils.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure 3: Synthesis of BODIPY-Labeled Fluorescent Conjugates</h3><div class="NLM_p">A solution of a Boc-protected amine (2.00 μmol) dissolved in DCM (0.50 mL) was treated with TFA (0.25 mL) and stirred at rt for 30 min. This was then diluted with toluene (10 mL) and concentrated in vacuo to one-fifth the volume; this was repeated three times before the solution was concentrated to dryness, affording the TFA salt of the conjugate. This was dissolved in DMF (500 μL), treated with DIPEA (25 μL) and then with a solution of BODIPYFL-X-NHS (1.00 mg, 2.00 μmol) in DMF (150 μL), BODIPY630/650-X-NHS (1.32 mg, 2.00 μmol) in DMF (150 μL), BODIPYFL-NHS, or BODIPY630/650-NHS; the latter two were generated in situ by mixing BODIPYFL-CO<sub>2</sub>H X (0.78 mg, 2.00 μmol) or BODIPY630/650-CO<sub>2</sub>H (0.90 mg, 2.00 μmol) with HATU (0.76 mg, 2.00 μmol), NHS (0.23 mg, 2.00 μmol), and DIPEA (25 μL) in DMF (150 μL) for 30 min before they were added. The solution was then allowed to react at room temperature in the absence of light for 1–4 h until completion was observed by LC-MS. The desired fluorescent conjugate was then purified directly from the reaction mixture by preparative reverse-phase HPLC and lyophilization.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-((5-(2,8-Dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-(1<i>H</i>-tetrazol-5-yl)thiazole-4-carboxamide (<b>3</b>)</h4><div class="NLM_p last">PyBroP (0.046 g, 0.1 mmol) was added to a stirred solution of 2-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)thiazole-4-carboxylic acid (<b>2</b>, 0.04 g, 0.082 mmol), 5-aminotetrazole monohydrate (0.018 g, 0.18 mmol), and triethylamine (0.036 g, 0.36 mmol) in DMF (1 mL). After 10 min, the reaction mixture was partitioned between 1 M hydrochloric acid and ethyl acetate. The ethyl acetate solution was washed with water and brine and evaporated to dryness. Purification was by silica-gel chromatography eluted with ethyl acetate/methanol/acetic acid (93:5:2). Yield: 0.025 g, 0.049 mmol, 49% (yellow solid). <sup>1</sup>H NMR (400 MHz, DMSO) δ: 12.73 (s, 1H), 12.17 (s, 1H), 11.96 (s, 1H), 8.74 (s, 1H), 7.46 (d, <i>J</i> = 7.8 Hz, 2H), 7.14 (ddd, <i>J</i> = 7.7, 1.9, 0.8 Hz, 2H), 7.10 (s, 2H), 7.08 (s, 1H), 6.75 (s, 2H), 5.75 (s, 1H), 5.25 (s, 2H), 2.23 (s, 6H). Rt: 3.02 (254 nm); (<i>m</i>/<i>z</i>): 555.0 (M+1).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 5-(2,8-Dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>4</b>)</h4><div class="NLM_p last">Compound <b>4</b> was prepared using the procedures for <b>34</b> and <b>6</b> with 5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (0.14 g, 0.42 mmol). Yield: 0.08 g, 0.2 mmol, 48% over the two steps (yellow solid). <sup>1</sup>H NMR (400 MHz, DMSO) δ: 12.53 (s, 1H), 7.47 (d, <i>J</i> = 7.8 Hz, 2H), 7.20 (s, 2H), 7.16 (ddd, <i>J</i> = 7.8, 1.9, 0.8 Hz, 2H), 7.01 (s, 1H), 6.95 (s, 2H), 5.82 (s, 1H), 3.17 (s, 3H), 2.29 (s, 6H). Rt: 2.87 (254 nm); (<i>m</i>/<i>z</i>): 361.4 (M+1)</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-((5-(7-Chloro-2-methyl-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-(1<i>H</i>-tetrazol-5-yl)thiazole-4-carboxamide (<b>5</b>)</h4><div class="NLM_p last">A stirred solution of <b>36</b> (65 mg, 0.120 mmol) in MeOH (10 mL) was treated with 2 M NaOH (0.18 mL, 0.36 mmol) and heated to reflux for 30 min under N<sub>2</sub>. Completion was observed by TLC, and the RM was concentrated to one-third the volume, diluted with ethyl acetate (20 mL), washed with 1 M HCl (10 mL) and brine (10 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford the corresponding acid as an orange solid (60 mg). A stirred solution of the acid (30 mg, 0.058 mmol) in DMF (3 mL) was treated with DIPEA (40 μL) and 5-aminotetrazole monohydrate (12 mg, 0.117 mmol) followed by PyBroP (41 mg, 0.087 mmol) and stirred at rt for 2 h until completion was observed by LC-MS. The RM was quenched with water (ca. two drops), diluted with ethyl acetate (20 mL), and partitioned with 1 M HCl (10 mL); the organics were extracted with ethyl acetate (2 × 10 mL), combined, washed with brine (10 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The DMF was azeotroped with toluene (3 × 50 mL) to afford an orange oil. This was purified by being washed with 10% MeOH/DCM before the desired compound was eluted with 10% MeOH/DCM and 1% acetic acid to afford the title compound, <b>5</b>, as an orange solid (10 mg, 0.017 mmol, 30%). LC-MS (ESI+) Rt: 2.79 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 581.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>23</sub>H<sub>15</sub>ClN<sub>9</sub>O<sub>2</sub>S<sub>3</sub>, 580.0205; found, 580.0186. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.90 (s, 1H), 8.50 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.66 (s, 1H), 7.50 (d, <i>J</i> = 2.3 Hz, 1H), 7.42 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 7.06 (s, 2H), 6.53 (s, 1H), 5.36 (d, <i>J</i> = 15.7 Hz, 1H), 5.30 (d, <i>J</i> = 15.7 Hz, 1H), 2.59 (s, 3H). N.B., −CONH and tetrazole-NH were not observed.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 5-(7-Chloro-2-methyl-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>6</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>34</b> (60 mg, 0.161 mmol) was converted to the title compound, <b>6</b>, which was isolated at 1% MeOH/DCM as a yellow solid (25 mg, 0.065 mmol, 40%). LC-MS (ESI+) Rt: 2.85 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 388.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.39 (s, 1H), 7.70 (d, <i>J</i> = 8.3 Hz, 1H), 7.38 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.35 (d, <i>J</i> = 2.1 Hz, 1H), 7.19 (s, 1H), 6.95 (d, <i>J</i> = 11.6 Hz, 1H), 6.91 (d, <i>J</i> = 11.6 Hz, 1H), 6.22 (s, 1H), 3.33 (s, 3H), 2.72 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ: 188.4, 166.9, 151.1, 147.9, 140.4, 135.7, 134.0, 132.7, 132.5, 130.7, 129.9, 129.3, 129.1, 120.3, 119.2, 45.9, 37.0, 19.4.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-(2-Amino-7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>7</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>45</b> (45 mg, 0.121 mmol) was converted to the title compound, <b>7</b>, and isolated at 2% MeOH/DCM as a yellow solid (4.8 mg, 0.012 mmol, 10%). LC-MS (ESI+) Rt: 2.51 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 389.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-(7-Chloro-2-(phenylamino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>8</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>46</b> (45 mg, 0.100 mmol) was converted to the title compound, <b>8</b>, which was isolated at 2% MeOH/DCM as a yellow solid (39 mg, 0.084 mmol, 84%). LC-MS (ESI+) Rt: 3.06 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 465.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.73 (s, 1H), 10.38 (s, 1H), 7.94 (s, 1H), 7.59 (dd, <i>J</i> = 8.7, 1.1 Hz, 2H), 7.55 (d, <i>J</i> = 8.7 Hz, 1H), 7.51 (d, <i>J</i> = 2.3 Hz, 1H), 7.39 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.6, 7.4 Hz, 2H), 7.03 (d, <i>J</i> = 11.7 Hz, 1H), 7.00 (d, <i>J</i> = 11.7 Hz, 1H), 7.02–6.98 (m, 1H), 5.74 (s, 1H), 3.39 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.4, 164.0, 155.2, 148.5, 148.4, 144.5, 141.0, 137.6, 134.7, 130.9, 129.5, 128.9, 128.5, 128.2, 122.4, 122.3, 118.2, 117.8, 117.4, 44.7, 37.3.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 5-(2-(Benzylamino)-7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>9</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>47</b> (30 mg, 0.065 mmol) was converted to the title compound, <b>95</b>, which was isolated at 2% MeOH/DCM as a yellow solid (25 mg, 0.053 mmol, 81%). LC-MS (ESI+) Rt: 3.01 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 478.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.65 (s, 1H), 8.42 (t, <i>J</i> = 5.8 Hz, 1H), 7.63 (s, 1H), 7.54 (d, <i>J</i> = 8.5 Hz, 1H), 7.44 (d, <i>J</i> = 2.3 Hz, 1H), 7.34–7.30 (m, 5H), 7.27–7.24 (m, 1H), 6.86 (s, 2H), 5.69 (s, 1H), 4.48 (dd, <i>J</i> = 15.3, 5.9 Hz, 1H), 4.41 (dd, <i>J</i> = 15.3, 5.6 Hz, 1H), 3.26 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.2, 169.5, 148.8, 148.5, 143.5, 139.0, 137.6, 134.2, 131.8, 130.8, 129.01, 128.84, 127.93, 127.90, 127.6, 126.9, 122.7, 117.5, 117.0, 48.1, 45.1, 37.2.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 5-(7-Chloro-2-(phenethylamino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>10</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>48</b> (35 mg, 0.071 mmol) was converted to the title compound, <b>10</b>, at 2% MeOH/DCM as a yellow solid (21 mg, 0.043 mmol, 60%). LC-MS (ESI+) Rt: 3.03 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 492.8 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.67 (s, 1H), 8.04 (t, <i>J</i> = 5.4 Hz, 1H), 7.64 (s, 1H), 7.57 (d, <i>J</i> = 8.6 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 7.32–7.24 (m, 4H), 7.22–7.18 (m, 1H), 6.87 (s, 2H), 5.72 (s, 1H), 3.52–3.45 (m, 2H), 3.27 (s, 3H), 2.87 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.2, 169.3, 148.5, 143.5, 142.4, 139.7, 137.6, 134.1, 131.9, 130.8, 129.14, 129.01, 128.8, 127.9, 126.73, 126.61, 122.7, 117.6, 116.6, 46.1, 45.2, 37.2, 35.1.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-(7-Chloro-2-(4-methylpiperazin-1-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>11</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>49</b> (47 mg, 0.103 mmol) was converted to the title compound, <b>11</b>, which was isolated at 5% MeOH/DCM with 0.1% 880 NH<sub>3</sub> as a yellow solid (4.5 mg, 0.0095 mmol, 9%). LC-MS (ESI+) Rt: 2.28 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 472.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.67 (s, 1H), 7.61 (d, <i>J</i> = 8.5 Hz, 1H), 7.54 (s, 1H), 7.47 (d, <i>J</i> = 2.3 Hz, 1H), 7.36 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 6.94 (d, <i>J</i> = 11.6 Hz, 1H), 6.91 (d, <i>J</i> = 11.7 Hz, 1H), 5.79 (s, 1H), 3.46–3.41 (m, 4H), 3.28 (s, 3H), 2.47–2.42 (m, 4H), 2.27 (s, 3H).</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-(7-Chloro-2-morpholino-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>12</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>50</b> (44 mg, 0.100 mmol) was converted to the title compound, <b>12</b>, which was isolated at 2% MeOH/DCM as a yellow solid (20 mg, 0.044 mmol, 44%). LC-MS (ESI+) Rt: 2.94 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 459.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.66 (s, 1H), 7.59 (d, <i>J</i> = 8.5 Hz, 1H), 7.56 (s, 1H), 7.46 (d, <i>J</i> = 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.95 (d, <i>J</i> = 11.6 Hz, 1H), 6.91 (d, <i>J</i> = 11.7 Hz, 1H), 5.77 (s, 1H), 3.69 (t, <i>J</i> = 4.9 Hz, 4H), 3.39 (t, <i>J</i> = 4.8 Hz, 4H), 3.28 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.2, 171.3, 149.2, 148.5, 143.3, 137.4, 134.1, 132.2, 131.0, 129.2, 128.0, 127.6, 122.4, 118.5, 117.3, 65.8, 48.3, 45.4, 37.2.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-(7-Chloro-2-(piperidin-1-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>13</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>51</b> (44 mg, 0.100 mmol) was converted to the title compound, <b>13</b>, which was isolated at 2% MeOH/DCM as a yellow solid (34 mg, 0.074 mmol, 74%). LC-MS (ESI+) Rt: 3.14 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 456.8 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.65 (s, 1H), 7.60 (d, <i>J</i> = 8.5 Hz, 1H), 7.51 (s, 1H), 7.44 (d, <i>J</i> = 2.3 Hz, 1H), 7.34 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.90 (d, <i>J</i> = 11.6 Hz, 1H), 6.87 (d, <i>J</i> = 11.7 Hz, 1H), 5.76 (s, 1H), 3.40 (s, 4H), 3.27 (s, 3H), 1.57 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.2, 171.0, 149.5, 148.5, 143.1, 137.4, 133.9, 132.4, 130.9, 129.2, 127.9, 127.0, 122.4, 117.8, 117.3, 49.2, 45.5, 37.2, 25.1, 23.9.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-(7-Chloro-2-((2-methoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>14</b>)</h4><div class="NLM_p">Following general procedure 2, <b>52</b> (40 mg, 0.093 mmol) was converted to the title compound, <b>14</b>, at 2% MeOH/DCM as a yellow solid (14 mg, 0.031 mmol, 34%). LC-MS (ESI+) Rt: 2.74 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 446.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.65 (s, 1H), 8.00 (t, <i>J</i> = 5.4 Hz, 1H), 7.63 (s, 1H), 7.55 (d, <i>J</i> = 8.5 Hz, 1H), 7.44 (d, <i>J</i> = 2.3 Hz, 1H), 7.33 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.86 (s, 2H,), 5.68 (s, 1H), 3.49–3.46 (m, 2H), 3.43–3.39 (m, 2H), 3.28 (s, 3H), 3.26 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.2, 169.4, 148.8, 148.5, 143.5, 137.6, 134.1, 130.8, 129.0, 127.8, 126.8, 122.7, 117.4, 116.7, 70.6, 58.4, 45.2, 44.2, 37.2.</div><div class="NLM_p last">The two enantiomers were isolated by chiral-HPLC: <b>20</b> (Rt: 34.46 min, 99% ee) and <b>21</b> (Rt: 43.43 min, 78% ee).</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-(7-Chloro-2-((3-methoxypropyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>15</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>53</b> (36 mg, 0.080 mmol) was converted to the title compound, <b>15</b>, which was isolated at 2% MeOH/DCM as a yellow solid (35 mg, 0.076 mmol, 95%). LC-MS (ESI+) Rt: 2.75 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 461.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.66 (s, 1H), 7.94 (t, <i>J</i> = 5.5 Hz, 1H), 7.65 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.87 (s, 2H), 5.70 (s, 1H), 3.38 (t, <i>J</i> = 6.2 Hz, 2H), 3.30 (s, 3H), 3.28–3.24 (m, 2H), 3.23 (s, 3H), 1.78 (app.qi, <i>J</i> = 6.6 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.2, 169.5, 149.0, 148.5, 143.4, 137.6, 134.1, 130.8, 129.0, 127.8, 126.7, 122.7, 117.5, 116.5, 110.0, 69.8, 58.4, 45.2, 41.9, 37.2, 29.2.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-(7-Chloro-2-((2-ethoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>16</b>)</h4><div class="NLM_p">Following general procedure 2, <b>54</b> (36 mg, 0.080 mmol) was converted to the title compound, <b>16</b>, which was isolated at 2% MeOH/DCM as a yellow solid (34 mg, 0.074 mmol, 92%). LC-MS (ESI+) Rt: 2.81 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 461.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.66 (s, 1H), 8.00 (t, <i>J</i> = 5.5 Hz, 1H), 7.64 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.87 (s, 2H), 5.70 (s, 1H), 3.53–3.50 (m, 2H), 3.45 (q, <i>J</i> = 7.0 Hz, 2H), 3.43–3.38 (m, 2H), 3.30 (s, 3H), 1.11 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.3, 169.4, 148.8, 148.5, 143.5, 137.6, 134.1, 132.0, 130.8, 129.0, 127.8, 126.7, 122.7, 117.5, 116.7, 68.5, 65.9, 45.2, 44.5, 37.2, 15.6.</div><div class="NLM_p last">The two enantiomers were isolated by chiral-HPLC: <b>22</b> (Rt: 28.32 min, 95% ee) and <b>23</b> (Rt: 36.68 min, 96% ee).</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-(7-Chloro-2-((2-isopropoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>17</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>55</b> (37 mg, 0.080 mmol) was converted to the title compound, <b>17</b>, which was isolated at 2% MeOH/DCM as a yellow solid (30 mg, 0.063 mmol, 79%). LC-MS (ESI+) Rt: 2.88 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 475.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.66 (s, 1H), 7.97 (t, <i>J</i> = 5.4 Hz, 1H), 7.63 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.87 (s, 2H), 5.70 (s, 1H), 3.57 (sep., <i>J</i> = 6.1 Hz, 1H), 3.52–3.49 (m, 2H), 3.39–3.37 (m, 2H), 3.30 (s, 3H), 1.08 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.2, 169.4, 148.5, 143.5, 137.6, 134.1, 132.0, 130.8, 129.0, 127.9, 126.7, 122.7, 117.5, 116.7, 71.3, 66.0, 45.2, 44.9, 37.2, 22.51, 22.48.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 5-(7-Chloro-2-((2-phenoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>56</b> (39 mg, 0.080 mmol) was converted to the title compound, <b>18</b>. This was isolated at 2% MeOH/DCM, and further purification was achieved by preparative RP-HPLC (Method 3), which isolated the title compound, <b>18</b>, at a retention time of 18.57 min. This compound was freeze-dried to an orange solid (8 mg, 0.016 mmol, 20%). LC-MS (ESI+) Rt: 3.02 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 509.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.66 (s, 1H), 8.20 (t, <i>J</i> = 5.3 Hz, 1H), 7.63 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 2.2 Hz, 1H), 7.35 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 7.29 (app.t, <i>J</i> = 8.0 Hz, 2H), 6.97–6.92 (m, 3H), 6.88 (s, 2H), 5.72 (s, 1H), 4.13 (t, <i>J</i> = 5.4 Hz, 2H), 3.64 (app.q, <i>J</i> = 5.4 Hz, 2H), 3.27 (s, 3H).</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-(7-Chloro-2-phenyl-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methyl-4-thioxo-3,4-dihydropyrimidin-2(1<i>H</i>)-one (<b>19</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>44</b> (15 mg, 0.035 mmol) was converted to the title compound, <b>19</b>, which was purified by FC (20–50% ethyl acetate/petroleum ether) and isolated at 50% ethyl acetate/petroleum ether as a yellow solid (12 mg, 0.027 mmol, 76%). LC-MS (ESI+) Rt: 3.20 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 450.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. LC-MS (ESI+) Rt: 6.99 min (254 nm, Method 2); (<i>m</i>/<i>z</i>): 450.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.76 (s, 1H), 7.96–7.94 (m, 2H), 7.88 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.58 (d, <i>J</i> = 2.1 Hz, 1H), 7.53–7.49 (m, 3H), 7.45 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.27 (d, <i>J</i> = 11.6 Hz, 1H), 7.22 (d, <i>J</i> = 11.8 Hz, 1H), 6.04 (s, 1H), 3.37 (s, 3H).. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.3, 167.2, 152.5, 148.5, 144.1, 137.0, 135.4, 133.2, 131.60, 131.50, 131.36, 131.1, 129.90, 129.79, 129.61, 129.0, 126.5, 122.0, 117.2, 45.0, 37.2.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-((5-(7-Chloro-2-((2-methoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-(1<i>H</i>-tetrazol-5-yl)thiazole-4-carboxamide (<b>24</b>)</h4><div class="NLM_p last">A stirred solution of <b>59</b> (140 mg, 0.23 mmol) in MeOH (10 mL) was treated with 2 M NaOH (0.35 mL, 0.69 mmol) and heated to reflux for 1 h under N<sub>2</sub>. Completion was observed by TLC, and the crude was evaporated directly onto silica, purified by FC, and washed with 5% MeOH/DCM before the desired compound was eluted with 20% MeOH/DCM with 1% acetic acid to afford a yellow solid. This was dissolved in EA (20 mL), washed with 1 M HCl (10 mL) and brine (10 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford the corresponding carboxylic acid as an orange solid (120 mg, 0.20 mmol, 91%). LC-MS (ESI+) Rt: 2.68 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 573.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. The acid (20 mg, 0.035 mmol) in DMF (1.5 mL) was treated with DIPEA (50 μL) and 5-aminotetrazole monohydrate (22 mg, 0.203 mmol) followed by PyBroP (24 mg, 0.051 mmol) and stirred at rt for 2 h until completion was observed by LC-MS. The RM was quenched with water (ca. two drops), diluted with EA (20 mL), and partitioned with 1 M HCl (10 mL), and the organics were extracted with EA (2 × 10 mL), combined, washed with brine (10 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The DMF was azeotroped with toluene (3 × 50 mL) to afford an orange oil. This was purified by being washed with 10% MeOH/DCM before the desired compound was eluted with 10% MeOH/DCM with 1% acetic acid to afford the title compound. Further purification was achieved by preparative RP-HPLC (Method 3), isolating the title compound, <b>24</b>, at a retention time of 7.37 min. This compound was freeze-dried to an orange solid (8 mg, 0.016 mmol, 34%). LC-MS (ESI+) Rt: 2.71 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 640.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. LC-MS (ESI+) Rt: 5.12 min (254 nm, Method 2); (<i>m</i>/<i>z</i>): 640.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>25</sub>H<sub>20</sub>ClN<sub>10</sub>O<sub>3</sub>S<sub>3</sub>, 639.0576; found, 639.0569. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.89 (s, 1H), 12.30–12.23 (m, 1H), 8.74 (s, 1H), 7.98 (t, <i>J</i> = 4.9 Hz, 1H), 7.76 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.40 (d, <i>J</i> = 2.2 Hz, 1H), 7.34 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.76 (s, 2H), 5.67 (s, 1H), 5.45 (d, <i>J</i> = 16.0 Hz, 1H), 5.30 (d, <i>J</i> = 16.0 Hz, 1H), 3.42–3.33 (m, 4H), 3.22 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.8, 176.9, 169.4, 165.9, 159.4, 148.0, 141.9, 137.5, 133.7, 131.2, 130.8, 129.44, 129.35, 128.9, 128.7, 127.8, 126.7, 122.6, 117.7, 116.7, 70.6, 58.3, 49.4, 46.3, 44.1.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-(3-Chlorophenyl)propanal (<b>26</b>)</h4><div class="NLM_p last">A stirred solution of 3-chloroiodobenzene (50.00 g, 210 mmol), allyl alcohol (21.4 mL, 18.27 g, 314 mmol), tetrabutylammonium chloride (58.26 g, 210 mmol), and NaHCO<sub>3</sub> (17.61 g, 210 mmol) dissolved in anhydrous DMF (150 mL) and cooled in an ice bath under N<sub>2</sub> was treated portionwise with Pd(OAc)<sub>2</sub> (1.40 g, 6.29 mmol) over 30 min. This was then heated to 50 °C for 18 h, and the consumption of 3-chloroiodobenzene was observed by TLC (15% ethyl acetate/petroleum ether). The reaction was concentrated in vacuo, and the DMF was azeotroped with toluene (3 × 200 mL). The resulting black gum was dissolved in Et<sub>2</sub>O (300 mL) and water (300 mL) and filtered, and the organics were extracted with Et<sub>2</sub>O (2 × 300 mL), combined, washed with brine (100 mL), dried over MgSO<sub>4</sub>, and concentrated in vacuo to afford a black oil. Further purification was achieved by FC (10–40% Et<sub>2</sub>O/PE), to afford the title compound, <b>27</b> (32.30 g, 192 mmol, 92%). LC-MS (ESI+) Rt: 2.72 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): not observed. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.81 (t, <i>J</i> = 1.2 Hz, 1H), 7.22–7.17 (m, 3H), 7.07 (dt, <i>J</i> = 7.1, 1.6 Hz, 1H), 2.93 (t, <i>J</i> = 7.4 Hz, 2H), 2.80–2.76 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ: 200.9, 142.5, 134.3, 129.9, 128.5, 126.6, 126.51, 44.9, 27.7.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Ethyl 5-(3-Chlorophenethyl)-2-methylthiazole-4-carboxylate (<b>27</b>)</h4><div class="NLM_p last">A stirred solution of <b>26</b> (24.00 g, 143 mmol) and ethyl dichloroacetate (22.42 g, 143 mmol) dissolved in anhydrous diethyl ether (120 mL) and cooled to below −10 °C in an ice–salt bath under N<sub>2</sub> was treated with a freshly prepared solution of sodium ethoxide (2.2 M, 50 mL, 110 mmol) over a 15 min period, and we ensured that the temperature did not rise above 0 °C. This generated a pale-orange suspension. This was stirred for 45 min and then warmed to 40 °C over 30 min. This was then quenched with water (250 mL), and the organics were extracted with diethyl ether (3 × 150 mL). These were combined, washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford to afford an orange oil. This was dissolved in ethanol (80 mL) and added dropwise to a warm solution of thioacetamide (16.09 g, 214 mmol) in ethanol (80 mL) that had been heated to 65 °C over a 10 min period. This was heated to reflux for 3 h, generating a red solution with a white precipitate, which was allowed to cool to rt and concentrated in vacuo. The residue was then diluted with diethyl ether (200 mL) and partitioned with NaHCO<sub>3</sub> (100 mL) and water (100 mL). The organics where extracted with diethyl ether (3 × 200 mL), combined, washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford a brown oil. This was purified by FC (10–30% ethyl acetate/petroleum ether) to afford the title compound, <b>27</b>, at 15% ethyl acetate/petroleum ether as a yellow solid (13.21 g, 42.7 mmol, 30%). LC-MS (ESI+) Rt: 3.04 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 310.0 [M(<sup>35</sup>Cl)+H]<sup>+ 1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.21–7.19 (m, 3H), 7.08–7.06 (m, 1H), 4.42 (q, <i>J</i> = 7.1 Hz, 2H), 3.48 (t, <i>J</i> = 7.8 Hz, 2H), 2.95 (t, <i>J</i> = 7.8 Hz, 2H), 2.67 (s, 3H), 1.41 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ: 162.5, 162.2, 148.4, 142.3, 140.6, 134.2, 129.7, 128.6, 126.73, 126.59, 61.2, 37.0, 28.8, 19.3, 14.5.</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 5-(3-Chlorophenethyl)-2-methylthiazole-4-carboxylic Acid (<b>28</b>)</h4><div class="NLM_p last">A stirred solution of <b>27</b> (13.00 g, 42.0 mmol) in THF (60 mL) was treated with a solution of NaOH (2.52g, 63.0 mmol) in water (60 mL). This was stirred for 24 h at rt and treated with 2 M HCl (100 mL), and the organics were extracted with ethyl acetate (3 × 100 mL), combined, washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford the title compound, <b>28</b>, as a pale-yellow solid (11.68 g, 41.4 mmol, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.38–9.07 (br.s, 1H), 7.25–7.19 (m, 3H), 7.10 (dt, <i>J</i> = 6.5, 1.9 Hz, 1H), 3.52 (t, <i>J</i> = 7.8 Hz, 2H), 2.98 (t, <i>J</i> = 7.8 Hz, 2H), 2.69 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ: 163.2, 149.6, 142.0, 139.6, 134.3, 129.8, 128.7, 126.8, 126.7, 36.8, 28.8, 18.9.</div></div><div id="sec4_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 7-Chloro-2-methyl-9,10-dihydro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-one (<b>29</b>)</h4><div class="NLM_p last">A stirred solution of <b>28</b> (11.27 g, 40 mmol) in DCM (120 mL) under N<sub>2</sub> was treated with oxalyl chloride (6.00 mL, 70 mmol) and catalytic DMF (ca. two drops) and stirred for 3 h at rt. This was then concentrated in vacuo. The residual oxalyl chloride was azeotroped with toluene (3 × 50 mL) to afford an orange solid. This was dissolved in DCM (175 mL), cooled in an ice bath under N<sub>2</sub>, and treated portionwise with aluminum(III)chloride (21.33 g, 160 mmol), generating a black solution. This was allowed to warm to rt and was stirred for 18 h. This was gradually added to a stirred slurry of ice and 2 M HCl (400 mL) and allowed to warm to rt. The organics were extracted with ethyl acetate (3 × 400 mL), combined, washed with brine (300 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford a crude solid. This was purified by FC (20–100% ethyl acetate/petroleum ether) to afford the title compound, <b>29</b>, at 50% ethyl acetate/petroleum ether as a beige solid (4.16 g, 15.6 mmol, 39%). LC-MS (ESI+) Rt: 2.70 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 264.1 [M(<sup>35</sup>Cl)+H]<sup>+ 1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.77 (d, <i>J</i> = 8.4 Hz, 1H), 7.54 (d, <i>J</i> = 2.1 Hz, 1H), 7.48 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 3.28–3.25 (m, 2H), 3.21–3.18 (m, 2H), 2.63 (s, 3H).</div></div><div id="sec4_4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 5-Bromo-2,4-di-<i>tert</i>-butoxypyrimidine (<b>31</b>)</h4><div class="NLM_p last">To a stirred solution of 5-bromo-2,4-dichloropyrimidine (5.00 g, 22.00 mmol) in anhydrous THF (70 mL) cooled in an ice bath under N<sub>2</sub>, a suspension of sodium <i>tert</i>-butoxide (6.35 g, 66.0 mmol) in anhydrous THF (50 mL) was added dropwise via a dropping funnel over a 30 min period. This was allowed to warm to rt and was stirred for a further 18 h, generating a dark-brown solution. The RM was then quenched with NH<sub>4</sub>Cl(aq) (10 mL) and diluted with water (100 mL), and the organics were extracted with ethyl acetate (3 × 75 mL), combined, washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford a black oil. Further purification was achieved by FC (2.5% diethyl ether/petroleum ether with 0.1% Et<sub>3</sub>N) to afford the title compound, <b>31</b>, as a clear oil that crystallized to a white solid on standing (4.08 g, 13.50 mmol, 61%). LC-MS (ESI+) Rt: 3.32 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 305.2 [M(<sup>81</sup>Br)+H]<sup>+</sup>, 303.2 [M(<sup>79</sup>Br)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.24 (s, 1H), 1.64 (s, 9H), 1.59 (s, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ: 165.7, 163.0, 159.0, 99.6, 83.3, 80.8, 28.3, 28.3.</div></div><div id="sec4_4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 7-Chloro-4-(2,4-di-<i>tert</i>-butoxypyrimidin-5-yl)-2-methyl-9,10-dihydro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-ol (<b>32</b>)</h4><div class="NLM_p last">A stirred solution of <b>31</b> (3.03 g, 10.00 mmol) in unstabilized, anhydrous THF (80 mL) under N<sub>2</sub> was cooled to −78 °C, treated dropwise with a solution of <i>n</i>-butyllithium (2.46 M in hexane, 4.1 mL, 10.50 mmol), and stirred for 30 min, generating a dark-orange solution. This was then treated dropwise with a solution of <b>29</b> (2.64 g, 10.00 mmol) that had been dissolved in unstabilized, anhydrous THF (20 mL); stirred at −78 °C for 15 min; allowed to warm to rt; and stirred again for 1 h. The RM was then quenched with NH<sub>4</sub>Cl (50 mL) and diluted with water (50 mL), and the organics were extracted with ethyl acetate (3 × 100 mL). These were combined, washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford an orange oil. Further purification was achieved by FC (5–20% ethyl acetate/petroleum ether) affording the title compound, <b>32</b>, at 15% ethyl acetate/petroleum ether as a clear oil that foamed and crystallized to a white solid under high vacuum (3.04 g, 6.23 mmol, 65%). LC-MS (ESI+) Rt: 3.36 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 488.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.88 (s, 1H), 7.38 (d, <i>J</i> = 8.5 Hz, 1H), 7.33 (d, <i>J</i> = 2.3 Hz, 1H), 7.24 (dd, <i>J</i> = 8.5, 2.4 Hz, 1H), 6.13 (s, 1H), 3.25–3.18 (m, 1H), 2.97–2.94 (m, 2H), 2.87–2.80 (m, 1H), 2.53 (s, 3H), 1.56 (s, 9H), 1.18 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.0, 163.2, 160.2, 156.1, 151.7, 143.3, 141.4, 131.84, 131.67, 129.37, 129.24, 125.8, 122.1, 81.2, 80.0, 75.3, 31.8, 28.6, 28.1, 26.9, 19.0.</div></div><div id="sec4_4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 5-(7-Chloro-2-methyl-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>33</b>)</h4><div class="NLM_p last">A stirred solution of 32 (1.54 mmol, 0.750 g) in trifluoroacetic acid (20 mL) was heated to reflux under N<sub>2</sub> for 72 h, generating a black solution. This was concentrated in vacuo to give a dark-red gum, which was triturated with Et<sub>2</sub>O (3 × 10 mL) to give an orange solid (454 mg). This was purified by FC (2–10% MeOH/DCM with 0.1% 880 NH<sub>3</sub>) to afford the title compound, <b>33</b>, at 4% MeOH/DCM with 0.1% 880 NH<sub>3</sub> as a pink solid (200 mg, 0.56 mmol, 36%). LC-MS (ESI+) Rt: 2.80 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 358.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.07 (s, 1H), 10.57 (d, <i>J</i> = 6.1 Hz, 1H), 7.53 (d, <i>J</i> = 8.3 Hz, 1H), 7.53 (d, <i>J</i> = 2.2 Hz, 1H), 7.45 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.08 (d, <i>J</i> = 11.7 Hz, 1H), 7.01 (d, <i>J</i> = 11.7 Hz, 1H), 6.66 (d, <i>J</i> = 5.5 Hz, 1H), 5.50 (s, 1H), 2.64 (s, 3H).</div></div><div id="sec4_4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 5-(7-Chloro-2-methyl-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>34</b>)</h4><div class="NLM_p last">A stirred suspension of <b>33</b> (100 mg, 0.28 mmol) in DCM (15 mL) under N<sub>2</sub> was treated with <i>N</i>,<i>O</i>-bis(trimethylsilyl)trifluoroacetamide (0.3 mL, 287 mg, 1.18 mmol) and heated to reflux for 18 h. This was cooled, treated with iodomethane (1.5 mL), and heated to 50 °C for 24 h until completion was observed by LC-MS. This was concentrated in vacuo to afford an oil, which was dissolved in MeOH and reconcentrated in vacuo to afford a solid. This was purified by FC (1–4% MeOH/DCM with 0.1% 880 NH<sub>3</sub>) to afford the title compound, <b>34</b>, at 2% MeOH/DCM with 0.1% 880 NH<sub>3</sub> (64 mg, 0.17 mmol, 61%). LC-MS (ESI+) Rt: 2.64 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 372.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.26 (s, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 7.51 (d, <i>J</i> = 2.2 Hz, 1H), 7.44 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.07 (d, <i>J</i> = 11.7 Hz, 1H), 7.01 (d, <i>J</i> = 11.7 Hz, 1H), 6.90 (s, 1H), 5.52 (s, 1H), 3.15 (s, 3H), 2.65 (s, 3H).</div></div><div id="sec4_4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Ethyl 2-((5-(7-Chloro-2-methyl-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)thiazole-4-carboxylate (<b>35</b>)</h4><div class="NLM_p last">A stirred suspension of <b>33</b> (160 mg, 0.28 mmol) in 1,2-dichloroethane (10 mL) was treated with <i>N</i>,<i>O</i>-bis(trimethylsilyl)trifluoroacetamide (0.3 mL, 1.18 mmol) and heated to reflux for 18 h under N<sub>2</sub>. This was then treated with ethyl 5-(bromomethyl)thiophene-3-carboxylate (104 mg, 0.42 mmol), dissolved in 1,2-dichloroethane (5 mL), and refluxed for 48 h. This was concentrated in vacuo to a gum, treated with MeOH (20 mL), and then reconcentrated in vacuo to a solid. This was purified by chromatography on a silica gel (1–5% MeOH/DCM) to afford the title compound, <b>35</b>, at 3% MeOH/DCM (84 mg, 0.16 mmol, 57%). LC-MS (ESI+) Rt: 2.82 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 526.9 [M(<sup>35</sup>Cl)+H]<sup>+ 1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.28–8.25 (br.s, 1H), 8.22 (s, 1H), 7.56 (d, <i>J</i> = 8.3 Hz, 1H), 7.38 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.29 (d, <i>J</i> = 2.3 Hz, 1H), 6.87 (s, 1H), 6.84 (d, <i>J</i> = 11.6 Hz, 1H), 6.75 (d, <i>J</i> = 11.7 Hz, 1H), 5.79 (s, 1H), 5.21 (d, <i>J</i> = 15.2 Hz, 1H), 4.98 (d, <i>J</i> = 15.2 Hz, 1H), 4.51 (q, <i>J</i> = 7.1 Hz, 2H), 2.71 (s, 3H), 1.48 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Ethyl 2-((5-(7-Chloro-2-methyl-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)thiazole-4-carboxylate (<b>36</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>35</b> (80 mg, 0.151 mmol) was converted to the title compound, <b>36</b>, at 2% MeOH/DCM as a yellow solid (68 mg, 0.125 mmol, 89%). LC-MS (ESI+) Rt: 3.01 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 542.8 [M(<sup>35</sup>Cl)+H]<sup>+ 1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.63 (s, 1H), 8.24 (s, 1H), 7.69 (d, <i>J</i> = 8.3 Hz, 1H), 7.36 (dd, <i>J</i> = 8.3, 2.1 Hz), 7.29 (d, <i>J</i> = 2.2 Hz, 1H), 7.25 (s, 1H), 6.91 (d, <i>J</i> = 11.6 Hz, 1H), 6.84 (d, <i>J</i> = 11.5 Hz, 1H), 6.20 (s, 1H), 5.26 (d, <i>J</i> = 15.1 Hz, 1H), 5.03 (d, <i>J</i> = 15.0 Hz, 1H), 4.52 (q, <i>J</i> = 7.1 Hz, 2H), 2.71 (s, 3H), 1.49 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Ethyl 2-Amino-5-(3-chlorophenethyl)thiazole-4-carboxylate (<b>37</b>)</h4><div class="NLM_p last">A stirred solution of <b>26</b> (18.50 g, 110 mmol) and ethyl dichloroacetate (17.29 g, 110 mmol), dissolved in anhydrous diethyl ether (90 mL) and cooled to below −10 °C in an ice–salt bath under N<sub>2</sub>, was treated with a freshly prepared solution of sodium ethoxide (2.2M, 50 mL, 110 mmol) over a 15 min period, and we ensured that the temperature did not rise above 0 °C. This generated a pale-orange suspension, which was stirred for 45 min and warmed to 40 °C over 30 min. This was then quenched with water (250 mL), and the organics were extracted with diethyl ether (3 × 150 mL). These were combined, washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford to afford an orange oil. This was dissolved in ethanol (60 mL) and added dropwise to a warm solution of thiourea (12.56 g, 165 mmol) in ethanol (60 mL) that had been heated to 65 °C over a 10 min period. This was heated to reflux for 2.5 h, generating a purple-red solution and a white precipitate, which was then allowed to cool to rt and concentrated in vacuo. The residue was then diluted with diethyl ether (200 mL) and partitioned with NaHCO<sub>3</sub> (100 mL) and water (100 mL). The organics were extracted with diethyl ether (3 × 200 mL), combined, washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford a brown oil. This was taken up in a diethyl ether (100 mL), filtered through a plug of silica, and washed with diethyl ether (3 × 200 mL). The filtrate was concentrated to afford an orange solid, which was triturated with diethyl ether/hexane to give the title compound, <b>37</b>, as a yellow solid (15.70 g, 50.5 mmol, 46%). LC-MS (ESI+) Rt: 2.81 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 311.3 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.21–7.19 (m, 3H), 7.09–7.07 (m, 1H), 5.09 (s, 2H), 4.36 (q, <i>J</i> = 7.1 Hz, 2H), 3.37 (t, <i>J</i> = 7.8 Hz, 2H), 2.91 (t, <i>J</i> = 7.8 Hz, 2H), 1.39 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ: 163.4, 162.3, 142.6, 139.5, 136.9, 134.3, 129.8, 128.8, 126.9, 126.6, 61.1, 37.1, 28.8, 14.6.</div></div><div id="sec4_4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Ethyl 2-Chloro-5-(3-chlorophenethyl)thiazole-4-carboxylate (<b>38</b>)</h4><div class="NLM_p last">A stirred solution of <b>37</b> (15.00 g, 48.26 mmol) in degassed, anhydrous acetonitrile (240 mL) under N<sub>2</sub> was treated with copper(II)chloride (12.92 g, 96.25 mmol) and then treated dropwise, via a syringe pump, with <i>tert</i>-butyl nitrite (11.50 mL, 96.25 mmol) over a 15 min period at rt. We ensured the temperature did not rise above 25 °C. This was stirred for a further 2 h at rt, quenched with 2 M HCl (250 mL), and stirred for 10 min, and then the organics were extracted with ethyl acetate (3 × 250 mL). These were combined, washed with brine (200 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford an orange oil. Further purification was achieved by FC (10% ethyl acetate/petroleum ether) to afford the title compound, <b>38</b>, as an orange oil (10.41 g. 31.53 mmol, 65%). LC-MS (ESI+) Rt: 3.18 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 330.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.21–7.18 (m, 3H), 7.05 (dt, <i>J</i> = 6.0, 2.1 Hz, 1H), 4.40 (q, <i>J</i> = 7.1 Hz, 2H), 3.48 (t, <i>J</i> = 7.7 Hz, 2H), 2.95 (t, <i>J</i> = 7.7 Hz, 2H), 1.40 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ: 161.2, 150.5, 148.3, 141.7, 139.8, 134.4, 129.9, 128.6, 126.9, 126.7, 61.6, 36.6, 28.9, 14.4.</div></div><div id="sec4_4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-Chloro-5-(3-chlorophenethyl)thiazole-4-carboxylic Acid (<b>39</b>)</h4><div class="NLM_p last">A stirred solution of <b>38</b> (10.00 g, 30.3 mmol) in THF (40 mL) was treated with a solution of NaOH (1.817 g, 45.4 mmol) in water (40 mL). This was stirred for 24 h at rt and treated with 2 M HCl (100 mL). The organics were extracted with ethyl acetate (3 × 100 mL), combined, washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford the title compound, <b>39</b>, as a pale-yellow solid (9.15 g, 30.3 mmol, 100%.). LC-MS (ESI+) Rt: 2.88 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 301.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.24–7.20 (m, 3H), 7.09–7.06 (m, 1H), 3.53 (t, <i>J</i> = 7.7 Hz, 2H), 2.98 (t, <i>J</i> = 7.7 Hz, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ: 162.4, 151.9, 148.6, 141.4, 138.8, 134.5, 130.0, 128.7, 127.0, 126.7, 36.4, 28.9.</div></div><div id="sec4_4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2,7-Dichloro-9,10-dihydro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-one (<b>40</b>)</h4><div class="NLM_p last">A stirred solution of <b>39</b> (7.00 g, 23.17 mmol) in DCM (70 mL) under N<sub>2</sub> was treated with oxalyl chloride (3.47 mL, 40.54 mmol) and catalytic DMF (ca. two drops) and stirred for 3 h at rt. This was then concentrated in vacuo. The residual oxalyl chloride was azeotroped with toluene (3 × 50 mL) to afford an orange solid. The solid was dissolved in DCM (100 mL), cooled in an ice bath under N<sub>2</sub>, and treated portionwise with aluminum(III)chloride (12.36 g, 92.68 mmol), generating a black solution. This was allowed to warm to rt and was stirred for 18 h. This was gradually added to a stirred slurry of ice and 2 M HCl (250 mL) and allowed to warm to rt. The organics were extracted with ethyl acetate (3 × 200 mL), combined, washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford an orange solid. This was triturated with diethyl ether/hexane to afford the title compound, <b>40</b>, as a beige solid (5.48 g, 19.28 mmol, 83%). LC-MS (ESI+) Rt: 2.88 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 284.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.78 (d, <i>J</i> = 8.4 Hz, 1H), 7.55 (d, <i>J</i> = 2.1 Hz, 1H), 7.48 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 3.29–3.26 (m, 2H), 3.24–3.21 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 183.5, 153.2, 148.6, 147.9, 142.1, 137.7, 137.0, 132.6, 129.9, 127.7, 33.5, 26.7.</div></div><div id="sec4_4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2,7-Dichloro-4-(2,4-di-<i>tert</i>-butoxypyrimidin-5-yl)-9,10-dihydro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-ol (<b>41</b>)</h4><div class="NLM_p last">A stirred solution of <b>31</b> (1.516 g, 5.00 mmol) in unstabilized, anhydrous THF (40 mL) under N<sub>2</sub> was cooled to −78 °C, treated dropwise with a solution of <i>n</i>-butyllithium (2.25 M in hexane, 2.33 mL, 5.25 mmol), and stirred for 30 min, generating a dark-orange solution. This was then treated dropwise with a solution of <b>82</b> (1.421 g, 5.00 mmol) that had been dissolved in unstabilized, anhydrous THF (10 mL); stirred at −78 °C for 15 min; allowed to warm to rt; and stirred for 1 h. The RM was then quenched with NH<sub>4</sub>Cl(aq) (20 mL) and diluted with water (20 mL), and the organics were extracted with ethyl acetate (3 × 50 mL). These were combined, washed with brine (20 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford an orange oil. Further purification was achieved by FC (5–20% ethyl acetate/petroleum ether) to afford the title compound, <b>41</b>, at 15% ethyl acetate/petroleum ether as a clear oil that foamed and crystallized to a white solid under high vacuum (2.00 g, 3.93 mmol, 79%). LC-MS (ESI+) Rt: 3.46 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 508.3 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.02 (d, <i>J</i> = 8.5 Hz, 1H), 7.67 (s, 1H), 7.31 (dd, <i>J</i> = 8.5, 2.3 Hz), 7.16 (d, <i>J</i> = 2.2 Hz, 1H), 5.16 (s, 1H), 3.12–3.04 (m, 2H), 2.87–2.77 (m, 1H), 2.72–2.66 (m, 1H), 1.61 (s, 9H), 1.43 (s, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ: 167.1, 163.5, 156.9, 150.8, 147.1, 142.6, 137.9, 133.11, 133.07, 129.9, 128.2, 126.5, 120.1, 82.5, 80.4, 74.4, 31.2, 28.42, 28.40, 26.7.</div></div><div id="sec4_4_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 5-(2,7-Dichloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>42</b>)</h4><div class="NLM_p last">A solution of <b>41</b> (1.990 g, 3.91 mmol) in 1,4-dioxane (19.5 mL) was treated with acetic acid (19.5 mL) and heated to 140 °C with stirring in a microwave (MW) for 10 min. This was concentrated in vacuo, and the residual acetic acid was azeotroped with toluene (3 × 50 mL) to afford a brown solid. Purification was achieved by FC (5% MeOH/DCM) to afford the title compound, <b>42</b>, as an orange solid (851 mg, 2.25 mmol, 58%). LC-MS (ESI+) Rt: 2.71 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 378.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.08 (s, 1H), 10.60 (s, 1H), 7.58 (d, <i>J</i> = 2.1 Hz, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 7.49 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.12 (d, <i>J</i> = 11.9 Hz, 1H) 7.07 (d, <i>J</i> = 11.7 Hz, 1H), 6.63 (s, 1H), 5.48 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 163.4, 151.2, 150.6, 149.0, 138.6, 136.2, 134.9, 133.1, 131.8, 131.5, 130.1, 129.8, 120.5, 108.3, 43.7.</div></div><div id="sec4_4_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 5-(2,7-Dichloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>43</b>)</h4><div class="NLM_p last">A stirred suspension of <b>42</b> (1.430 g, 3.80 mmol) in 1,2-dichloroethane (40 mL) under N<sub>2</sub> was treated with <i>N</i>,<i>O</i>-bis(trimethylsilyl)trifluoroacetamide (4.1 mL, 3.912g, 15.20 mmol) and heated to reflux for 18 h, generating an orange solution. This was cooled, treated with iodomethane (4.7 mL, 10.737 g, 76.0 mmol) and heated to 50 °C for 6 h until completion was observed by LC-MS. This was concentrated in vacuo to afford an orange oil, which was dissolved in MeOH and reconcentrated in vacuo to afford a yellow solid. This was triturated with diethyl ether (3 × 30 mL) to afford the title compound, <b>43</b> an orange solid (1.466 g, 3.73 mmol, 98%). LC-MS (ESI+) Rt: 2.83 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 392.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.27 (s, 1H), 7.56 (d, <i>J</i> = 2.3 Hz, 1H), 7.55 (d, <i>J</i> = 8.3 Hz, 1H), 7.48 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.11 (d, <i>J</i> = 11.8 Hz, 1H), 7.05 (d, <i>J</i> = 11.7 Hz, 1H), 6.87 (d, <i>J</i> = 0.9 Hz, 1H), 5.50 (s, 1H), 3.14 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 163.1, 151.1, 150.6, 148.8, 143.2, 136.2, 134.8, 133.2, 132.1, 131.8, 131.5, 130.2, 129.7, 120.6, 108.4, 43.9, 36.0.</div></div><div id="sec4_4_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 5-(7-Chloro-2-phenyl-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>44</b>)</h4><div class="NLM_p last">A suspension of <b>43</b> (39 mg, 0.099 mmol), phenylboronic acid (15 mg, 0.12 mmol), Na<sub>2</sub>CO<sub>3</sub> (32 mg, 0.30 mmol), bis(triphenylphosphine) palladium(II)chloride (7 mg, 0.01 mmol) in 1,4-dioxane (0.8 mL) and water (0.2 mL) was heated in a MW to 150 °C for 5 min, generating a black solution. This was concentrated directly onto silica and purified by FC (20–50% ethyl acetate/toluene) to afford the title compound, <b>44</b>, at 30% ethyl acetate/toluene (29 mg, 0.067 mmol, 68%). LC-MS (ESI+) Rt: 3.01 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 433.8 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. LC-MS (ESI+) Rt: 6.22 min (254 nm, Method 2); (<i>m</i>/<i>z</i>): 434.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup> (N.B. 85% purity at 254 nm; 95% purity at 220 nm). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.30 (s, 1H), 7.96–7.94 (m, 2H), 7.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.56 (d, <i>J</i> = 2.2 Hz, 1H), 7.53–7.49 (m, 3H), 7.48 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.19 (d, <i>J</i> = 11.7 Hz, 1H), 7.11 (d, <i>J</i> = 11.8 Hz, 1H), 7.06 (s, 1H), 5.62 (s, 1H), 3.18 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 167.4, 163.2, 151.7, 151.1, 143.3, 136.4, 135.1, 133.2, 131.6, 131.1, 130.8, 130.0, 129.8, 129.3, 126.47, 126.44, 121.4, 110.0, 108.8, 43.9, 36.1.</div></div><div id="sec4_4_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 5-(2-Amino-7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>45</b>)</h4><div class="NLM_p last">A stirred solution of <b>43</b> (140 mg, 0.357 mmol) in 1,4-dioxane (1 mL) was treated with 880 NH<sub>3</sub> (1 mL) and heated in a MW to 100 °C with stirring for 4 h. The RM was concentrated directly onto silica and purified by FC (5–20% MeOH DCM with 0.1% 880 NH<sub>3</sub>) to afford the title compound, <b>45</b>, at 20% MeOH DCM with 0.1% 880 NH<sub>3</sub> (68 mg, 0.182 mmol, 51%). LC-MS (ESI+) Rt: 2.37 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 372.8 [M(<sup>35</sup>Cl)+H]<sup>+ 1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.23 (s, 1H), 7.44 (d, <i>J</i> = 8.7 Hz, 1H), 7.43 (d, <i>J</i> = 2.4 Hz, 1H), 7.37 (dd, <i>J</i> = 8.2, 2.3 Hz), 7.36–7.32 (br.s, 2H), 6.93 (s, 1H), 6.79 (d, <i>J</i> = 11.6 Hz, 1H), 6.76 (d, <i>J</i> = 11.8 Hz, 1H), 5.22 (s, 1H), 3.16 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.9, 163.2, 151.1, 142.8, 137.0, 134.0, 133.2, 131.7, 131.0, 129.4, 128.2, 126.0, 122.2, 117.3, 108.9, 43.9, 36.1</div></div><div id="sec4_4_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 5-(7-Chloro-2-(phenylamino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>46</b>)</h4><div class="NLM_p last">A stirred solution of <b>43</b> (75 mg, 0.191 mmol) and aniline (0.07 mL, 0.76 mmol) dissolved in 1,4-dioxane (2 mL) were treated with concd HCl (ca. two drops) and heated with stirring in a MW at 140 °C for 1 h. This was evaporated directly onto silica and purified by FC (2–5% MeOH/DCM with 0.1% 880 NH<sub>3</sub>) to afford the title compound, <b>46</b>, at 3% MeOH/DCM with 0.1% 880 NH<sub>3</sub> as a pale-yellow solid (63 mg, 0.14 mmol, 74%). LC-MS (ESI+) Rt: 2.92 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 448.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.46–11.03 (br.s, 1H), 10.73–10.19 (br.s, 1H), 7.61 (d, <i>J</i> = 7.7 Hz, 2H), 7.50 (d, <i>J</i> = 8.5 Hz, 1H), 7.47 (d, <i>J</i> = 2.1 Hz, 1H), 7.40 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.33 (app.t, <i>J</i> = 7.9 Hz, 2H), 7.13 (s, 1H), 6.98 (t, <i>J</i> = 7.4 Hz, 1H), 6.94–6.88 (m, 2H), 5.29 (s, 1H), 3.19 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 164.3, 151.3, 147.6, 143.52, 141.1, 137.0, 134.4, 132.7, 131.1, 129.5, 129.4, 128.6, 127.75, 127.73, 122.2, 121.9, 118.5, 117.8, 108.8, 43.6, 36.2.</div></div><div id="sec4_4_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 5-(2-(Benzylamino)-7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>47</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (75 mg, 0.191 mmol) was reacted with benzylamine (0.08 mL, 0.76 mmol) to afford the title compound, <b>47</b>, at 4% MeOH/DCM with 0.1% 880 NH<sub>3</sub> as a pale-yellow solid (45 mg, 0.097 mmol, 51%). LC-MS (ESI+) Rt: 2.81 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 462.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.25 (s, 1H, s, 1H), 8.41 (t, <i>J</i> = 5.8 Hz, 1H), 7.45 (d, <i>J</i> = 8.5 Hz, 1H), 7.43 (d, <i>J</i> = 2.3 Hz, 1H), 7.38–7.32 (m, 5H), 7.29–7.24 (m, 1H), 7.03 (s, 1H), 6.82 (d, <i>J</i> = 11.6 Hz, 1H), 6.78 (d, <i>J</i> = 11.7 Hz, 1H), 5.22 (s, 1H), 4.50 (dd, <i>J</i> = 15.2, 5.8 Hz, 1H), 4.42 (dd, <i>J</i> = 15.3, 5.8 Hz, 1H), 3.16 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.6, 163.3, 151.1, 147.8, 143.1, 139.0, 137.0, 134.2, 132.9, 131.0, 129.3, 128.8, 128.3, 128.0, 127.6, 126.2, 122.2, 117.2, 108.9, 48.1, 43.8, 36.2.</div></div><div id="sec4_4_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 5-(7-Chloro-2-(phenethylamino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>48</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (75 mg, 0.191 mmol) was reacted with phenethylamine (0.10 mL, 0.76 mmol) to afford the title compound, <b>48</b>, at 3% MeOH/DCM with 0.1% 880 NH<sub>3</sub> as a pale-yellow solid (51 mg, 0.10 mmol, 54%). LC-MS (ESI+) Rt: 2.82 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 477.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.23 (s, 1H), 8.00 (t, <i>J</i> = 5.4 Hz, 1H), 7.44 (d, <i>J</i> = 8.5 Hz, 1H), 7.42 (d, <i>J</i> = 2.2 Hz, 1H), 7.36 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.31–7.23 (m, 4H), 7.19 (tt, <i>J</i> = 6.9, 2.0 Hz, 1H), 6.98 (s, 1H), 6.80 (d, <i>J</i> = 11.6 Hz, 1H), 6.76 (d, <i>J</i> = 11.8 Hz, 1H), 5.22 (s, 1H), 3.49–3.41 (m, 2H), 3.15 (s, 3H), 2.86 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.5, 163.3, 151.1, 148.0, 143.0, 139.7, 137.1, 134.1, 133.1, 131.0, 129.32, 129.16, 128.8, 128.2, 126.6, 126.1, 122.2, 116.8, 108.9, 46.2, 43.9, 36.2, 35.1.</div></div><div id="sec4_4_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 5-(7-Chloro-2-(4-methylpiperazin-1-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>49</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (75 mg, 0.191 mmol) was reacted with <i>N</i>-methylpiperazine (0.08 mL, 0.76 mmol) to afford the title compound, <b>49</b>, at 6% MeOH/DCM with 0.1% 880 NH<sub>3</sub> as a pale-yellow solid (64 mg, 0.14 mmol, 71%). LC-MS (ESI+) Rt: 2.13 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 456.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.25 (s, 1H), 7.47 (d, <i>J</i> = 8.6 Hz, 1H), 7.45 (d, <i>J</i> = 2.2 Hz, 1H), 7.38 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 6.96 (s, 1H), 6.88 (d, <i>J</i> = 11.6 Hz, 1H), 6.82 (d, <i>J</i> = 11.7 Hz, 1H), 5.29 (s, 1H), 3.46–3.42 (m, 4H), 3.16 (s, 3H), 2.52–2.47 (m, 4H), 2.29–2.25 (m, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 171.0, 163.2, 151.1, 148.3, 142.9, 136.8, 134.2, 133.2, 131.1, 129.5, 128.4, 126.8, 121.9, 118.7, 108.7, 53.9, 47.8, 45.8, 44.1, 36.2.</div></div><div id="sec4_4_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 5-(7-Chloro-2-morpholino-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>50</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (75 mg, 0.191 mmol) was reacted with morpholine (0.07 mL, 0.76 mmol) to afford the title compound, <b>50</b>, at 3% MeOH/DCM with 0.1% 880 NH<sub>3</sub> as a pale-yellow solid (65 mg, 0.147 mmol, 77%). LC-MS (ESI+) Rt: 2.70 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 443.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.25 (s, 1H), 7.47 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.39 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 6.97 (s, 1H), 6.89 (d, <i>J</i> = 11.6 Hz, 1H), 6.83 (d, <i>J</i> = 11.7 Hz, 1H), 5.29 (s, 1H), 3.70 (t, <i>J</i> = 4.9 Hz, 4H), 3.40 (t, <i>J</i> = 4.8 Hz, 4H), 3.16 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 171.4, 163.3, 151.1, 148.2, 142.9, 136.8, 134.2, 133.2, 131.1, 129.5, 128.4, 126.9, 121.9, 118.7, 108.7, 65.8, 49.1, 48.2, 36.2.</div></div><div id="sec4_4_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 5-(7-Chloro-2-(piperidin-1-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>51</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (75 mg, 0.191 mmol) was reacted with piperidine (0.08 mL, 0.76 mmol) to afford the title compound, <b>51</b>, at 3% MeOH/DCM with 0.1% 880 NH<sub>3</sub> as a pale-yellow solid (60 mg, 0.136 mmol, 71%). LC-MS (ESI+) Rt: 2.88 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 441.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.23 (s, 1H), 7.46 (d, <i>J</i> = 8.5 Hz, 1H), 7.43 (d, <i>J</i> = 2.2 Hz, 1H), 7.36 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 6.94 (s, 1H), 6.84 (d, <i>J</i> = 11.6 Hz, 1H), 6.78 (d, <i>J</i> = 11.7 Hz, 1H), 5.26 (s, 1H), 3.43–3.40 (m, 4H), 3.14 (s, 3H), 1.58 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 171.1, 163.3, 151.1, 148.5, 142.8, 136.9, 134.1, 133.3, 131.1, 129.4, 128.3, 126.3, 122.0, 118.0, 108.7, 49.2, 44.1, 36.2, 25.1, 23.9.</div></div><div id="sec4_4_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 5-(7-Chloro-2-((2-methoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>52</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (75 mg, 0.191 mmol) was reacted with 2-methoxyethylamine (0.07 mL, 0.76 mmol) to afford the title compound, <b>52</b>, at 4% MeOH/DCM with 0.1% 880 NH<sub>3</sub> as a pale-yellow solid (55 mg, 0.128 mmol, 67%). LC-MS (ESI+) Rt: 2.51 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 430.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.23 (s, 1H), 7.98 (t, <i>J</i> = 5.3 Hz, 1H), 7.44 (d, <i>J</i> = 8.6 Hz, 1H), 7.42 (d, <i>J</i> = 2.3 Hz, 1H), 7.36 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 6.99 (s, 1H), 6.79 (d, <i>J</i> = 11.6 Hz, 1H), 6.76 (d, <i>J</i> = 11.8 Hz, 1H), 5.21 (s, 1H), 3.48–3.45 (m, 2H), 3.26 (s, 3H), 3.24–3.23 (m, 2H), 3.15 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.6, 163.3, 161.6, 151.1, 147.8, 143.0, 137.0, 134.1, 131.0, 129.3, 128.2, 126.1, 122.3, 116.9, 108.8, 70.6, 58.4, 44.2, 43.9, 36.1.</div></div><div id="sec4_4_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 5-(7-Chloro-2-((3-methoxypropyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>53</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (50 mg, 0.127 mmol) was reacted with 3-methoxypropylamine (0.05 mL, 0.51 mmol) to afford the title compound, <b>53</b>, which was isolated at 5% MeOH/DCM as a pale-yellow solid (52 mg, 0.117 mmol, 92%). LC-MS (ESI+) Rt: 2.54 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 445.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.23 (s, 1H), 7.90 (t, <i>J</i> = 5.5 Hz, 1H), 7.44 (d, <i>J</i> = 8.4 Hz, 1H), 7.42 (d, <i>J</i> = 2.2 Hz, 1H), 7.35 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.00 (s, 1H), 6.80 (d, <i>J</i> = 11.6 Hz, 1H), 6.75 (d, <i>J</i> = 11.7 Hz, 1H), 5.21 (s, 1H), 3.37 (t, <i>J</i> = 6.2 Hz, 2H), 3.28–3.23 (m, 2H), 3.22 (s, 3H), 3.15 (s, 3H), 1.76 (app.qi, <i>J</i> = 6.5 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.7, 163.3, 151.1, 148.0, 143.0, 137.0, 134.1, 133.0, 131.0, 129.3, 128.2, 126.0, 122.3, 116.7, 108.9, 69.8, 58.4, 43.9, 41.9, 36.1, 29.2.</div></div><div id="sec4_4_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 5-(7-Chloro-2-((2-ethoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>54</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (50 mg, 0.127 mmol) was reacted with 2-ethoxyethylamine (0.05 mL, 0.51 mmol) to afford the title compound, <b>54</b>, at 5% MeOH/DCM as a pale-yellow solid (51 mg, 0.115 mmol, 90%). LC-MS (ESI+) Rt: 2.60 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 445.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.24 (s, 1H), 7.98 (t, <i>J</i> = 5.5 Hz, 1H), 7.45 (d, <i>J</i> = 8.5 Hz, 1H), 7.43 (d, <i>J</i> = 2.3 Hz, 1H), 7.37 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.01 (s, 1H), 6.81 (d, <i>J</i> = 11.6 Hz, 1H), 6.77 (d, <i>J</i> = 11.7 Hz, 1H), 5.23 (s, 1H), 3.51 (t, <i>J</i> = 5.7 Hz, 2H), 3.45 (q, <i>J</i> = 7.0 Hz, 2H), 3.43–3.37 (m, 2H), 3.17 (s, 3H), 1.11 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.6, 163.3, 151.1, 147.8, 143.0, 137.0, 134.1, 133.1, 131.0, 129.3, 128.2, 126.1, 122.3, 116.9, 108.9, 68.5, 65.9, 44.5, 43.9, 36.1, 15.6.</div></div><div id="sec4_4_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 5-(7-Chloro-2-((2-isopropoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>55</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (50 mg, 0.127 mmol) was reacted with 2-isopropoxyethylamine (0.06 mL, 0.51 mmol) to afford the title compound, <b>55</b>, which was isolated at 5% MeOH/DCM as a pale-yellow solid (49 mg, 0.107 mmol, 84%). LC-MS (ESI+) Rt: 2.68 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 459.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.24 (s, 1H), 7.94 (t, <i>J</i> = 5.5 Hz, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.43 (d, <i>J</i> = 2.1 Hz, 1H), 7.37 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.00 (s, 1H), 6.81 (d, <i>J</i> = 11.6 Hz, 1H), 6.77 (d, <i>J</i> = 11.7 Hz, 1H), 5.23 (s, 1H), 3.57 (sep., <i>J</i> = 6.1 Hz, 1H), 3.52–3.49 (m, 2H), 3.42–3.36 (m, 2H), 3.16 (s, 3H), 1.09 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.6, 163.3, 151.1, 147.8, 143.0, 137.0, 134.1, 133.1, 131.0, 129.3, 128.2, 126.0, 122.3, 116.9, 108.9, 71.3, 66.1, 44.9, 43.9, 36.1, 22.51, 22.49.</div></div><div id="sec4_4_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 5-(7-Chloro-2-((2-phenoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-1-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>56</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (50 mg, 0.127 mmol) was reacted with 2-phenoxyethylamine (0.07 mL, 0.51 mmol) to afford the title compound, <b>56</b>, at 4% MeOH/DCM as a pale-yellow solid (53 mg, 0.108 mmol, 85%). LC-MS (ESI+) Rt: 2.85 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 483.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.24 (s, 1H), 8.17 (t, <i>J</i> = 5.5 Hz, 1H), 7.46 (d, <i>J</i> = 8.4 Hz, 1H), 7.44 (d, <i>J</i> = 2.2 Hz, 1H), 7.38 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.29 (dd, <i>J</i> = 8.5, 7.5 Hz, 2H), 7.00 (s, 1H), 7.01–6.92 (m, 3H), 6.82 (d, <i>J</i> = 11.6 Hz, 1H), 6.79 (d, <i>J</i> = 11.7 Hz, 1H), 5.26 (s, 1H), 4.13 (t, <i>J</i> = 5.4 Hz, 2H), 3.64 (app.q, <i>J</i> = 5.1 Hz, 2H), 3.16 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.4, 163.3, 158.8, 151.1, 148.3, 147.7, 143.0, 137.0, 134.1, 131.0, 130.0, 129.4, 128.3, 126.2, 122.2, 117.2, 114.9, 108.8, 66.2, 43.9, 36.1.</div></div><div id="sec4_4_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Ethyl 2-((5-(2,7-Dichloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)thiazole-4-carboxylate (<b>57</b>)</h4><div class="NLM_p last">A stirred suspension of <b>42</b> (851 mg, 2.25 mmol) in 1,2-dichloroethane (20 mL) was treated with <i>N</i>,<i>O</i>-bis(trimethylsilyl)trifluoroacetamide (1.8 mL, 6.75 mmol) and heated to reflux for 18 h under N<sub>2</sub>, generating an orange solution. This was then treated with ethyl 2-(bromomethyl)thiazole-4-carboxylate (591 mg, 2.36 mmol) that had been dissolved in 1,2-dichloroethane (3 mL) and refluxed for 72 h. This was concentrated in vacuo to a gum, treated with MeOH (20 mL), and then reconcentrated in vacuo to a brown solid. This was triturated with diethyl ether (3 × 50 mL) to give the title compound, <b>57</b>, as a brown solid (1.125 g, 2.06 mmol, 91%). LC-MS (ESI+) Rt: 2.95 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 546.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.49 (s, 1H), 8.50 (s, 1H), 7.59 (d, <i>J</i> = 8.5 Hz, 1H), 7.54 (d, <i>J</i> = 2.2 Hz, 1H), 7.51 (dd, <i>J</i> = 8.2, 2.3 Hz, 1H), 7.03 (d, <i>J</i> = 11.9 Hz, 1H), 7.03 (d, <i>J</i> = 1.1 Hz, 1H), 6.96 (d, <i>J</i> = 11.7 Hz, 1H), 5.55 (d, <i>J</i> = 0.9 Hz, 1H), 5.20 (d, <i>J</i> = 15.8 Hz, 1H), 5.16 (d, <i>J</i> = 15.9 Hz, 1H), 4.34 (q, <i>J</i> = 7.1 Hz, 2H), 1.33 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 166.6, 162.7, 161.0, 150.67, 150.55, 148.6, 146.4, 142.0, 136.2, 134.5, 133.3, 132.00, 131.81, 131.5, 130.5, 130.1, 129.7, 120.6, 109.0, 61.4, 48.4, 44.1, 14.7.</div></div><div id="sec4_4_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Ethyl 2-((5-(7-Chloro-2-((2-methoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)thiazole-4-carboxylate (<b>58</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>57</b> (400 mg, 0.73 mmol) was reacted with 2-methoxyethylamine (0.25 mL, 2.92 mmol) to afford the title compound, <b>58</b>, at 3% MeOH/DCM as a pale-yellow solid (250 mg, 0.43 mmol, 59%). LC-MS (ESI+) Rt: 2.69 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 585.8 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.46 (s, 1H), 8.51 (s, 1H), 7.97 (t, <i>J</i> = 5.4 Hz, 1H), 7.46 (d, <i>J</i> = 8.4 Hz, 1H), 7.39 (d, <i>J</i> = 2.1 Hz, 1H), 7.37 (dd, <i>J</i> = 8.1, 2.3 Hz, 1H), 7.18 (s, 1H), 6.68 (d, <i>J</i> = 11.6 Hz, 1H), 6.65 (d, <i>J</i> = 11.7 Hz, 1H), 5.27 (d, <i>J</i> = 15.9 Hz, 1H), 5.22 (s, 1H), 5.15 (d, <i>J</i> = 15.9 Hz, 1H), 4.34 (q, <i>J</i> = 7.0 Hz, 2H), 3.46–3.44 (m, 2H), 3.39 (app.q, <i>J</i> = 5.6 Hz, 2H), 3.25 (s, 3H), 1.33 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 169.5, 166.5, 163.0, 161.0, 150.7, 147.4, 146.3, 141.8, 137.0, 133.8, 133.0, 131.0, 130.6, 129.2, 128.2, 126.0, 122.3, 116.9, 109.3, 70.6, 61.3, 58.4, 48.5, 44.16, 43.99, 14.7.</div></div><div id="sec4_4_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Ethyl 2-((5-(7-Chloro-2-((2-methoxyethyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)thiazole-4-carboxylate (<b>59</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>58</b> (240 mg, 0.41 mmol) was converted to the title compound, <b>59</b>, which was isolated at 2% MeOH/DCM as a yellow solid (200 mg, 0.33 mmol, 81%). LC-MS (ESI+) Rt: 2.87 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 601.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.87 (s, 1H), 8.55 (s, 1H), 8.02–7.98 (br.s, 1H), 7.74 (s, 1H), 7.56 (d, <i>J</i> = 8.5 Hz, 1H), 7.40 (d, <i>J</i> = 2.3 Hz, 1H), 7.36 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.75 (s, 2H), 5.65 (s, 1H), 5.39 (d, <i>J</i> = 15.8 Hz, 1H), 5.26 (d, <i>J</i> = 15.8 Hz, 1H), 4.35 (q, <i>J</i> = 7.0 Hz, 2H), 3.42–3.40 (m, 2H), 3.37–3.35 (m, 2H), 3.23 (s, 3H), 1.34 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.8, 169.3, 165.5, 161.0, 147.9, 146.4, 141.9, 137.5, 133.7, 132.1, 130.93, 130.81, 128.9, 127.8, 126.7, 122.7, 117.6, 116.7, 70.6, 61.4, 58.4, 49.2, 45.3, 44.1, 14.7.</div></div><div id="sec4_4_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 3-((5-(2,8-Dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-5-(methoxycarbonyl)benzoic Acid (<b>61</b>) and 5-((5-(2,8-Dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)isophthalic Acid (<b>60</b>)</h4><div class="NLM_p last">Step A: <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide (0.76 g, 2.96 mmol) was added to a stirred suspension of 5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione<a onclick="showRef(event, 'patent1'); return false;" href="javascript:void(0);" class="ref patent1">(31)</a> (0.49 g, 1.48 mmol) in 1,2-dichloroethane (6 mL), and the reaction mixture was heated under reflux under nitrogen. After 1.5 h, dimethyl 5-(bromomethyl)isophthalate (0.43 g, 1.48 mmol) was added. The reaction mixture was heated under reflux for a further 16 h. After the reaction mixture cooled, the volatiles were removed under vacuum. Purification was by silica-gel chromatography, and the eluent was ethyl acetate/petroleum ether, 50:50, which gave dimethyl 5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)isophthalate (0.7 g, 1.3 mmol, 87%). LC-MS (ESI+) Rt: 3.10 (254 nm, Method 1); (<i>m</i>/<i>z</i>): 537.2 (M+1). Step B: Lawesson’s reagent (0.8 g, 2 mmol) and the product from step A (0.7 g, 1.3 mmol) in 1,4-dioxane (8 mmol) were heated under reflux under nitrogen. After 16 h, the volatiles were evaporated under vacuum. Purification was by silica-gel chromatography, and the eluent was ethyl acetate/toluene, 30:70, which gave dimethyl 5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)isophthalate (0.4 g, 0.72 mmol, 55%) as a yellow solid. LC-MS (ESI+) Rt: 3.19 (254 nm, Method 1); (<i>m</i>/<i>z</i>): 553.7 (M+1). Step C: A sodium hydroxide solution (0.4 mmol, 0.4 mL of a 1 M solution in water) was added to a mixture of the product from step B (0.11 g, 0.2 mmol) in methanol (1 mL), toluene (0.5 mL), and water (0.5 mL). After 4 h, the reaction mixture was partitioned between 2 M hydrochloric acid and ethyl acetate. The ethyl acetate layer was washed with brine, dried (magnesium sulfate), filtered, and evaporated in vacuo. Purification was by silica-gel chromatography, and the eluents were 2% acetic acid in ethyl acetate/toluene (25:75 and then 80:20). Yield of <b>61</b>: 0.07 g, 0.13 mmol, 65% (yellow solid). <sup>1</sup>H NMR (400 MHz, DMSO) δ: 13.47 (s, 1H), 12.62 (s, 1H), 8.49 (tt, J = 3.9, 1.7 Hz, 1H), 8.12 (td, J = 13.7, 1.6 Hz, 2H), 7.45 (d, J = 7.8 Hz, 2H), 7.15 (dd, J = 7.9, 1.9 Hz, 2H), 7.09 (td, J = 5.1, 1.9 Hz, 2H), 7.02 (s, 1H), 6.70 (s, 2H), 5.72 (s, 1H), 4.99 (t, J = 4.0 Hz, 2H), 3.97 (s, 3H), 2.27 (s, 6H). LC-MS (ESI+) Rt: 3.05 (254 nm); (<i>m</i>/<i>z</i>): 539.6 (M+1). Yield of <b>60</b>: 0.02 g, 0.038 mmol, 19% (yellow solid). <sup>1</sup>H NMR (400 MHz, DMSO) δ: 13.47 (s, 2H), 12.62 (s, 1H), 8.49 (q, J = 2.0 Hz, 1H), 8.09 (d, J = 1.6 Hz, 2H), 7.45 (d, J = 7.9 Hz, 2H), 7.15 (dd, J = 7.9, 1.9 Hz, 2H), 7.07 (d, J = 1.9 Hz, 2H), 7.02 (s, 1H), 6.70 (s, 2H), 5.72 (s, 1H), 4.98 (s, 2H), 2.27 (s, 6H). LC-MS (ESI+) Rt: 2.81 (254 nm, Method 1); (<i>m</i>/<i>z</i>): 525.2 (M+1).</div></div><div id="sec4_4_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Methyl 3-((2-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzoate (<b>62</b>)</h4><div class="NLM_p last">PyBroP (0.19 g, 0.4 mmol) was added to a stirred solution of 3-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-5-(methoxycarbonyl)benzoic acid (0.15 g, 0.28 mmol), <i>tert</i>-butyl (2-aminoethyl)carbamate (0.058 g, 0.36 mmol), and triethylamine (0.15 g, 1.5 mmol) in DMF (2 mL). After 0.5 h, the solution was diluted with ethyl acetate (15 mL) and washed with water (2 × 4 mL) and brine (1 × 4 mL). The solution was evaporated to dryness under reduced pressure. Purification was by silica-gel chromatography, and the eluent was 70:30 ethyl acetate/petroleum ether (40–60). Yield: 0.1 g, 0.15 mmol, 53% (yellow solid). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.47 (s, 1H), 8.50 (s, 1H), 8.04 (dt, J = 7.1, 1.8 Hz, 2H), 7.63–7.58 (m, 1H), 7.50 (d, J = 7.8 Hz, 2H), 7.16 (dd, J = 7.9, 1.5 Hz, 1H), 7.07 (s, 1H), 6.90 (s, 1H), 6.68 (s, 2H), 5.74 (s, 1H), 5.33 (s, 1H), 5.10–5.05 (m, 1H), 4.79 (s, 2H), 4.02 (s, 3H), 3.68–3.60 (m, 2H), 3.50–3.44 (m, 2H), 2.32 (s, 6H), 1.44 (s, 8H). LC-MS (ESI+) Rt: 3.14 (254 nm, Method 1); (<i>m</i>/<i>z</i>): 681.2 (M+1)</div></div><div id="sec4_4_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Methyl 3-((2,2-Dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-13-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzoate (<b>63</b>)</h4><div class="NLM_p last">PyBroP (0.11 g, 0.24 mmol) was added to a stirred solution of 3-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-5-(methoxycarbonyl)benzoic acid (0.1 g, 0.186 mmol), <i>tert</i>-butyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate (0.05 g, 0.2 mmol), and triethylamine (0.1 g, 1 mmol) in DMF (2 mL). After 0.5 h, the solution was diluted with ethyl acetate (15 mL) and washed with water (2 × 4 mL) and brine (1 × 4 mL). The solution was evaporate to dryness under reduced pressure. Purification was by silica-gel chromatography, and the eluent was ethyl acetate. Yield: 0.09 g, 0.12 mmol, 63% (yellow solid). <sup>1</sup>H NMR (400 MHz, DMSO) δ: 12.61 (s, 1H), 8.89 (t, J = 5.5 Hz, 1H), 8.48 (t, J = 1.6 Hz, 1H), 8.05 (t, J = 1.7 Hz, 1H), 8.00 (t, J = 1.6 Hz, 1H), 7.44 (d, J = 7.9 Hz, 2H), 7.14 (ddd, J = 7.8, 1.9, 0.8 Hz, 2H), 7.05 (dd, J = 1.9, 0.8 Hz, 2H), 6.94 (s, 1H), 6.76 (t, J = 5.6 Hz, 1H), 6.62 (s, 2H), 5.71 (s, 1H), 4.95 (s, 2H), 3.97 (s, 3H), 3.65–3.56 (m, 4H), 3.56–3.47 (m, 4H), 3.39 (t, J = 12.3 Hz, 1H), 3.33–3.30 (m, 1H), 3.07 (q, J = 6.0 Hz, 2H), 2.27 (s, 6H), 1.37 (s, 9H). LC-MS (ESI+) Rt: 3.19 (254 nm, Method 1); (<i>m</i>/<i>z</i>): 769.6 (M+1)</div></div><div id="sec4_4_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>tert</i>-Butyl (2-(3-((2<i>H</i>-Tetrazol-5-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzamido)ethyl)carbamate (<b>64</b>)</h4><div class="NLM_p">Lithium hydroxide (0.04 g, 1.6 mmol) in water (0.5 mL) was added to a stirred solution of methyl 3-((2-((<i>tert</i>-butoxycarbonyl)amino)ethyl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzoate (0.1 g, 0.15 mmol) in methanol (1.5 mL). After 16 h, the mixture was partitioned between ethyl acetate and a 2 M hydrochloric acid solution. The ethyl acetate solution was washed with brine, dried (magnesium sulfate), filtered, and evaporated in vacuo to give 3-((2-((<i>tert</i>-butoxycarbonyl)amino)ethyl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzoic acid (0.08 g) as a yellow solid. LC-MS (ESI+) Rt: 2.99 (254 nm, Method 1); (<i>m</i>/<i>z</i>): 667.5 (M+1)</div><div class="NLM_p last">PyBroP (0.16 g, 0.34 mmol) was added to a stirred solution of 3-((2-((<i>tert</i>-butoxycarbonyl)amino)ethyl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzoic acid (0.09 g, 0.135 mmol), 5-aminotetrazole monohydrate (0.055 g, 0.54 mmol), and triethylamine (0.13 g, 1.3 mmol) in DMF (2 mL). After 0.5 h, the solution was diluted with ethyl acetate (15 mL) and washed with 2 M hydrochloric acid (1 × 4 mL), water (2 × 4 mL), and brine (1 × 4 mL). The solution was evaporated to dryness under reduced pressure. Purification was by silica-gel chromatography, and the eluent was methanol/dichloromethane, 5:95, and then 2% acetic acid in methanol/dichloromethane, 5:95. Yield: 0.03 g, 0.04 mmol, 30% (yellow solid). <sup>1</sup>H NMR (400 MHz, DMSO) δ: 12.66–12.59 (m, 1H), 12.45–11.87 (m, 1H), 8.83–8.67 (m, 1H), 8.57–8.43 (m, 1H), 8.09–7.94 (m, 2H), 7.49–7.41 (m, 2H), 7.31–7.23 (m, 1H), 7.22–7.17 (m, 2H), 7.14–7.10 (m, 1H), 7.04–7.00 (m, 1H), 6.99–6.89 (m, 1H), 6.67–6.48 (m, 2H), 5.75–5.69 (m, 1H), 5.03–4.88 (m, 2H), 3.44–3.33 (m, 2H), 3.24–3.09 (m, 2H), 2.30–2.20 (m, 6H), 1.38 (s, 9H). LC-MS (ESI+) Rt: 2.98 (254 nm, Method 1); (<i>m</i>/<i>z</i>): 734.3 (M+1).</div></div><div id="sec4_4_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>tert</i>-Butyl (2-(2-(2-(3-((2<i>H</i>-Tetrazol-5-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzamido)ethoxy)ethoxy)ethyl)carbamate (<b>65</b>)</h4><div class="NLM_p last">Lithium hydroxide (0.04 g, 1.6 mmol) in water (0.5 mL) was added to a stirred solution of methyl 3-((2,2-dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-13-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzoate (0.035 g, 0.046 mmol) in methanol (1.5 mL). After 16 h, the mixture was partitioned between ethyl acetate and a 2 M hydrochloric acid solution. The ethyl acetate solution was washed with brine, dried (magnesium sulfate), filtered, and evaporated in vacuo to give 3-((2,2-dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-13-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzoic acid. Yield: 0.032 g (yellow solid). <sup>1</sup>H NMR LC-MS (ESI+) Rt: 3.04 (254 nm, Method 1); (<i>m</i>/<i>z</i>): 755.6 (M+1). PyBroP (0.042 g, 0.09 mmol) was added to a stirred solution of 3-((2,2-dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-13-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzoic acid (0.05 g, 0.067 mmol), 5-aminotetrazole monohydrate (0.02 g, 0.2 mmol), and triethylamine (0.03 g, 0.3 mmol) in DMF (1 mL). After 0.5 h, the solution was diluted with ethyl acetate (15 mL) and washed with 2 M hydrochloric acid (1 × 4 mL), water (2 × 4 mL), and brine (1 × 4 mL). The solution was evaporate to dryness under reduced pressure. Purification was by silica-gel chromatography, and the eluent was methanol/dichloromethane, 5:95, and then 2% acetic acid in methanol/dichloromethane, 5:95. Yield: 0.009 g, 0.01 mmol, 14% (yellow solid). <sup>1</sup>H NMR (400 MHz, DMSO) δ: 12.64 (s, 1H), 12.51 (s, 1H), 8.76 (t, J = 5.6 Hz, 1H), 8.57 (s, 1H), 8.03 (d, 1H), 7.44 (d, J = 7.9 Hz, 2H), 7.12 (dd, J = 8.1, 1.9 Hz, 2H), 7.00 (d, J = 1.9 Hz, 2H), 6.90 (s, 1H), 6.79–6.73 (m, 1H), 6.54 (s, 2H), 5.73 (s, 1H), 4.97 (s, 2H), 3.71–3.57 (m, 4H), 3.54 (dd, J = 6.1, 4.1 Hz, 4H), 3.40 (d, J = 6.7 Hz, 2H), 3.07 (q, J = 6.0 Hz, 2H), 2.22 (s, 6H), 1.37 (s, 9H). LC-MS (ESI+) Rt: 3.02 (254 nm, Method 1); (<i>m</i>/<i>z</i>): 822.3 (M+1)</div></div><div id="sec4_4_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (<i>E</i>)-<i>N</i>1-(2-(2-(4-(2-(5,5-Difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)ethyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>3-(1<i>H</i>-tetrazol-5-yl)isophthalamide (<b>66</b>)</h4><div class="NLM_p last">Following general procedure 3 with <i>tert</i>-butyl (2-(3-((2<i>H</i>-tetrazol-5-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzamido)ethyl)carbamate (3.2 mg, 4.3 × 10<sup>–3</sup> mmol) and 2,5-dioxopyrrolidin-1-yl (<i>E</i>)-2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetate (2.3 mg, 4.2 × 10<sup>–3</sup> mmol), the title compound was generated. Yield: 0.67 mg, 0.627 × 10<sup>–3</sup> mmol, 15%. LC-MS (ESI+) Rt: 3.19 (254 nm); (<i>m</i>/<i>z</i>): 1066.4 (M+1).</div></div><div id="sec4_4_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> (<i>E</i>)-<i>N</i>1-(2-(6-(2-(4-(2-(5,5-Difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)hexanamido)ethyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>3-(1<i>H</i>-tetrazol-5-yl)isophthalamide (<b>67</b>)</h4><div class="NLM_p last">Following general procedure 3 with <i>tert</i>-butyl (2-(3-((2<i>H</i>-tetrazol-5-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzamido)ethyl)carbamate (2.2 mg, 3 × 10<sup>–3</sup> mmol) and 2,5-dioxopyrrolidin-1-yl (<i>E</i>)-6-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)hexanoate (2.0 mg, 3 × 10<sup>–3</sup> mmol), the title compound was generated. Yield: 1.2 mg, 1 × 10<sup>–3</sup> mmol, 45%. LC-MS (ESI+) Rt: 7.35 (254 nm); (<i>m</i>/<i>z</i>): 1179.4 (M+1).</div></div><div id="sec4_4_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (<i>E</i>)-<i>N</i>1-(2-(2-(2-(2-(4-(2-(5,5-Difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)ethoxy)ethoxy)ethyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>3-(1<i>H</i>-tetrazol-5-yl)isophthalamide (<b>68</b>)</h4><div class="NLM_p last">Following general procedure 3 with <i>tert</i>-butyl (2-(2-(2-(3-((2<i>H</i>-tetrazol-5-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzamido)ethoxy)ethoxy)ethyl)carbamate (3.4 mg, 4.14 × 10<sup>–3</sup> mmol) and 2,5-dioxopyrrolidin-1-yl (<i>E</i>)-2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetate (2.26 mg, 4.14 × 10<sup>–3</sup> mmol), the title compound was generated. Yield: 0.7 mg, 0.67 × 10<sup>–3</sup> mmol, 17%. LC-MS (ESI+) Rt: 7.46 (254 nm); (<i>m</i>/<i>z</i>): 1154.6 (M+1).</div></div><div id="sec4_4_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (<i>E</i>)-<i>N</i>1-(18-(4-(2-(5,5-Difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)-10,17-dioxo-3,6-dioxa-9,16-diazaoctadecyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>3-(1<i>H</i>-tetrazol-5-yl)isophthalamide (<b>69</b>)</h4><div class="NLM_p last">HCl (4 M) in 1,4-dioxane (1 mL) was added to <i>tert</i>-butyl (2-(2-(2-(3-((2<i>H</i>-tetrazol-5-yl)carbamoyl)-5-((5-(2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulen-5-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)benzamido)ethoxy)ethoxy)ethyl)carbamate (1.5 mg, 1.82 × 10<sup>–3</sup> mmol). The solution was stirred for 2 h and then evaporated to dryness in vacuo. DMF (0.5 mL), then di-isopropylethylamine (10 mg), and then 2,5-dioxopyrrolidin-1-yl (<i>E</i>)-6-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)hexanoate (1.2 mg, 1.8 × 10<sup>–3</sup> mmol) were added to the solution. The reaction mixture was stirred in the dark and under nitrogen overnight. Purification was by reverse-phase preparative HPLC eluted with a gradient of 50–60% MeCN in water (0.1% formic acid) over 20 min. The fraction containing the product was lyophilized. Yield: 1.002 mg, 0.79 × 10<sup>–3</sup> mmol, 41%. LC-MS (ESI+) Rt: 7.41 (254 nm); (<i>m</i>/<i>z</i>): 1267.0 (M+1).</div></div><div id="sec4_4_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>tert</i>-Butyl 3-((7-Chloro-4-(1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)propanoate (<b>70</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (200 mg, 0.51 mmol) was reacted with β-alanine-<i>tert</i>-butyl ester hydrochloride (370 mg, 2.04 mmol) to afford the title compound, <b>70</b>, which was isolated at 5% MeOH/DCM as a pale-yellow solid (248 mg, 0.494 mmol, 96%). LC-MS (ESI+) Rt: 2.79 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 500.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.20 (s, 1H), 7.97 (t, <i>J</i> = 5.5 Hz, 1H), 7.46 (d, <i>J</i> = 8.4 Hz, 1H), 7.44 (d, <i>J</i> = 2.2 Hz, 1H), 7.38 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.03 (s, 1H), 6.82 (d, <i>J</i> = 11.6 Hz, 1H), 6.79 (d, <i>J</i> = 11.7 Hz, 1H), 5.22 (s, 1H), 3.48–3.42 (m, 2H), 3.17 (s, 3H), 1.39 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 171.0, 169.3, 163.3, 151.1, 147.8, 143.1, 137.0, 134.2, 133.14, 133.00, 132.96, 131.0, 126.2, 122.2, 117.0, 108.9, 80.5, 43.8, 40.5, 36.2, 35.2, 28.2.</div></div><div id="sec4_4_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>tert</i>-Butyl 6-((7-Chloro-4-(1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)hexanoate (<b>71</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>43</b> (200 mg, 0.51 mmol) was reacted with <i>tert</i>-butyl 6-aminohexanoate (382 mg, 2.04 mmol) to afford the title compound, <b>71</b>, at 5% MeOH/DCM as a pale-yellow solid (248 mg, 0.494 mmol, 97%). LC-MS (ESI+) Rt: 2.91 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 543.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.24 (s, 1H), 7.92 (t, <i>J</i> = 5.4 Hz, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.43 (d, <i>J</i> = 2.2 Hz, 1H), 7.37 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.01 (s, 1H), 6.81 (d, <i>J</i> = 11.6 Hz, 1H), 6.76 (d, <i>J</i> = 11.7 Hz, 1H), 5.23 (s, 1H), 3.22–3.15 (m, 2H), 3.17 (s, 3H), 2.18 (t, <i>J</i> = 7.3 Hz, 2H), 1.56–1.49 (m, 4H), 1.38 (s, 9H), 1.34–1.30 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 172.7, 169.8, 163.3, 151.1, 148.0, 142.9, 137.1, 134.1, 133.1, 131.0, 129.3, 128.2, 125.9, 122.3, 116.6, 108.9, 79.8, 44.6, 43.9, 36.2, 35.2, 28.7, 28.2, 26.3, 24.8.</div></div><div id="sec4_4_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 3-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)propanoic Acid (<b>72</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>70</b> (200 mg, 0.40 mmol) was converted to the thiouracil, which was isolated at 2% MeOH/DCM as a yellow solid (124 mg). The intermediate product (100 mg, 0.193 mmol) was dissolved in DCM (12 mL), treated with trifluoroacetic acid (6 mL), and stirred at rt for 30 min until completion was observed by TLC. The RM was diluted with toluene (25 mL) and concentrated in vacuo to one-fifth the volume; this was repeated three times before the product was concentrated to dryness to afford a yellow solid. This was purified by FC and washed with 5% MeOH/DCM, and the title compound, <b>72</b>, was eluted with 20% MeOH/DCM with 1% acetic acid as a yellow solid (34 mg, 0.074 mmol, 39%). LC-MS (ESI+) Rt: 2.61 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 460.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.66 (s, 1H), 12.45–12.07 (br.s, 1H), 7.99 (t, <i>J</i> = 5.2 Hz, 1H), 7.71 (s, 1H), 7.55 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.88 (s, 2H), 5.68 (s, 1H), 3.44 (app.q, <i>J</i> = 6.1 Hz, 2H), 3.31 (s, 3H).</div></div><div id="sec4_4_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)hexanoic Acid (<b>73</b>)</h4><div class="NLM_p last">Following general procedure 2, <b>71</b> (200 mg, 0.40 mmol) was converted to the thiouracil, which was isolated at 2% MeOH/DCM as a yellow solid (124 mg). This was dissolved in DCM (14 mL), treated with trifluoroacetic acid (7 mL), and stirred at rt for 30 min until completion was observed by TLC. The RM was diluted with toluene (25 mL) and concentrated in vacuo to one-fifth the volume; this was repeated three times before the product was concentrated to dryness to afford a yellow solid. This was purified by FC and washed with 5% MeOH/DCM, and the title compound, <b>73</b>, was eluted with 20% MeOH/DCM with 1% acetic acid as a yellow solid (80 mg, 0.159 mmol, 74%). LC-MS (ESI+) Rt: 2.67 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 502.9 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.80–12.53 (br.s, 1H), 12.16–11.93 (br.s, 1H), 7.94 (t, <i>J</i> = 5.3 Hz, 1H), 7.62 (s, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.34 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.86 (s, 2H), 5.71 (s, 1H), 3.29 (s, 3H), 3.23–3.18 (m, 2H), 2.20 (t, <i>J</i> = 7.3 Hz, 2H), 1.56–1.48 (m, 4H), 1.36–1.29 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.2, 174.9, 169.6, 149.1, 148.5, 143.3, 137.6, 134.0, 132.0, 130.8, 129.0, 127.8, 126.58, 126.56, 122.7, 117.5, 116.4, 45.3, 44.7, 37.2, 34.1, 26.5, 24.7.</div></div><div id="sec4_4_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>tert</i>-Butyl (2-(3-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)propanamido)ethyl)carbamate (<b>74</b>)</h4><div class="NLM_p last">A stirred solution of <b>72</b> (10 mg, 0.022 mmol) in DMF (1 mL) was treated with DIPEA (50 μL) and <i>N</i>-Boc-ethylenediamine (21 mg, 0.132 mmol) followed by PyBroP (15 mg, 0.033 mmol) and stirred at rt for 1 h until completion was observed by LC-MS. The RM was quenched with water (ca. two drops), concentrated in vacuo, and azeotroped with toluene (2 × 25 mL) to afford an orange oil. This was purified by FC (1–5% MeOH/DCM) to afford the title compound, <b>74</b>, at 4% MeOH/DCM as a yellow solid (5.2 mg, 0.0086 mmol, 39%). LC-MS (ESI+) Rt: 2.75 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 603.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.67 (s, 1H), 7.95 (t, <i>J</i> = 5.5 Hz, 1H), 7.91 (t, <i>J</i> = 5.4 Hz, 1H), 7.74 (s, 1H), 7.55 (d, <i>J</i> = 8.6 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.88 (s, 2H), 6.78 (t, <i>J</i> = 5.3 Hz, 1H), 5.66 (s, 1H), 3.45 (app.q, <i>J</i> = 6.5 Hz, 2H), 3.32 (s, 3H), 3.07–3.03 (m, 2H), 2.96 (app.q, <i>J</i> = 6.1 Hz, 2H), 2.38 (t, <i>J</i> = 6.8 Hz, 2H), 1.38 (s, 9H).</div></div><div id="sec4_4_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> <i>tert</i>-Butyl (2-(6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)hexanamido)ethyl)carbamate (<b>75</b>)</h4><div class="NLM_p last">A stirred solution of <b>73</b> (30 mg, 0.060 mmol) in DMF (3 mL) was treated with DIPEA (150 μL) and <i>N</i>-Boc-ethylenediamine (58 mg, 0.362 mmol) followed by PyBroP (42 mg, 0.090 mmol) and stirred at rt for 1 h until completion was observed by LC-MS. The RM was quenched with water (ca. two drops), concentrated in vacuo, and azeotroped with toluene (2 × 25 mL) to afford an orange oil. This was purified by FC (1–5% MeOH/DCM) to afford the title compound, <b>75</b>, at 4% MeOH/DCM (15 mg, 0.023 mmol, 39%). LC-MS (ESI+) Rt: 2.80 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 645.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.66 (s, 1H), 7.93 (t, <i>J</i> = 5.4 Hz, 1H), 7.78–7.77 (m, 1H), 7.62 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.34 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.86 (s, 2H), 6.77 (t, <i>J</i> = 5.5 Hz, 1H), 5.71 (s, 1H), 3.29 (s, 3H), 3.22–3.17 (m, 2H), 3.05 (app.q, <i>J</i> = 5.8 Hz, 2H), 2.98–2.94 (m, 2H), 2.04 (t, <i>J</i> = 7.3 Hz, 2H), 1.55–1.47 (m, 4H), 1.37 (s, 9H), 1.31 (t, <i>J</i> = 7.6 Hz, 2H).</div></div><div id="sec4_4_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> <i>tert</i>-Butyl (2-(2-(2-(3-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)propanamido)ethoxy)ethoxy)ethyl)carbamate (<b>76</b>)</h4><div class="NLM_p last">A stirred solution of <b>72</b> (10 mg, 0.022 mmol) in DMF (1 mL) was treated with DIPEA (50 μL) and <i>N</i>-Boc-2,2′-(ethylenedioxy)diethylamine (33 mg, 0.132 mmol) followed by PyBroP (15 mg, 0.033 mmol) and stirred at rt for 1 h until completion was observed by LC-MS. The RM was quenched with water (ca. two drops), concentrated in vacuo, and azeotroped with toluene (2 × 25 mL) to afford an orange oil. This was purified by FC (1–5% MeOH/DCM) to afford the title compound, <b>76</b>, at 4% MeOH/DCM as a yellow solid (8.8 mg, 0.0127 mmol, 58%). LC-MS (ESI+) Rt: 2.76 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 691.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.67 (s, 1H), 7.95 (t, <i>J</i> = 5.5 Hz, 2H), 7.79 (s, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 7.45 (d, <i>J</i> = 2.3 Hz, 1H), 7.34 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.88 (s, 2H), 6.76 (t, <i>J</i> = 5.4 Hz, 1H), 5.64 (s, 1H).</div></div><div id="sec4_4_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>tert</i>-Butyl (2-(2-(2-(6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)hexanamido)ethoxy)ethoxy)ethyl)carbamate (<b>77</b>)</h4><div class="NLM_p last">A stirred solution of <b>73</b> (30 mg, 0.060 mmol) in DMF (3 mL) was treated with DIPEA (150 μL) and <i>N</i>-Boc-ethylenediamine (58 mg, 0.362 mmol) followed by PyBroP (42 mg, 0.090 mmol) and stirred at rt for 1 h until completion was observed by LC-MS. The RM was quenched with water (ca. two drops), concentrated in vacuo, and azeotroped with toluene (2 × 25 mL) to afford an orange oil. This was purified by FC (1–5% MeOH/DCM) to afford the title compound, <b>77</b>, at 4% MeOH/DCM (16 mg, 0.022 mmol, 36%). LC-MS (ESI+) Rt: 2.81 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 733.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.66 (s, 1H), 7.93 (t, <i>J</i> = 5.4 Hz, 1H), 7.81 (t, <i>J</i> = 5.6 Hz, 1H), 7.62 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.44 (d, <i>J</i> = 2.3 Hz, 1H), 7.34 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 6.86 (s, 2H), 6.76 (t, <i>J</i> = 5.0 Hz, 1H), 5.71 (s, 1H), 3.51–3.49 (m, 2H), 3.38 (q, <i>J</i> = 5.3 Hz, 6H), 3.29 (s, 3H), 3.22–3.16 (m, 4H), 3.06 (q, <i>J</i> = 6.0 Hz, 2H), 2.06 (t, <i>J</i> = 7.4 Hz, 2H), 1.57–1.52 (m, 4H), 1.37 (s, 9H), 1.33–1.27 (m, 2H).</div></div><div id="sec4_4_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> (<i>E</i>)-3-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(2-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)ethyl)propanamide (<b>78</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>74</b> was converted to the BODIPY630/650 conjugate, <b>78</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>78</b> at a retention time of 13.45 min. This compound was freeze-dried to a blue, iridescent solid (0.52 mg, 0.54 μmol, 27%). LC-MS (ESI+) Rt: 3.04 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 935.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>45</sub>H<sub>39</sub>BClF<sub>2</sub>N<sub>8</sub>O<sub>4</sub>S<sub>3</sub>, 935.2001; found, 935.2002. [M + Na]<sup>+</sup> calcd for C<sub>45</sub>H<sub>38</sub>BClF<sub>2</sub>N<sub>8</sub>NaO<sub>4</sub>S<sub>3</sub>, 957.1820; found, 957.1838.</div></div><div id="sec4_4_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> (<i>E</i>)-<i>N</i>-(2-(3-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)propanamido)ethyl)-6-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)hexanamide (<b>79</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>74</b> was converted to the BODIPY630/650-X conjugate, <b>79</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>79</b> at a retention time of 13.37 min. This compound was freeze-dried to a blue, iridescent solid (0.85 mg, 0.81 μmol, 41%). LC-MS (ESI+) Rt: 3.01 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 1048.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>51</sub>H<sub>48</sub>BClF<sub>2</sub>N<sub>9</sub>O<sub>5</sub>S<sub>3</sub>, 1046.2694; found, 1046.2657.</div></div><div id="sec4_4_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> (<i>E</i>)-<i>N</i>-(2-(2-(2-(3-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)propanamido)ethoxy)ethoxy)ethyl)-6-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)hexanamide (<b>80</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>76</b> was converted to the BODIPY630/650-X conjugate, <b>80</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>80</b> at a retention time of 13.03 min. This compound was freeze-dried to a blue, iridescent solid (0.57 mg, 0.50 μmol, 25%). LC-MS (ESI+) Rt: 3.01 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 1136.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>55</sub>H<sub>56</sub>BClF<sub>2</sub>N<sub>9</sub>O<sub>7</sub>S<sub>3</sub>, 1134.3220; found, 1134.3160.</div></div><div id="sec4_4_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> (<i>E</i>)-6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(2-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-5λ<sup>4</sup>,6λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)ethyl)hexanamide (<b>81</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>75</b> was converted to the BODIPY630/650 conjugate, <b>81</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>81</b> at a retention time of 13.05 min. This compound was freeze-dried to a blue, iridescent solid (0.41 mg, 0.42 μmol, 21%). LC-MS (ESI+) Rt: 3.04 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 977.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>48</sub>H<sub>45</sub>BClF<sub>2</sub>N<sub>8</sub>O<sub>4</sub>S<sub>3</sub>, 977.2470; found, 977.2558. [M + Na]<sup>+</sup> calcd for C<sub>48</sub>H<sub>44</sub>BClF<sub>2</sub>N<sub>8</sub>NaO<sub>4</sub>S<sub>3</sub>, 999.2289; found, 999.2380. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>48</sub>H<sub>43</sub>BClF<sub>2</sub>N<sub>8</sub>O<sub>4</sub>S<sub>3</sub>, 975.2325; found, 975.2272.</div></div><div id="sec4_4_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> (<i>E</i>)-6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(2-(2-(2-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)ethoxy)ethoxy)ethyl)hexanamide (<b>82</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>77</b> was converted to the BODIPY630/650 conjugate, <b>82</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>82</b> at a retention time of 13.69 min. This compound was freeze-dried to a blue, iridescent solid (0.22 mg, 0.21 μmol, 10%). LC-MS (ESI+) Rt: 3.05 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 1065.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>52</sub>H<sub>51</sub>BClF<sub>2</sub>N<sub>8</sub>O<sub>6</sub>S<sub>3</sub>, 1063.2849; found, 1063.2803.</div></div><div id="sec4_4_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> (<i>E</i>)-6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(2-(6-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)hexanamido)ethyl)hexanamide (<b>83</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>75</b> was converted to the BODIPY630/650-X conjugate, <b>83</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>83</b> at a retention time of 13.27 min. This compound was freeze-dried to a blue, iridescent solid (0.39 mg, 0.36 μmol, 18%). LC-MS (ESI+) Rt: 3.02 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 1090.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>54</sub>H<sub>56</sub>BClF<sub>2</sub>N<sub>9</sub>O<sub>5</sub>S<sub>3</sub>, 1090.3311; found, 1090.3293. [M + Na]<sup>+</sup> calcd for C<sub>54</sub>H<sub>55</sub>BClF<sub>2</sub>N<sub>9</sub>NaO<sub>5</sub>S<sub>3</sub>, 1112.3130; found, 1112.3129.</div></div><div id="sec4_4_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> (<i>E</i>)-6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(18-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)-10,17-dioxo-3,6-dioxa-9,16-diazaoctadecyl)hexanamide (<b>84</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>77</b> was converted to the BODIPY630/650-X conjugate, <b>84</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>84</b> at a retention time of 13.28. This compound was freeze-dried to a blue, iridescent solid (0.47 mg, 0.40 μmol, 20%). LC-MS (ESI+) Rt: 3.02 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 1178.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>58</sub>H<sub>64</sub>BClF<sub>2</sub>N<sub>9</sub>O<sub>7</sub>S<sub>3</sub>, 1178.3835; found, 1178.3933. [M + Na]<sup>+</sup> calcd for C<sub>58</sub>H<sub>63</sub>BClF<sub>2</sub>N<sub>9</sub>NaO<sub>7</sub>S<sub>3</sub>, 1200.3654; found, 1200.3772. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>58</sub>H<sub>62</sub>BClF<sub>2</sub>N<sub>9</sub>O<sub>7</sub>S<sub>3</sub>, 1176.3689; found, 1176.3647.</div></div><div id="sec4_4_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 3-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(2-(3-(5,5-difluoro-7,9-dimethyl-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)propanamido)ethyl)propanamide (<b>85</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>74</b> was converted to the BODIPYFL conjugate, <b>85</b>. This was purified by preparative RP-HPLC (Method 3), which isolated  <b>85</b> at a retention time of 13.82 min. This compound was   freeze-dried to a red-green, iridescent solid (0.84 mg, 1.08 μmol, 54%). LC-MS (ESI+) Rt: 2.80 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 777.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>):  [M + H] <sup>+</sup> calcd for C<sub>36</sub>H<sub>37</sub>BClF<sub>2</sub>N <sub>8</sub>O<sub>3</sub>S<sub>2</sub>, 777.2174; found, 777.2106.   [M + Na] <sup>+</sup> calcd for C<sub>36</sub>H<sub>36</sub>BClF<sub>2</sub>N <sub>8</sub>NaO<sub>3</sub>S<sub>2</sub>, 799.1994; found, 799.1960. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>36</sub>H<sub>35</sub>BClF<sub>2</sub>N<sub>8</sub>O<sub>3</sub>S<sub>2</sub>, 775.2029; found, 775.2007.</div></div><div id="sec4_4_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> <i>N</i>-(2-(3-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)propanamido)ethyl)-6-(3-(5,5-difluoro-7,9-dimethyl-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)propanamido)hexanamide (<b>86</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>74</b> was converted to the BODIPYFL-X conjugate, <b>86</b>. This was purified by preparative RP-HPLC (Method 3), which isolated  <b>86</b> at a retention time of 14.37 min. This compound was   freeze-dried to a red-green, iridescent solid (0.54 mg, 0.61 μmol, 30%). LC-MS (ESI+) Rt: 2.81 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 890.1 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>):  [M + H] <sup>+</sup> calcd for C<sub>42</sub>H<sub>48</sub>BClF<sub>2</sub>N <sub>9</sub>O<sub>4</sub>S<sub>2</sub>, 890.3015; found, 890.3014.   [M + Na] <sup>+</sup> calcd for C<sub>42</sub>H<sub>47</sub>BClF<sub>2</sub>N <sub>9</sub>NaO<sub>4</sub>S<sub>2</sub>, 912.2834; found, 912.2862. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>42</sub>H<sub>46</sub>BClF<sub>2</sub>N<sub>9</sub>O<sub>4</sub>S<sub>2</sub>, 888.2869; found, 888.2853.</div></div><div id="sec4_4_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> <i>N</i>-(2-(2-(2-(3-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)propanamido)ethoxy)ethoxy)ethyl)-6-(3-(5,5-difluoro-7,9-dimethyl-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)propanamido)hexanamide (<b>87</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>76</b> was converted to the BODIPYFL-X conjugate, <b>87</b>. This was purified by preparative RP-HPLC (Method 3), which isolated  <b>87</b> at a retention time of 14.47 min. This compound was   freeze-dried to a red-green, iridescent solid (0.46 mg, 0.47 μmol, 24%). LC-MS (ESI+) Rt: 2.78 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 978.3 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>):  [M + Na] <sup>+</sup> calcd for C<sub>46</sub>H<sub>55</sub>BClF<sub>2</sub>N <sub>9</sub>NaO<sub>6</sub>S<sub>2</sub>, 1000.3359; found, 1000.3457. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>46</sub>H<sub>54</sub>BClF<sub>2</sub>N<sub>9</sub>O<sub>6</sub>S<sub>2</sub>, 976.3394; found, 976.3355.</div></div><div id="sec4_4_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(2-(3-(5,5-difluoro-7,9-dimethyl-5<i>H</i>-5λ<sup>4</sup>,6λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)propanamido)ethyl)hexanamide (<b>88</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>75</b> was converted to the BODIPYFL conjugate, <b>88</b>. This was purified by preparative RP-HPLC (Method 3), which isolated  <b>88</b> at a retention time of 15.19 min. This compound was   freeze-dried to a red-green, iridescent solid (0.71 mg, 0.87 μmol, 43%). LC-MS (ESI+) Rt: 2.82 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 819.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>):  [M + H] <sup>+</sup> calcd for C<sub>39</sub>H<sub>43</sub>BClF<sub>2</sub>N <sub>8</sub>O<sub>3</sub>S<sub>2</sub>, 819.2644; found, 819.2598.   [M + Na] <sup>+</sup> calcd for C<sub>39</sub>H<sub>42</sub>BClF<sub>2</sub>N <sub>8</sub>NaO<sub>3</sub>S<sub>2</sub>, 841.2463; found, 841.2419.</div></div><div id="sec4_4_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(2-(2-(2-(3-(5,5-difluoro-7,9-dimethyl-5<i>H</i>-5λ<sup>4</sup>,6λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)propanamido)ethoxy)ethoxy)ethyl)hexanamide (<b>89</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>77</b> was converted to the BODIPYFL conjugate, <b>89</b>. This was purified by preparative RP-HPLC (Method 3), which isolated  <b>89</b> at a retention time of 15.97 min. This compound was   freeze-dried to a red-green, iridescent solid (0.41 mg, 0.45 μmol, 23%). LC-MS (ESI+) Rt: 2.83 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 907.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>):  [M + H] <sup>+</sup> calcd for C<sub>43</sub>H<sub>51</sub>BClF<sub>2</sub>N <sub>8</sub>O<sub>5</sub>S<sub>2</sub>, 907.3168; found, 907.3160.   [M + Na] <sup>+</sup> calcd for C<sub>43</sub>H<sub>50</sub>BClF<sub>2</sub>N <sub>8</sub>NaO<sub>5</sub>S<sub>2</sub>, 929.2987; found, 929.2989.</div></div><div id="sec4_4_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(2-(6-(3-(5,5-difluoro-7,9-dimethyl-5<i>H</i>-5λ<sup>4</sup>,6λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)propanamido)hexanamido)ethyl)hexanamide (<b>90</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>75</b> was converted to the BODIPYFL-X conjugate, <b>90</b>. This was purified by preparative RP-HPLC (Method 3), which isolated  <b>90</b> at a retention time of 15.59 min. This compound was   freeze-dried to a red-green, iridescent solid (0.43 mg, 0.46 μmol, 23%). LC-MS (ESI+) Rt: 2.79 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 932.3 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>):  [M + H] <sup>+</sup> calcd for C<sub>45</sub>H<sub>54</sub>BClF<sub>2</sub>N <sub>9</sub>O<sub>4</sub>S<sub>2</sub>, 932.3484; found, 932.3534.   [M + Na] <sup>+</sup> calcd for C<sub>45</sub>H<sub>53</sub>BClF<sub>2</sub>N <sub>9</sub>NaO<sub>4</sub>S<sub>2</sub>, 954.3304; found, 954.3387.</div></div><div id="sec4_4_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 6-((7-Chloro-4-(1-methyl-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)-<i>N</i>-(19-(5,5-difluoro-7,9-dimethyl-5<i>H</i>-5λ<sup>4</sup>,6λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)-10,17-dioxo-3,6-dioxa-9,16-diazanonadecyl)hexanamide (<b>91</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>77</b> was converted to the BODIPYFL-X conjugate, <b>91</b>. This was purified by preparative RP-HPLC (Method 3), which isolated  <b>91</b> at a retention time of 15.92 min. This compound was   freeze-dried to a red-green, iridescent solid (0.45 mg, 0.44 μmol, 22%). LC-MS (ESI+) Rt: 2.80 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 1020.4 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>):  [M + H] <sup>+</sup> calcd for C<sub>49</sub>H<sub>62</sub>BClF<sub>2</sub>N <sub>9</sub>O<sub>6</sub>S<sub>2</sub>, 1020.4009; found, 1020.4011.   [M + Na] <sup>+</sup> calcd for C<sub>49</sub>H<sub>61</sub>BClF<sub>2</sub>N <sub>9</sub>NaO<sub>6</sub>S<sub>22</sub>, 1042.3828; found, 1042.3837.</div></div><div id="sec4_4_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Ethyl 2-((5-(2-((3-(<i>tert</i>-Butoxy)-3-oxopropyl)amino)-7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)thiazole-4-carboxylate (<b>92</b>)</h4><div class="NLM_p last">Following general procedure 1, <b>57</b> (547 mg, 1.00 mmol) was reacted with β-alanine-<i>tert</i>-butyl ester hydrochloride (727 mg, 4.00 mmol) to afford the title compound, <b>92</b>, at 3% MeOH/DCM as a pale-yellow solid (585 mg, 0.89 mmol, 89%). LC-MS (ESI+) Rt: 2.97 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 656.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. The product was reacted following general procedure 2, and the intermediate uracil (492 mg, 0.75 mmol) was converted to the title compound, <b>92</b>, which was isolated at 1.5% MeOH/DCM as a yellow solid (240 mg, 0.36 mmol, 48%). LC-MS (ESI+) Rt: 3.13 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 672.0 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.88 (s, 1H), 8.56 (s, 1H), 7.97 (t, <i>J</i> = 5.5 Hz, 1H), 7.79 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.41 (d, <i>J</i> = 2.3 Hz, 1H), 7.36 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 6.77 (s, 2H), 5.67 (s, 1H), 5.40 (d, <i>J</i> = 15.8 Hz, 1H), 5.27 (d, <i>J</i> = 15.8 Hz, 1H), 4.35 (q, <i>J</i> = 6.9 Hz, 2H), 3.42 (app.q, <i>J</i> = 6.2 Hz, 2H), 2.46 (t, <i>J</i> = 6.4 Hz, 2H), 1.35 (s, 9H), 1.34 (t, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 189.8, 171.1, 169.1, 165.4, 161.0, 148.0, 146.4, 137.5, 133.8, 130.99, 130.97, 130.83, 128.9, 127.9, 126.8, 122.7, 117.7, 116.8, 110.0, 80.4, 61.4, 49.3, 45.3, 35.2, 28.2, 22.5, 14.4.</div></div><div id="sec4_4_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> Ethyl 2-((5-(2-((3-((2-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)amino)-3-oxopropyl)amino)-7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)thiazole-4-carboxylate (<b>93</b>)</h4><div class="NLM_p last">A stirred solution of <b>92</b> (200 mg, 0.30 mmol) in DCM (12 mL) was treated with trifluoroacetic acid (6 mL) and stirred at rt for 30 min until completion was observed by TLC. The RM was diluted with toluene (25 mL) and concentrated in vacuo to one-fifth the volume; this was repeated three times before the product was concentrated to dryness to afford a yellow solid. LC-MS (ESI+) Rt: 2.77 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 616.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. The intermediate (45 mg, 0.073 mmol) in DCM (3 mL) was treated with Et<sub>3</sub>N (60 μL) and <i>N</i>-Boc-ethylenediamine (70 mg, 0.438 mmol) followed by HATU (56 mg, 0.146 mmol) and stirred at rt for 24 h until completion was observed by LC-MS. The RM was quenched with MeOH (1 mL) and concentrated directly onto silica. This was purified by FC (1–5% MeOH/DCM) to afford the title compound, <b>93</b>, at 5% MeOH/DCM as a yellow solid (35 mg, 0.046 mmol, 63%). LC-MS (ESI+) Rt: 2.88 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 758.2 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.86 (s, 1H), 8.55 (s, 1H), 7.91 (t, <i>J</i> = 5.7 Hz, 1H), 7.88 (t, <i>J</i> = 6.3 Hz, 1H), 7.75 (s, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 1H), 7.40 (d, <i>J</i> = 2.2 Hz, 1H), 7.36 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 6.78–6.75 (m, 1H), 6.75 (s, 2H), 5.68 (s, 1H), 5.41 (d, <i>J</i> = 15.8 Hz, 1H), 5.26 (d, <i>J</i> = 15.8 Hz, 1H), 4.35 (q, <i>J</i> = 7.0 Hz, 2H), 3.42 (app.q, <i>J</i> = 6.2 Hz, 2H), 3.04 (app.q, <i>J</i> = 6.0 Hz, 2H), 2.97–2.93 (m, 2H), 2.34 (t, <i>J</i> = 6.7 Hz, 3H), 1.39–1.36 (m, 9H), 1.34 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_4_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> <i>tert</i>-Butyl (2-(3-((4-(1-((4-((1<i>H</i>-Tetrazol-5-yl)carbamoyl)thiazol-2-yl)methyl)-2-oxo-4-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-2-yl)amino)propanamido)ethyl)carbamate (<b>94</b>)</h4><div class="NLM_p last">A stirred solution of <b>93</b> (30 mg, 0.040 mmol) in MeOH (4 mL) was treated with 1 M NaOH (120 μL, 0.120 mmol) and heated to reflux for 4 h under N<sub>2</sub> until completion was observed by LC-MS. This was cooled, treated with 1 M HCl (120 μL, 0.120 mmol), diluted with toluene (25 mL), and concentrated in vacuo to one-fifth the volume; this was repeated three times before the product was concentrated to dryness to afford a yellow solid. This was dissolved in DMF (2 mL), treated with DIPEA (35 μL) and 5-aminotetrazole monohydrate (25 mg, 0.240 mmol) followed by PyBroP (28 mg, 0.60 mmol), and stirred at rt for 4 h until completion was observed by LC-MS. The RM was quenched with water (ca. two drops) and concentrated in vacuo. The DMF was azeotroped with toluene (3 × 50 mL) to afford an orange oil. This was purified by FC and washed with 10% MeOH/DCM before the title compound, <b>94</b>, was eluted with 10% MeOH/DCM with 1% acetic acid (9 mg, 0.011 mmol, 28%). LC-MS (ESI+) Rt: 2.68 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 797.4 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>32</sub>H<sub>32</sub>ClN<sub>12</sub>O<sub>5</sub>S<sub>3</sub>, 795.1475; found, 795.1437. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.92–12.78 (br.s, 1H), 8.53–8.43 (br.s, 1H), 7.99–7.89 (s, 2H), 7.74–7.68 (br.s, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 1H), 7.40 (d, <i>J</i> = 2.2 Hz, 1H), 7.35 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 6.78–6.76 (m, 2H), 5.68 (s, 1H), 5.40 (d, <i>J</i> = 15.9 Hz, 1H), 5.29 (d, <i>J</i> = 15.9 Hz, 1H), 4.12–4.09 (m, 2H), 3.41 (app.q, <i>J</i> = 6.5 Hz, 2H), 3.06–3.03 (m, 2H), 2.99–2.94 (m, 2H), 1.36–1.21 (m, 9H).</div></div><div id="sec4_4_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> (<i>E</i>)-2-((5-(7-Chloro-2-((3-((2-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)ethyl)amino)-3-oxopropyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-(1<i>H</i>-tetrazol-5-yl)thiazole-4-carboxamide (<b>95</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>94</b> was converted to the BODIPY630/650 conjugate, <b>95</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>95</b> at a retention time of 10.80 min. This compound was freeze-dried to a blue, iridescent solid (0.35 mg, 0.31 μmol, 16%). LC-MS (ESI+) Rt: 3.00 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 1129.5 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>50</sub>H<sub>41</sub>BClF<sub>2</sub>N<sub>14</sub>O<sub>5</sub>S<sub>4</sub>, 1129.2011; found, 1129.2000. [M + Na]<sup>+</sup> calcd for C<sub>50</sub>H<sub>40</sub>BClF<sub>2</sub>N<sub>14</sub>NaO<sub>5</sub>S<sub>4</sub>, 1151.1831; found, 1151.1823. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>50</sub>H<sub>39</sub>BClF<sub>2</sub>N<sub>14</sub>O<sub>5</sub>S<sub>4</sub>, 1127.1866; found, 1127.1818.</div></div><div id="sec4_4_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> (<i>E</i>)-2-((5-(7-Chloro-2-((3-((2-(3-(5,5-difluoro-7,9-dimethyl-5<i>H</i>-5λ<sup>4</sup>,6λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)propanamido)ethyl)amino)-3-oxopropyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-(1<i>H</i>-tetrazol-5-yl)thiazole-4-carboxamide (<b>96</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>94</b> was converted to the BODIPYFL conjugate, <b>96</b>. This was purified by preparative RP-HPLC (Method 3), which isolated <b>96</b> at a retention time of 12.05 min. This compound was  freeze-dried to a red-green, iridescent solid (0.21 mg, 0.22 μmol, 11%). LC-MS (ESI+) Rt: 2.76 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 971.4 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>):  [M + H] <sup>+</sup> calcd for C<sub>41</sub>H<sub>39</sub>BClF<sub>2</sub>N <sub>14</sub>O<sub>4</sub>S<sub>3</sub>, 971.2185; found, 971.2189.   [M + Na] <sup>+</sup> calcd for C<sub>41</sub>H<sub>38</sub>BClF<sub>2</sub>N <sub>14</sub>NaO<sub>4</sub>S<sub>3</sub>, 993.2004; found, 993.2002.</div></div><div id="sec4_4_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> (<i>E</i>)-2-((5-(7-Chloro-2-((3-((2-(6-(2-(4-(2-(5,5-difluoro-7-(thiophen-2-yl)-5<i>H</i>-4λ<sup>4</sup>,5λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)vinyl)phenoxy)acetamido)hexanamido)ethyl)amino)-3-oxopropyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-(1<i>H</i>-tetrazol-5-yl)thiazole-4-carboxamide (<b>97</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>94</b> was converted to the BODIPY630/650-X conjugate, <b>97</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>97</b> at a retention time of 11.28 min. This compound was freeze-dried to a blue, iridescent solid (0.44 mg, 0.35 μmol, 18%). LC-MS (ESI+) Rt: 2.99 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 1242.4 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>56</sub>H<sub>52</sub>BClF<sub>2</sub>N<sub>15</sub>O<sub>6</sub>S<sub>4</sub>, 1242.2852; found, 1242.2858. [M + Na]<sup>+</sup> calcd for C<sub>50</sub>H<sub>40</sub>BClF<sub>2</sub>N<sub>14</sub>NaO<sub>5</sub>S<sub>4</sub>, 1264.2671; found, 1264.2624.</div></div><div id="sec4_4_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> (<i>E</i>)-2-((5-(7-Chloro-2-((3-((2-(6-(3-(5,5-difluoro-7,9-dimethyl-5<i>H</i>-5λ<sup>4</sup>,6λ<sup>4</sup>-dipyrrolo[1,2-<i>c</i>:2′,1′-<i>f</i>][1,3,2]diazaborinin-3-yl)propanamido)hexanamido)ethyl)amino)-3-oxopropyl)amino)-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazol-4-yl)-2-oxo-4-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)methyl)-<i>N</i>-(1<i>H</i>-tetrazol-5-yl)thiazole-4-carboxamide (<b>98</b>)</h4><div class="NLM_p last">Following general procedure 3, <b>94</b> was converted to the BODIPYFL-X conjugate, <b>98</b>. This was purified by preparative RP-HPLC (Method 4), which isolated <b>94</b> at a retention time of 12.69 min. This compound was  freeze-dried to a red-green, iridescent solid (0.35 mg, 0.31 μmol, 18%). LC-MS (ESI+) Rt: 2.75 min (254 nm, Method 1); (<i>m</i>/<i>z</i>): 1084.6 [M(<sup>35</sup>Cl)+H]<sup>+</sup>. H.MS-TOF (ESI+) (<i>m</i>/<i>z</i>):  [M + H] <sup>+</sup> calcd for C<sub>47</sub>H<sub>50</sub>BClF<sub>2</sub>N <sub>15</sub>O<sub>5</sub>S<sub>3</sub>, 1084.3026; found, 1085.3014.   [M + Na] <sup>+</sup> calcd for C<sub>47</sub>H<sub>49</sub>BClF<sub>2</sub>N <sub>15</sub>O<sub>5</sub>S<sub>3</sub>, 1106.2845; found, 1128.2825. H.MS-TOF (ESI−) (<i>m</i>/<i>z</i>): [M–H]<sup>−</sup> calcd for C<sub>47</sub>H<sub>48</sub>BClF<sub>2</sub>N<sub>15</sub>O<sub>5</sub>S<sub>3</sub>, 1082.2880; found, 1082.2839.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> General Pharmacology Methods</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> cDNA Constructs</h4><div class="NLM_p last">To create the NLuc-P2Y<sub>2</sub>R constructs, human P2Y<sub>2</sub>R DNA (obtained from the Missouri S&T cDNA Resource Center) was amplified by PCR to remove the methionine start signal and cloned into pCR2.1 (linearized vector, Invitrogen). P2Y<sub>2</sub>R was then subcloned in-frame with the membrane-signal sequence of the 5HT<sub>3A</sub> receptor and the full-length sequence of nanoluciferase. The NLuc-tagged receptors expressed in 1321N1 cells exhibited normal calcium signals (EC<sub>50</sub> for UTPγS of 91 ± 12 nM, <i>n</i> = 3).</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Cell Culture and Cell-Line Generation</h3><div class="NLM_p last">The 1321N1 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal calf serum (FCS HI) and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine at 37 °C with 5% CO<sub>2</sub>. Mixed-population NLuc-P2Y2R-1321N1 cell lines were generated by transfecting the NLuc-P2Y<sub>2</sub>R construct using Lipofectamine 2000 (Life Technologies) according to the manufacturer’s instructions and then subjecting the cells to selective pressure (1 mg/mL G418) for 2–3 weeks. The mixed cell population was then dilution-cloned to obtain cell lines originating from a single cell. Screening for the active clones was initially performed with the calcium-mobilization assay and was followed by the detection of luminescence upon the addition of the NLuc substrate, furimazine. On this basis, a single, active, cloned cell line was selected for use in all of the NanoBRET assays. The 1321N1 cells expressing wild-type P2Y<sub>2</sub>R (P2Y<sub>2</sub>R-1321N1) were gifted by Dr. Elizabeth Rosethorne, University of Nottingham.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> Calcium-Mobilization Assay</h3><div class="NLM_p last">P2Y<sub>2</sub>-1321N1 cells seeded into black-sided 96-well view plates were incubated at 37 °C without CO<sub>2</sub> for 45 min in a total volume of 100 μL of a HEPES-buffered saline solution (HBSS; 10 mM HEPES, 10 mM glucose, 145 mM NaCl, 5 mM KCl, 1 mM MgSO<sub>4</sub>, 2 mM sodium pyruvate, and 1.3 mM CaCl<sub>2</sub>) containing 2.5 mM probenecid, 2.3 μM Fluo 4AM, 0.023% pluronic acid, 0.5 mM Brilliant Black, 1 U/mL apyrase, and the ligand under investigation or the vehicle. The plates were then loaded onto a plate reader (FLEXstation, Molecular Devices), and the fluorescence was measured (excitation: 485 nm, emission: 525 nm) every 1.52 s for up to 200 s after the addition of UTPγS at 15 s. For the investigation of the BODIPYFL-labeled ligands, Fluo 4AM was replaced with 2.0 μM X-Rhod-1 AM (excitation: 584 nm, emission: 612 nm).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> NanoBRET Assay</h3><div class="NLM_p last">The saturation and competition binding assays were performed according to the methodology of Stoddart.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Briefly, the assays were performed on stably transfected NLucP2Y<sub>2</sub>-1321N1 cells that had been seeded 24 h prior to the experiment in white Thermo Scientific Matrix 96-well microplates. The medium in each well was removed and replaced with HBSS containing apyrase (1 U/mL) and the required concentration of the fluorescent ligand with or without the competing ligand. Upon the addition of the fluorescent ligand, the cells were incubated for 1 h at 37 °C without CO<sub>2</sub>. The NLuc substrate, furimazine (Promega), was then added to a final concentration of 10 μM, and the plate was incubated for a further 5 min at 37 °C without CO<sub>2</sub>. The luminescence and resulting BRET were measured using a PHERAstar FS plate reader (BMG Labtech) at room temperature. For the assays involving <b>97</b>, sequential measurements of the filtered light emissions were made at 460 nm (80 nm bandpass) and >610 nm (long-pass), and the raw BRET ratios were calculated by dividing the >610 nm emissions by the 460 nm emissions. For the assays involving <b>98</b>, the measurements were made at 475 nm (30 nm bandpass) and 535 nm (30 nm bandpass), and the raw BRET ratios were calculated by dividing the 535 nm emissions by the 475 nm emissions.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> Confocal Microscopy</h3><div class="NLM_p last">The P2Y<sub>2</sub>R-1321N1 cells were grown to approximately 80% confluency on eight-well Labtek chambered cover glasses (Nunc Nalgene) in normal growth medium. The growth medium was removed and replaced with HBSS containing apyrase (1 U/mL) and either <b>1</b> (10 μM) or the vehicle, and the cells incubated for 30 min at 37 °C without CO<sub>2</sub>. The cells were then incubated with <b>97</b> or <b>98</b> at the required concentration for 10 min at room temperature prior to the collection of the single-equatorial confocal images. The images were obtained on a Zeiss LSM710 confocal microscope using a 40× c-Apochromat 1.2NA water-immersion objective. For <b>97</b>, the images were collected using a 633 nm excitation wavelength and a 488/561/633 dichroic, and the emissions were collected through a 650LP filter. For <b>98</b>, a 488 nm excitation wavelength was used with the same dichroic, and the emissions were collected using an LP575 filter. In each case, a pinhole diameter of 1 airy unit was used, and the laser power, gain, and offset were kept the same for all of the samples within each experiment. For both <b>97</b> and <b>98</b>, the images presented are as representative of an individual experiment with matched conditions. Linear adjustments to the image brightness and contrast have been applied equally across all of the comparative images using Zen software in order to prepare the images for presentation.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> Data Analysis</h3><div class="NLM_p">All of the data were analyzed using GraphPad Prism 6.</div><div class="NLM_p">For the calcium-mobilization experiments, as none of the compounds synthesized as part of this study showed any partial-agonist actions, the estimated affinity values (p<i>K</i><sub>b</sub>) were calculated from the shifts of the agonist-concentration–response curves in the presence of the fluorescent antagonists using <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>:<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_m001.gif" alt="" id="_i125" /></img><span class="labelSpan">(1)</span></span>where DR (dose ratio) is the ratio of the agonist concentration required to stimulate an identical response in the presence and absence of the antagonist, b. The p<i>K</i><sub>b</sub> is −log <i>K</i><sub>b</sub>.</div><div class="NLM_p">The total and nonspecific saturation binding curves were fitted simultaneously using <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>:<span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_m002.gif" alt="" id="_i126" /></img><span class="labelSpan">(2)</span></span>where <i>B</i><sub>max</sub> is the maximum specific BRET signal, [b] is the nanomolar concentration of the fluorescent ligand, <i>K</i><sub>d</sub> is the equilibrium dissociation constant in nanomolar, <i>M</i> is the slope of the nonspecific-binding component, and <i>C</i> is the intercept with the <i>Y</i>-axis. The p<i>K</i><sub>d</sub> is −logK<sub>d</sub>.</div><div class="NLM_p last">The competition binding curves were fitted using <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>:<span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_m003.gif" alt="" id="_i127" /></img><span class="labelSpan">(3)</span></span>where [L] is the nanomolar concentration of <b>98</b>, and <i>K</i><sub>d</sub> is the equilibrium dissociation constant of <b>98</b> in nanomolar. The IC<sub>50</sub> was calculated as in <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>:<span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_m004.gif" alt="" id="_i128" /></img><span class="labelSpan">(4)</span></span>where [A] is the concentration of the unlabeled competing drug, and the IC<sub>50</sub> is the molar concentration of the competing ligand required to inhibit 50% of the specific binding of the labeled ligand at a given concentration ([L]).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i129"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00139" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00139" class="ext-link">10.1021/acs.jmedchem.8b00139</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular-formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Description of the VCD structure determination and figure showing the binding of the BODIPY630/650-labeled (<b>78</b>–<b>84</b>) and BODIPYFL-labeled (<b>85</b>–<b>91</b>) ligands in NLuc-P2Y<sub>2</sub>-1321N1 cells using the NanoBRET assay (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_001.csv">jm8b00139_si_001.csv (4.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_002.pdf">jm8b00139_si_002.pdf (884.04 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00139" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Stocks</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Centre for Biomolecular Sciences, University Park Nottingham, Nottingham NG7 2RD, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3046-137X" title="Orcid link">http://orcid.org/0000-0003-3046-137X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f19c98929990949ddf82859e929a82b19f9e8585989f9699909cdf9092df849a"><span class="__cf_email__" data-cfemail="b5d8dcd6ddd4d0d99bc6c1dad6dec6f5dbdac1c1dcdbd2ddd4d89bd4d69bc0de">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Conroy</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Centre for Biomolecular Sciences, University Park Nottingham, Nottingham NG7 2RD, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas D. Kindon</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Centre for Biomolecular Sciences, University Park Nottingham, Nottingham NG7 2RD, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqueline Glenn</span> - <span class="hlFld-Affiliation affiliation">Division
of Physiology, Pharmacology & Neuroscience, Medical School, University of Nottingham, Nottingham NG7 2UH, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
of Membrane Proteins and Receptors, University
of Birmingham and University of Nottingham, the Midlands NG7 2UH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leigh A. Stoddart</span> - <span class="hlFld-Affiliation affiliation">Division
of Physiology, Pharmacology & Neuroscience, Medical School, University of Nottingham, Nottingham NG7 2UH, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
of Membrane Proteins and Receptors, University
of Birmingham and University of Nottingham, the Midlands NG7 2UH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard J. Lewis</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech
Unit, AstraZeneca, Mölndal, Gothenburg 431 83, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen J. Hill</span> - <span class="hlFld-Affiliation affiliation">Division
of Physiology, Pharmacology & Neuroscience, Medical School, University of Nottingham, Nottingham NG7 2UH, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
of Membrane Proteins and Receptors, University
of Birmingham and University of Nottingham, the Midlands NG7 2UH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barrie Kellam</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Centre for Biomolecular Sciences, University Park Nottingham, Nottingham NG7 2RD, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
of Membrane Proteins and Receptors, University
of Birmingham and University of Nottingham, the Midlands NG7 2UH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0030-9908" title="Orcid link">http://orcid.org/0000-0003-0030-9908</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.C. and N.D.K. contributed equally to this work. S.J.H., B.K., and M.J.S. conceived the study and managed the project. S.C., N.D.K., and M.J.S. performed the chemical syntheses. R.J.L. performed the VCD structural determination. S.J.H., L.A.S., S.C., N.D.K., B.K., and M.J.S. participated in the research design. J.G. conducted the pharmacology experiments. J.G., L.A.S., and S.J.H. performed the pharmacology-data analysis. All of the authors wrote or contributed to the writing of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by the U.K. Medical Research Council (grant numbers MR/L016389/1 and MR/N020081/1) and an MRC-funded research studentship for S.C. (MRC-funded Ph.D. studentship reference number 1365529).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d86e11133-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i131">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56445" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56445" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Elizabeth Rosethorne for supplying the P2Y<sub>2</sub>-1321N1 astrocytoma cells, Mr. Nickolaj Groenewoud for assistance with the molecular biology, and Miss Seema Rajani for assistance with the confocal-microscopy work.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine 5′-triphosphate</p></td></tr><tr><td class="NLM_term">BODIPY</td><td class="NLM_def"><p class="first last">boron-dipyrromethene</p></td></tr><tr><td class="NLM_term">BODIPY</td><td class="NLM_def"><p class="first last">boron-dipyrromethene</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence-resonance-energy transfer</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">FC</td><td class="NLM_def"><p class="first last">flash chromatography</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>d</sub></td><td class="NLM_def"><p class="first last">dissociation constant of a labeled ligand–receptor complex</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">dissociation constant of a ligand–receptor complex determined through a binding assay</p></td></tr><tr><td class="NLM_term">LC-MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">microwave</p></td></tr><tr><td class="NLM_term">NanoBRET</td><td class="NLM_def"><p class="first last">nanoluciferase-bioluminescence-resonance-energy transfer</p></td></tr><tr><td class="NLM_term">NLuc</td><td class="NLM_def"><p class="first last">nanoluciferase</p></td></tr><tr><td class="NLM_term">PREP</td><td class="NLM_def"><p class="first last">preparative</p></td></tr><tr><td class="NLM_term">RM</td><td class="NLM_def"><p class="first last">reaction mixture</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reverse phase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">UTPγS</td><td class="NLM_def"><p class="first last">uridine-5′-(γ-thio)-triphosphate</p></td></tr><tr><td class="NLM_term">VCD</td><td class="NLM_def"><p class="first last">vibrational circular dichroism</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i133">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbracchio, M. P.</span></span> <span> </span><span class="NLM_article-title">International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1124/pr.58.3.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1124%2Fpr.58.3.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=16968944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=281-341&issue=3&author=M.+P.+Abbracchio&title=International+Union+of+Pharmacology+LVIII%3A+Update+on+the+P2Y+G+Protein-Coupled+Nucleotide+Receptors%3A+From+Molecular+Mechanisms+and+Pathophysiology+to+Therapy&doi=10.1124%2Fpr.58.3.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy</span></div><div class="casAuthors">Abbracchio, Maria P.; Burnstock, Geoffrey; Boeynaems, Jean-Marie; Barnard, Eric A.; Boyer, Jose L.; Kennedy, Charles; Knight, Gillian E.; Fumagalli, Marta; Gachet, Christian; Jacobson, Kenneth A.; Weisman, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-341</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  There have been many advances in our knowledge about different aspects of P2Y receptor signaling since the last review published by our International Union of Pharmacol. subcommittee.  More receptor subtypes have been cloned and characterized and most orphan receptors deorphanized, so that it is now possible to provide a basis for a future subdivision of P2Y receptor subtypes.  More is known about the functional elements of the P2Y receptor mols. and the signaling pathways involved, including interactions with ion channels.  There have been substantial developments in the design of selective agonists and antagonists to some of the P2Y receptor subtypes.  There are new findings about the mechanisms underlying nucleotide release and ectoenzymic nucleotide breakdown.  Interactions between P2Y receptors and receptors to other signaling mols. have been explored as well as P2Y-mediated control of gene transcription.  The distribution and roles of P2Y receptor subtypes in many different cell types are better understood and P2Y receptor-related compds. are being explored for therapeutic purposes.  These and other advances are discussed in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3-m5Cf-JzaLVg90H21EOLACvtfcHk0liwqGoEJ_SGEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLbF&md5=b302ee34857a5f45d740e4f2e962ed42</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.3%26sid%3Dliteratum%253Aachs%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology%2520LVIII%253A%2520Update%2520on%2520the%2520P2Y%2520G%2520Protein-Coupled%2520Nucleotide%2520Receptors%253A%2520From%2520Molecular%2520Mechanisms%2520and%2520Pathophysiology%2520to%2520Therapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26issue%3D3%26spage%3D281%26epage%3D341%26doi%3D10.1124%2Fpr.58.3.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C.</span></span> <span> </span><span class="NLM_article-title">Is There a Basis for Distinguishing Two Types of P2-Purinoceptor?</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">433</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1016/0306-3623(85)90001-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2F0306-3623%2885%2990001-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=2996968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADyaL2MXlsFChtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1985&pages=433-440&issue=5&author=G.+Burnstockauthor=C.+Kennedy&title=Is+There+a+Basis+for+Distinguishing+Two+Types+of+P2-Purinoceptor%3F&doi=10.1016%2F0306-3623%2885%2990001-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a basis for distinguishing two types of P2-purinoceptor?</span></div><div class="casAuthors">Burnstock, G.; Kennedy, C.</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">433-40</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    </div><div class="casAbstract">A review with approx. 70 refs. of studies indicating that the P2-purinergic receptors may be sepd. into 2 subtypes largely on the basis of the rank order of agonist potency of structural analogs of ATP and also on the activity of antagonists at the P2-purinoceptor.  Differences in the structure of P2-purinoceptors in various tissues may be useful in the development of drugs for the treatment of vascular, gastrointestinal, and urinogenital disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpejfAeAGiLzrVg90H21EOLACvtfcHk0lgm5gx1cjEE2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsFChtr0%253D&md5=0edabb89502eb887e0cfabc936e06601</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2885%2990001-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252885%252990001-1%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DKennedy%26aufirst%3DC.%26atitle%3DIs%2520There%2520a%2520Basis%2520for%2520Distinguishing%2520Two%2520Types%2520of%2520P2-Purinoceptor%253F%26jtitle%3DGen.%2520Pharmacol.%26date%3D1985%26volume%3D16%26issue%3D5%26spage%3D433%26epage%3D440%26doi%3D10.1016%2F0306-3623%2885%2990001-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazarowski, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutts, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, T. K.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Selectivity of the Cloned Human P2U-Purinoceptor: Potent Activation by Diadenosine Tetraphosphate</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1619</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1995.tb16382.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1111%2Fj.1476-5381.1995.tb16382.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=8564228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVKktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1995&pages=1619-1627&issue=1&author=E.+R.+Lazarowskiauthor=W.+C.+Wattauthor=M.+J.+Stuttsauthor=R.+C.+Boucherauthor=T.+K.+Harden&title=Pharmacological+Selectivity+of+the+Cloned+Human+P2U-Purinoceptor%3A+Potent+Activation+by+Diadenosine+Tetraphosphate&doi=10.1111%2Fj.1476-5381.1995.tb16382.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate</span></div><div class="casAuthors">Lazarowski, Eduardo R.; Watt, William C.; Stutts, M. Jackson; Boucher, Richard C.; Harden, T. Kendall</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1619-27</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">The human P2U-purinoceptor was stably expressed in 1321N1 human astrocytoma cells and the pharmacol. selectivity of the expressed receptor was studied by measurement of inositol lipid hydrolysis.  High basal levels of inositol phosphates occurred in P2U-purinoceptor-expressing cells.  This phenomenon was shown to be due to release of large amts. of ATP from 1321N1 cells, and could be circumvented by adoption of an assay protocol that did not involve medium changes.  UTP, ATP and ATPγS were full and potent agonists for activation of phospholipase C with EC50 values of 140 nM, 230 nM, and 1.72 μM, resp.  5BrUTP, 2C1ATP and 8BrATP were also full agonists although less potent than their natural congeners.  Little or no effect was obsd. with the selective P2y-, P2X-, and P2T-purinoceptor agonists, 2MeSATP, α,β-MeATP, and 2MeSADP, resp.  Diadenosine tetraphosphate, Ap4A, was a surprisingly potent agonist at the expressed P2U-purinoceptor with an EC50 (720 nM) in the range of the most potent P2U-purinoceptor agonists.  Ap4A may be a physiol. important activator of P2U-purinoceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdomI8KI4cx7Vg90H21EOLACvtfcHk0lgm5gx1cjEE2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVKktLY%253D&md5=f5f4f71d7f0df38f26e501094e3373f5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb16382.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb16382.x%26sid%3Dliteratum%253Aachs%26aulast%3DLazarowski%26aufirst%3DE.%2BR.%26aulast%3DWatt%26aufirst%3DW.%2BC.%26aulast%3DStutts%26aufirst%3DM.%2BJ.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DHarden%26aufirst%3DT.%2BK.%26atitle%3DPharmacological%2520Selectivity%2520of%2520the%2520Cloned%2520Human%2520P2U-Purinoceptor%253A%2520Potent%2520Activation%2520by%2520Diadenosine%2520Tetraphosphate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D116%26issue%3D1%26spage%3D1619%26epage%3D1627%26doi%3D10.1111%2Fj.1476-5381.1995.tb16382.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocks, M. J.</span></span> <span> </span><span class="NLM_article-title">Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9981</span>– <span class="NLM_lpage">10005</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9981-10005&issue=22&author=S.+Conroyauthor=N.+Kindonauthor=B.+Kellamauthor=M.+J.+Stocks&title=Drug-like+Antagonists+of+P2Y+Receptors-From+Lead+Identification+to+Drug+Development&doi=10.1021%2Facs.jmedchem.5b01972"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01972%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DS.%26aulast%3DKindon%26aufirst%3DN.%26aulast%3DKellam%26aufirst%3DB.%26aulast%3DStocks%26aufirst%3DM.%2BJ.%26atitle%3DDrug-like%2520Antagonists%2520of%2520P2Y%2520Receptors-From%2520Lead%2520Identification%2520to%2520Drug%2520Development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D22%26spage%3D9981%26epage%3D10005%26doi%3D10.1021%2Facs.jmedchem.5b01972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strilic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraj, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettschureck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">Platelet-Derived Nucleotides Promote Tumor-Cell Transendothelial Migration and Metastasis <i>via</i> P2Y<sub>2</sub> Receptor</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">130</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2Fj.ccr.2013.05.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=130-137&issue=1&author=D.+Schumacherauthor=B.+Strilicauthor=K.+K.+Sivarajauthor=N.+Wettschureckauthor=S.+Offermanns&title=Platelet-Derived+Nucleotides+Promote+Tumor-Cell+Transendothelial+Migration+and+Metastasis+via+P2Y2+Receptor&doi=10.1016%2Fj.ccr.2013.05.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DD.%26aulast%3DStrilic%26aufirst%3DB.%26aulast%3DSivaraj%26aufirst%3DK.%2BK.%26aulast%3DWettschureck%26aufirst%3DN.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DPlatelet-Derived%2520Nucleotides%2520Promote%2520Tumor-Cell%2520Transendothelial%2520Migration%2520and%2520Metastasis%2520via%2520P2Y2%2520Receptor%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26issue%3D1%26spage%3D130%26epage%3D137%26doi%3D10.1016%2Fj.ccr.2013.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Virgilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliani, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adinolfi, E.</span></span> <span> </span><span class="NLM_article-title">P2 Receptors in Cancer Progression and Metastatic Spreading</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2016.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2Fj.coph.2016.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=27262778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC28XotF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=17-25&author=F.+Di%0AVirgilioauthor=S.+Falzoniauthor=A.+L.+Giulianiauthor=E.+Adinolfi&title=P2+Receptors+in+Cancer+Progression+and+Metastatic+Spreading&doi=10.1016%2Fj.coph.2016.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">P2 receptors in cancer progression and metastatic spreading</span></div><div class="casAuthors">Di Virgilio, Francesco; Falzoni, Simonetta; Giuliani, Anna Lisa; Adinolfi, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-25</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor microenvironment is nucleoside and nucleotide rich.  Adenosine is a key determinant of the highly immunosuppressive tumor interstitium.  Extracellular ATP also affects anti-tumor immunity, albeit its effects on host-tumor interaction are incompletely understood.  We give here an overview of recent literature covering the role of nucleotide-selective (P2) plasma membrane receptors in tumor growth and progression.  P2 receptors are expressed on both host and cancer cells, where depending on the receptor subtype, the inflammatory infiltrate and the tumor cell type they may drive an anti-tumor response or promote tumor progression.  It is anticipated that knowledge of the pharmacol., biochem. and functional activity of the P2 receptors will allow a better understanding of host-tumor interaction and the development of innovative anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxdlW1FuqvubVg90H21EOLACvtfcHk0lgKPtJlREk4nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotF2rtbY%253D&md5=7caad662c50efbf79cea14fc42fdc8b2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2016.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2016.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26aulast%3DFalzoni%26aufirst%3DS.%26aulast%3DGiuliani%26aufirst%3DA.%2BL.%26aulast%3DAdinolfi%26aufirst%3DE.%26atitle%3DP2%2520Receptors%2520in%2520Cancer%2520Progression%2520and%2520Metastatic%2520Spreading%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2016%26volume%3D29%26spage%3D17%26epage%3D25%26doi%3D10.1016%2Fj.coph.2016.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmouty-Quintana, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zissel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lungarella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Virgilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeynaems, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idzko, M.</span></span> <span> </span><span class="NLM_article-title">The Purinergic Receptor Subtype P2Y<sub>2</sub> Mediates Chemotaxis of Neutrophils and Fibroblasts in Fibrotic Lung Disease</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">35962</span>– <span class="NLM_lpage">35972</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.16414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.18632%2Foncotarget.16414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=35962-35972&issue=22&author=T.+M%C3%BCllerauthor=S.+Fayauthor=R.+P.+Vieiraauthor=H.+Karmouty-Quintanaauthor=S.+Cickoauthor=K.+Ayataauthor=G.+Zisselauthor=T.+Goldmannauthor=G.+Lungarellaauthor=D.+Ferrariauthor=F.+Di+Virgilioauthor=B.+Robayeauthor=J.-M.+Boeynaemsauthor=M.+R.+Blackburnauthor=M.+Idzko&title=The+Purinergic+Receptor+Subtype+P2Y2+Mediates+Chemotaxis+of+Neutrophils+and+Fibroblasts+in+Fibrotic+Lung+Disease&doi=10.18632%2Foncotarget.16414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.16414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.16414%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%26aulast%3DFay%26aufirst%3DS.%26aulast%3DVieira%26aufirst%3DR.%2BP.%26aulast%3DKarmouty-Quintana%26aufirst%3DH.%26aulast%3DCicko%26aufirst%3DS.%26aulast%3DAyata%26aufirst%3DK.%26aulast%3DZissel%26aufirst%3DG.%26aulast%3DGoldmann%26aufirst%3DT.%26aulast%3DLungarella%26aufirst%3DG.%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26aulast%3DRobaye%26aufirst%3DB.%26aulast%3DBoeynaems%26aufirst%3DJ.-M.%26aulast%3DBlackburn%26aufirst%3DM.%2BR.%26aulast%3DIdzko%26aufirst%3DM.%26atitle%3DThe%2520Purinergic%2520Receptor%2520Subtype%2520P2Y2%2520Mediates%2520Chemotaxis%2520of%2520Neutrophils%2520and%2520Fibroblasts%2520in%2520Fibrotic%2520Lung%2520Disease%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26issue%3D22%26spage%3D35962%26epage%3D35972%26doi%3D10.18632%2Foncotarget.16414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougall, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKechnie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meghani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocks, M. J.</span></span> <span> </span><span class="NLM_article-title">From UTP to AR-C118925, the Discovery of a Potent Non Nucleotide Antagonist of the P2Y<sub>2</sub> Receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4849</span>– <span class="NLM_lpage">4853</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2Fj.bmcl.2017.09.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4849-4853&issue=21&author=N.+Kindonauthor=A.+Davisauthor=I.+Dougallauthor=J.+Dixonauthor=T.+Johnsonauthor=I.+Waltersauthor=S.+Thomauthor=K.+McKechnieauthor=P.+Meghaniauthor=M.+J.+Stocks&title=From+UTP+to+AR-C118925%2C+the+Discovery+of+a+Potent+Non+Nucleotide+Antagonist+of+the+P2Y2+Receptor&doi=10.1016%2Fj.bmcl.2017.09.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DKindon%26aufirst%3DN.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DDougall%26aufirst%3DI.%26aulast%3DDixon%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DWalters%26aufirst%3DI.%26aulast%3DThom%26aufirst%3DS.%26aulast%3DMcKechnie%26aufirst%3DK.%26aulast%3DMeghani%26aufirst%3DP.%26aulast%3DStocks%26aufirst%3DM.%2BJ.%26atitle%3DFrom%2520UTP%2520to%2520AR-C118925%252C%2520the%2520Discovery%2520of%2520a%2520Potent%2520Non%2520Nucleotide%2520Antagonist%2520of%2520the%2520P2Y2%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D21%26spage%3D4849%26epage%3D4853%26doi%3D10.1016%2Fj.bmcl.2017.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindon, N. D.</span>; <span class="NLM_string-name">Meghani, P.</span>; <span class="NLM_string-name">Thom, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-oxo-4-thioxopyrimidin-1-ylmethylheterocyclylcarboxylates as P2-purinoceptor 7-transmembrane G-protein Coupled Receptor Antagonists</span>. <span class="NLM_patent">WO9854180</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=N.+D.+Kindon&author=P.+Meghani&author=S.+Thom&title=Preparation+of+2-oxo-4-thioxopyrimidin-1-ylmethylheterocyclylcarboxylates+as+P2-purinoceptor+7-transmembrane+G-protein+Coupled+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKindon%26aufirst%3DN.%2BD.%26atitle%3DPreparation%2520of%25202-oxo-4-thioxopyrimidin-1-ylmethylheterocyclylcarboxylates%2520as%2520P2-purinoceptor%25207-transmembrane%2520G-protein%2520Coupled%2520Receptor%2520Antagonists%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugar, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, A. D.</span></span> <span> </span><span class="NLM_article-title">Nucleotide-Mediated Mucin Secretion from Differentiated Human Bronchial Epithelial Cells</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2003-0211OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1165%2Frcmb.2003-0211OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=15231488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot12ntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=446-455&issue=4&author=P.+A.+Kempauthor=R.+A.+Sugarauthor=A.+D.+Jackson&title=Nucleotide-Mediated+Mucin+Secretion+from+Differentiated+Human+Bronchial+Epithelial+Cells&doi=10.1165%2Frcmb.2003-0211OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide-mediated mucin secretion from differentiated human bronchial epithelial cells</span></div><div class="casAuthors">Kemp, Philip A.; Sugar, Rosemary A.; Jackson, Alan D.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">446-455</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Most current cell-based models for examg. the regulation of mucin secretion demonstrate low signal-to-noise ratios, making exptl. manipulation and data interpretation difficult.  Using ATP (ATP) as a mucin secretagogue, we have developed a model of agonist-induced mucin secretion in differentiated human bronchial epithelial cells.  Mucin secretory signals were estd. using enzyme-linked lectin assay, and typical signals of 300-400% of baseline were obsd. in response to a 30-min exposure to ATP (100 μM).  ATP and uridine triphosphate equipotently stimulated mucin secretion consistent with mediation via P2Y2 receptor activation.  Suramin and AR-C118925XX, a competitive P2Y2 receptor antagonist, inhibited adenosine 5'-o-(3-thiotriphosphate) (ATP-γS)-induced mucin secretion.  A selective Gq G-protein antagonist (GP-ANT)-2A completely abrogated ATP-γS-induced mucin secretion.  Pertussis toxin and the Gi/o-specific, GP-ANT-2, had no effect.  The phospholipase C inhibitor, D609, and the protein kinase C inhibitor, calphostin C, substantially inhibited ATP-γS-induced mucin secretion.  Phorbol myristate acetate also stimulated mucin secretion in a calphostin C-sensitive manner.  ATP-γS-induced mucin secretion was inhibited by the Ca2+ chelator, 1,2-bis(o-aminophenoxy) ethane-N,N,N',N'-tetra-acetic acid tetra (acetoxymethyl) ester.  Ionomycin and thapsigargin both stimulated mucin secretion.  Our data are broadly consistent with known G-protein-coupling and downstream signaling events assocd. with the P2Y2 receptor.  The exceptional signal-to-noise ratios obtained using this model have permitted clear evaluation of the involvement of these mechanisms in agonist-induced mucin secretion from differentiated human bronchial epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj6XFmsXBGVrVg90H21EOLACvtfcHk0ligKeEThRuFSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot12ntLg%253D&md5=05567b0a6b6f4c1f88e45bc44ae82392</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2003-0211OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2003-0211OC%26sid%3Dliteratum%253Aachs%26aulast%3DKemp%26aufirst%3DP.%2BA.%26aulast%3DSugar%26aufirst%3DR.%2BA.%26aulast%3DJackson%26aufirst%3DA.%2BD.%26atitle%3DNucleotide-Mediated%2520Mucin%2520Secretion%2520from%2520Differentiated%2520Human%2520Bronchial%2520Epithelial%2520Cells%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2004%26volume%3D31%26issue%3D4%26spage%3D446%26epage%3D455%26doi%3D10.1165%2Frcmb.2003-0211OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rafehi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbiel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attah, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Characterization, and in Vitro Evaluation of the Selective P2Y<sub>2</sub> Receptor Antagonist AR-C118925</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1007/s11302-016-9542-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1007%2Fs11302-016-9542-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=89-103&issue=1&author=M.+Rafehiauthor=J.+C.+Burbielauthor=I.+Y.+Attahauthor=A.+Abdelrahmanauthor=C.+E.+M%C3%BCller&title=Synthesis%2C+Characterization%2C+and+in+Vitro+Evaluation+of+the+Selective+P2Y2+Receptor+Antagonist+AR-C118925&doi=10.1007%2Fs11302-016-9542-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs11302-016-9542-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-016-9542-3%26sid%3Dliteratum%253Aachs%26aulast%3DRafehi%26aufirst%3DM.%26aulast%3DBurbiel%26aufirst%3DJ.%2BC.%26aulast%3DAttah%26aufirst%3DI.%2BY.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DSynthesis%252C%2520Characterization%252C%2520and%2520in%2520Vitro%2520Evaluation%2520of%2520the%2520Selective%2520P2Y2%2520Receptor%2520Antagonist%2520AR-C118925%26jtitle%3DPurinergic%2520Signalling%26date%3D2017%26volume%3D13%26issue%3D1%26spage%3D89%26epage%3D103%26doi%3D10.1007%2Fs11302-016-9542-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, H.</span></span> <span> </span><span class="NLM_article-title">Development of Selective Agonists and Antagonists of P2Y Receptors</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1007/s11302-008-9106-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1007%2Fs11302-008-9106-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=75-89&issue=1&author=K.+A.+Jacobsonauthor=A.+A.+Ivanovauthor=S.+de+Castroauthor=T.+K.+Hardenauthor=H.+Ko&title=Development+of+Selective+Agonists+and+Antagonists+of+P2Y+Receptors&doi=10.1007%2Fs11302-008-9106-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs11302-008-9106-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-008-9106-2%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DHarden%26aufirst%3DT.%2BK.%26aulast%3DKo%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520Selective%2520Agonists%2520and%2520Antagonists%2520of%2520P2Y%2520Receptors%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26issue%3D1%26spage%3D75%26epage%3D89%26doi%3D10.1007%2Fs11302-008-9106-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jayasekara, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">4-Alkyloxyimino Derivatives of Uridine-5′-Triphosphate: Distal Modification of Potent Agonists as a Strategy for Molecular Probes of P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub> Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3874</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1021/jm500367e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500367e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3874-3883&issue=9&author=P.+S.+Jayasekaraauthor=M.+O.+Barrettauthor=C.+B.+Ballauthor=K.+A.+Brownauthor=E.+Hammesauthor=R.+Balasubramanianauthor=T.+K.+Hardenauthor=K.+A.+Jacobson&title=4-Alkyloxyimino+Derivatives+of+Uridine-5%E2%80%B2-Triphosphate%3A+Distal+Modification+of+Potent+Agonists+as+a+Strategy+for+Molecular+Probes+of+P2Y2%2C+P2Y4%2C+and+P2Y6+Receptors&doi=10.1021%2Fjm500367e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm500367e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500367e%26sid%3Dliteratum%253Aachs%26aulast%3DJayasekara%26aufirst%3DP.%2BS.%26aulast%3DBarrett%26aufirst%3DM.%2BO.%26aulast%3DBall%26aufirst%3DC.%2BB.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DHammes%26aufirst%3DE.%26aulast%3DBalasubramanian%26aufirst%3DR.%26aulast%3DHarden%26aufirst%3DT.%2BK.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3D4-Alkyloxyimino%2520Derivatives%2520of%2520Uridine-5%25E2%2580%25B2-Triphosphate%253A%2520Distal%2520Modification%2520of%2520Potent%2520Agonists%2520as%2520a%2520Strategy%2520for%2520Molecular%2520Probes%2520of%2520P2Y2%252C%2520P2Y4%252C%2520and%2520P2Y6%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D9%26spage%3D3874%26epage%3D3883%26doi%3D10.1021%2Fjm500367e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Böhme, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Illuminating the Life of GPCRs</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.1186/1478-811X-7-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1186%2F1478-811X-7-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=19602276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A280%3ADC%252BD1MrltVKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=16&issue=1&author=I.+B%C3%B6hmeauthor=A.+G.+Beck-Sickinger&title=Illuminating+the+Life+of+GPCRs&doi=10.1186%2F1478-811X-7-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating the life of GPCRs</span></div><div class="casAuthors">Bohme Ilka; Beck-Sickinger Annette G</div><div class="citationInfo"><span class="NLM_cas:title">Cell communication and signaling : CCS</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> The investigation of biological systems highly depends on the possibilities that allow scientists to visualize and quantify biomolecules and their related activities in real-time and non-invasively.  G-protein coupled receptors represent a family of very dynamic and highly regulated transmembrane proteins that are involved in various important physiological processes.  Since their localization is not confined to the cell surface they have been a very attractive "moving target" and the understanding of their intracellular pathways as well as the identified protein-protein-interactions has had implications for therapeutic interventions.  Recent and ongoing advances in both the establishment of a variety of labeling methods and the improvement of measuring and analyzing instrumentation, have made fluorescence techniques to an indispensable tool for GPCR imaging.  The illumination of their complex life cycle, which includes receptor biosynthesis, membrane targeting, ligand binding, signaling, internalization, recycling and degradation, will provide new insights into the relationship between spatial receptor distribution and function.  This review covers the existing technologies to track GPCRs in living cells.  Fluorescent ligands, antibodies, auto-fluorescent proteins as well as the evolving technologies for chemical labeling with peptide- and protein-tags are described and their major applications concerning the GPCR life cycle are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuNF2niqBaepVVjGoY74BafW6udTcc2ebtFkZR54AxxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrltVKhug%253D%253D&md5=246281fd5b3c42b28bc56c1f9d01f156</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-7-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-7-16%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6hme%26aufirst%3DI.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DIlluminating%2520the%2520Life%2520of%2520GPCRs%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2009%26volume%3D7%26issue%3D1%26spage%3D16%26doi%3D10.1186%2F1478-811X-7-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span> <span> </span><span class="NLM_article-title">Toward Fluorescent Probes for G-Protein-Coupled Receptors (GPCRs)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8187</span>– <span class="NLM_lpage">8203</span>, <span class="refDoi"> DOI: 10.1021/jm401823z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401823z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8187-8203&issue=20&author=Z.+Maauthor=L.+Duauthor=M.+Li&title=Toward+Fluorescent+Probes+for+G-Protein-Coupled+Receptors+%28GPCRs%29&doi=10.1021%2Fjm401823z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401823z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401823z%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DToward%2520Fluorescent%2520Probes%2520for%2520G-Protein-Coupled%2520Receptors%2520%2528GPCRs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8187%26epage%3D8203%26doi%3D10.1021%2Fjm401823z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, M. E.</span></span> <span> </span><span class="NLM_article-title">Fluorescent Approaches for Understanding Interactions of Ligands with G Protein Coupled Receptors</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1838</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2013.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2Fj.bbamem.2013.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=24055822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOgsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=15-33&issue=1&author=R.+Sridharanauthor=J.+Zuberauthor=S.+M.+Connellyauthor=E.+Mathewauthor=M.+E.+Dumont&title=Fluorescent+Approaches+for+Understanding+Interactions+of+Ligands+with+G+Protein+Coupled+Receptors&doi=10.1016%2Fj.bbamem.2013.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors</span></div><div class="casAuthors">Sridharan, Rajashri; Zuber, Jeffrey; Connelly, Sara M.; Mathew, Elizabeth; Dumont, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">1PA</span>),
    <span class="NLM_cas:pages">15-33</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are responsible for a wide variety of signaling responses in diverse cell types.  Despite major advances in the detn. of structures of this class of receptors, the underlying mechanisms by which binding of different types of ligands specifically elicits particular signaling responses remain unclear.  The use of fluorescence spectroscopy can provide important information about the process of ligand binding and ligand-dependent conformational changes in receptors, esp. kinetic aspects of these processes that can be difficult to ext. from x-ray structures.  Here, the authors present an overview of the extensive array of fluorescent ligands that have been used in studies of GPCRs and describe spectroscopic approaches for assaying binding and probing the environment of receptor-bound ligands with particular attention to examples involving yeast pheromone receptors.  In addn., the authors discuss the use of fluorescence spectroscopy for detecting and characterizing conformational changes in receptors induced by the binding of ligands.  Such studies have provided strong evidence for diversity of receptor conformations elicited by different ligands, consistent with the idea that GPCRs are not simple on and off switches.  This diversity of states constitutes an underlying mechanistic basis for biased agonism, the observation that different stimuli can produce different responses from a single receptor.  It is likely that continued tech. advances will allow fluorescence spectroscopy to play an important role in continued probing of structural transitions in GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_MCI4Gleo1rVg90H21EOLACvtfcHk0lhE_jAgsqqfYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOgsbjP&md5=c6958b3b707da56efb8a2e6513c3b579</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DSridharan%26aufirst%3DR.%26aulast%3DZuber%26aufirst%3DJ.%26aulast%3DConnelly%26aufirst%3DS.%2BM.%26aulast%3DMathew%26aufirst%3DE.%26aulast%3DDumont%26aufirst%3DM.%2BE.%26atitle%3DFluorescent%2520Approaches%2520for%2520Understanding%2520Interactions%2520of%2520Ligands%2520with%2520G%2520Protein%2520Coupled%2520Receptors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26issue%3D1%26spage%3D15%26epage%3D33%26doi%3D10.1016%2Fj.bbamem.2013.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cottet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faklaris, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durroux, T.</span></span> <span> </span><span class="NLM_article-title">Original Fluorescent Ligand-Based Assays Open New Perspectives in G-Protein Coupled Receptor Drug Screening</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.3390/ph4010202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.3390%2Fph4010202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=202-214&issue=12&author=M.+Cottetauthor=O.+Faklarisauthor=J.+M.+Zwierauthor=E.+Trinquetauthor=J.-P.+Pinauthor=T.+Durroux&title=Original+Fluorescent+Ligand-Based+Assays+Open+New+Perspectives+in+G-Protein+Coupled+Receptor+Drug+Screening&doi=10.3390%2Fph4010202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3390%2Fph4010202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph4010202%26sid%3Dliteratum%253Aachs%26aulast%3DCottet%26aufirst%3DM.%26aulast%3DFaklaris%26aufirst%3DO.%26aulast%3DZwier%26aufirst%3DJ.%2BM.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DOriginal%2520Fluorescent%2520Ligand-Based%2520Assays%2520Open%2520New%2520Perspectives%2520in%2520G-Protein%2520Coupled%2520Receptor%2520Drug%2520Screening%26jtitle%3DPharmaceuticals%26date%3D2011%26volume%3D4%26issue%3D12%26spage%3D202%26epage%3D214%26doi%3D10.3390%2Fph4010202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, E. K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheal, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfleger, K. D. G.</span></span> <span> </span><span class="NLM_article-title">Application of BRET to Monitor Ligand Binding to GPCRs</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1038/nmeth.3398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1038%2Fnmeth.3398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=26030448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=661-663&issue=7&author=L.+A.+Stoddartauthor=E.+K.+M.+Johnstoneauthor=A.+J.+Whealauthor=J.+Gouldingauthor=M.+B.+Robersauthor=T.+Machleidtauthor=K.+V.+Woodauthor=S.+J.+Hillauthor=K.+D.+G.+Pfleger&title=Application+of+BRET+to+Monitor+Ligand+Binding+to+GPCRs&doi=10.1038%2Fnmeth.3398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Application of BRET to monitor ligand binding to GPCRs</span></div><div class="casAuthors">Stoddart, Leigh A.; Johnstone, Elizabeth K. M.; Wheal, Amanda J.; Goulding, Joelle; Robers, Matthew B.; Machleidt, Thomas; Wood, Keith V.; Hill, Stephen J.; Pfleger, Kevin D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-663</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bioluminescence resonance energy transfer (BRET) is a well-established method for investigating protein-protein interactions.  Here we present a BRET approach to monitor ligand binding to G protein-coupled receptors (GPCRs) on the surface of living cells made possible by the use of fluorescent ligands in combination with a bioluminescent protein (NanoLuc) that can be readily expressed on the N terminus of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKCGBtnUo25LVg90H21EOLACvtfcHk0lhE_jAgsqqfYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbbI&md5=b829c12d21f0079ceb4222be2ebf6f32</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.3398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.3398%26sid%3Dliteratum%253Aachs%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DJohnstone%26aufirst%3DE.%2BK.%2BM.%26aulast%3DWheal%26aufirst%3DA.%2BJ.%26aulast%3DGoulding%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DK.%2BV.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DPfleger%26aufirst%3DK.%2BD.%2BG.%26atitle%3DApplication%2520of%2520BRET%2520to%2520Monitor%2520Ligand%2520Binding%2520to%2520GPCRs%26jtitle%3DNat.%2520Methods%26date%3D2015%26volume%3D12%26issue%3D7%26spage%3D661%26epage%3D663%26doi%3D10.1038%2Fnmeth.3398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5638</span>– <span class="NLM_lpage">5645</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00338</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Shsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5638-5645&issue=13&author=A.+H.+Hansenauthor=E.+Sergeevauthor=S.+K.+Pandeyauthor=B.+D.+Hudsonauthor=E.+Christiansenauthor=G.+Milliganauthor=T.+Ulven&title=Development+and+Characterization+of+a+Fluorescent+Tracer+for+the+Free+Fatty+Acid+Receptor+2+%28FFA2%2FGPR43%29&doi=10.1021%2Facs.jmedchem.7b00338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43)</span></div><div class="casAuthors">Hansen, Anders Hoejgaard; Sergeev, Eugenia; Pandey, Sunil K.; Hudson, Brian D.; Christiansen, Elisabeth; Milligan, Graeme; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5638-5645</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The free fatty acid receptor 2 (FFA2/GPR43) is considered a potential target for treatment of metabolic and inflammatory diseases.  Here we describe the development of the first fluorescent tracer for FFA2 intended as a tool for assessment of thermodn. and kinetic binding parameters of unlabeled ligands.  Starting with a known azetidine FFA2 antagonist, we used a carboxylic acid moiety known not to be crit. for receptor interaction as attachment point for a nitrobenzoxadiazole (NBD) fluorophore.  This led to the development of 4 (TUG-1609), a fluorescent tracer for FFA2 with favorable spectroscopic properties and high affinity, as detd. by bioluminescence resonance energy transfer (BRET)-based satn. and kinetic binding expts., as well as a high specific to nonspecific BRET binding signal.  A BRET-based competition binding assay with 4 was also established and used to det. binding consts. and kinetics of unlabeled ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdOUn9oB6w8LVg90H21EOLACvtfcHk0ljvX3Bky5GTeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Shsro%253D&md5=23b6686e714c04768bf89723bd6a84ee</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00338%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DA.%2BH.%26aulast%3DSergeev%26aufirst%3DE.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDevelopment%2520and%2520Characterization%2520of%2520a%2520Fluorescent%2520Tracer%2520for%2520the%2520Free%2520Fatty%2520Acid%2520Receptor%25202%2520%2528FFA2%252FGPR43%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5638%26epage%3D5645%26doi%3D10.1021%2Facs.jmedchem.7b00338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span> <i>Instant JChem</i>, 16.2.15.0 2016; <span class="NLM_publisher-name">ChemAxon</span>: <span class="NLM_publisher-loc">Budapest</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Instant+JChem%2C+16.2.15.0+2016%3B+ChemAxon%3A+Budapest%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DInstant%2520JChem%26pub%3DChemAxon%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindon, N. D.</span>; <span class="NLM_string-name">Meghani, P.</span>; <span class="NLM_string-name">Thom, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Pyrimidinediones and Thioxopyrimidinones as P2-purinoceptor 7-transmembrane (TM) G-protein Coupled Receptor Antagonists</span>. <span class="NLM_patent">WO9926944</span>, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=N.+D.+Kindon&author=P.+Meghani&author=S.+Thom&title=Preparation+of+Pyrimidinediones+and+Thioxopyrimidinones+as+P2-purinoceptor+7-transmembrane+%28TM%29+G-protein+Coupled+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKindon%26aufirst%3DN.%2BD.%26atitle%3DPreparation%2520of%2520Pyrimidinediones%2520and%2520Thioxopyrimidinones%2520as%2520P2-purinoceptor%25207-transmembrane%2520%2528TM%2529%2520G-protein%2520Coupled%2520Receptor%2520Antagonists%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukor, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nafie, L. A.</span></span> <span> </span><span class="NLM_article-title">Determination of Absolute Configuration of Chiral Molecules Using Vibrational Optical Activity: A Review</span>. <i>Appl. Spectrosc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1366/11-06321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1366%2F11-06321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=21740631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovV2jtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=699-723&issue=7&author=Y.+Heauthor=W.+Boauthor=R.+K.+Dukorauthor=L.+A.+Nafie&title=Determination+of+Absolute+Configuration+of+Chiral+Molecules+Using+Vibrational+Optical+Activity%3A+A+Review&doi=10.1366%2F11-06321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of absolute configuration of chiral molecules using vibrational optical activity: a review</span></div><div class="casAuthors">He, Yanan; Wang, Bo; Dukor, Rina K.; Nafie, Laurence A.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Spectroscopy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">699-723</span>CODEN:
                <span class="NLM_cas:coden">APSPA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-7028</span>.
    
            (<span class="NLM_cas:orgname">Society for Applied Spectroscopy</span>)
        </div><div class="casAbstract">A review.  Detn. of the abs. handedness, known as abs. configuration (AC), of chiral mols. is an important step in any field related to chirality, esp. in the pharmaceutical industry.  Vibrational optical activity (VOA) has become a powerful tool for the detn. of the AC of chiral mols. in the soln. state after nearly forty years of evolution.  VOA offers a novel alternative, or supplement, to X-ray crystallog., permitting AC detns. on neat liq., oil, and soln. samples without the need to grow single crystals of the pure chiral sample mols. as required for X-ray anal.  By comparing the sign and intensity of the measured VOA spectrum with the corresponding ab initio d. functional theory (DFT) calcd. VOA spectrum of a chosen configuration, one can unambiguously assign the AC of a chiral mol.  Comparing measured VOA spectra with calcd. VOA spectra of all the conformers can also provide soln.-state conformational populations.  VOA consists of IR vibrational CD (VCD) and vibrational Raman optical activity (ROA).  Currently, VCD is used routinely by researchers in a variety of backgrounds, including mol. chirality, asym. synthesis, chiral catalysis, drug screening, pharmacol., and natural products.  Although the application of ROA in AC detn. lags behind that of VCD, with the recent implementation of ROA subroutines in com. quantum chem. software, ROA will in the future complement VCD for AC detn.  In this review, the basic principles of the application of VCD to the detn. of abs. configuration in chiral mols. are described.  The steps required for VCD spectral measurement and calcn. are outlined, followed by brief descriptions of recently published papers reporting the detn. of AC in small org., pharmaceutical, and natural product mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBwQY6usjp5rVg90H21EOLACvtfcHk0ljvX3Bky5GTeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovV2jtL0%253D&md5=cd48886d271835460a76afd1d016dc2c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1366%2F11-06321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1366%252F11-06321%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DBo%26aufirst%3DW.%26aulast%3DDukor%26aufirst%3DR.%2BK.%26aulast%3DNafie%26aufirst%3DL.%2BA.%26atitle%3DDetermination%2520of%2520Absolute%2520Configuration%2520of%2520Chiral%2520Molecules%2520Using%2520Vibrational%2520Optical%2520Activity%253A%2520A%2520Review%26jtitle%3DAppl.%2520Spectrosc.%26date%3D2011%26volume%3D65%26issue%3D7%26spage%3D699%26epage%3D723%26doi%3D10.1366%2F11-06321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaizen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monde, K.</span></span> <span> </span><span class="NLM_article-title">Vibrational CD (VCD) Spectroscopy as a Powerful Tool for Chiral Analysis of Flavor Compounds</span>. <i>ACS Symp. Ser.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1212</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1021/bk-2015-1212.ch003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bk-2015-1212.ch003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1212&publication_year=2015&pages=35-56&author=Y.+Yaguchiauthor=A.+Nakahashiauthor=N.+Miuraauthor=T.+Taniguchiauthor=D.+Sugimotoauthor=M.+Emuraauthor=K.+Zaizenauthor=Y.+Kusanoauthor=K.+Monde&title=Vibrational+CD+%28VCD%29+Spectroscopy+as+a+Powerful+Tool+for+Chiral+Analysis+of+Flavor+Compounds&doi=10.1021%2Fbk-2015-1212.ch003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbk-2015-1212.ch003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbk-2015-1212.ch003%26sid%3Dliteratum%253Aachs%26aulast%3DYaguchi%26aufirst%3DY.%26aulast%3DNakahashi%26aufirst%3DA.%26aulast%3DMiura%26aufirst%3DN.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DD.%26aulast%3DEmura%26aufirst%3DM.%26aulast%3DZaizen%26aufirst%3DK.%26aulast%3DKusano%26aufirst%3DY.%26aulast%3DMonde%26aufirst%3DK.%26atitle%3DVibrational%2520CD%2520%2528VCD%2529%2520Spectroscopy%2520as%2520a%2520Powerful%2520Tool%2520for%2520Chiral%2520Analysis%2520of%2520Flavor%2520Compounds%26jtitle%3DACS%2520Symp.%2520Ser.%26date%3D2015%26volume%3D1212%26spage%3D35%26epage%3D56%26doi%3D10.1021%2Fbk-2015-1212.ch003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nafie, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukor, R. K.</span></span> <span> </span><span class="NLM_article-title">Structural Determination of Molecular Stereochemistry Using VCD Spectroscopy and a Conformational Code: Absolute Configuration and Solution Conformation of a Chiral Liquid Pesticide, (R)-(+)-Malathion</span>. <i>Chirality</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1E</span>),  <span class="NLM_fpage">E172</span>– <span class="NLM_lpage">E180</span>, <span class="refDoi"> DOI: 10.1002/chir.20793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1002%2Fchir.20793" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=E172-E180&issue=1E&author=H.+Izumiauthor=A.+Ogataauthor=L.+A.+Nafieauthor=R.+K.+Dukor&title=Structural+Determination+of+Molecular+Stereochemistry+Using+VCD+Spectroscopy+and+a+Conformational+Code%3A+Absolute+Configuration+and+Solution+Conformation+of+a+Chiral+Liquid+Pesticide%2C+%28R%29-%28%2B%29-Malathion&doi=10.1002%2Fchir.20793"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fchir.20793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchir.20793%26sid%3Dliteratum%253Aachs%26aulast%3DIzumi%26aufirst%3DH.%26aulast%3DOgata%26aufirst%3DA.%26aulast%3DNafie%26aufirst%3DL.%2BA.%26aulast%3DDukor%26aufirst%3DR.%2BK.%26atitle%3DStructural%2520Determination%2520of%2520Molecular%2520Stereochemistry%2520Using%2520VCD%2520Spectroscopy%2520and%2520a%2520Conformational%2520Code%253A%2520Absolute%2520Configuration%2520and%2520Solution%2520Conformation%2520of%2520a%2520Chiral%2520Liquid%2520Pesticide%252C%2520%2528R%2529-%2528%252B%2529-Malathion%26jtitle%3DChirality%26date%3D2009%26volume%3D21%26issue%3D1E%26spage%3DE172%26epage%3DE180%26doi%3D10.1002%2Fchir.20793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillet, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span> <span> </span><span class="NLM_article-title">Assessment of Additive/Nonadditive Effects in Structure–Activity Relationships: Implications for Iterative Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">7552</span>– <span class="NLM_lpage">7562</span>, <span class="refDoi"> DOI: 10.1021/jm801070q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801070q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7552-7562&issue=23&author=Y.+Patelauthor=V.+J.+Gilletauthor=T.+Howeauthor=J.+Pastorauthor=J.+Oyarzabalauthor=P.+Willett&title=Assessment+of+Additive%2FNonadditive+Effects+in+Structure%E2%80%93Activity+Relationships%3A+Implications+for+Iterative+Drug+Design&doi=10.1021%2Fjm801070q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm801070q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801070q%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DY.%26aulast%3DGillet%26aufirst%3DV.%2BJ.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DWillett%26aufirst%3DP.%26atitle%3DAssessment%2520of%2520Additive%252FNonadditive%2520Effects%2520in%2520Structure%25E2%2580%2593Activity%2520Relationships%253A%2520Implications%2520for%2520Iterative%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D23%26spage%3D7552%26epage%3D7562%26doi%3D10.1021%2Fjm801070q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchings, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulito, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolliffe, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, W. V.</span></span> <span> </span><span class="NLM_article-title">Arylpiperazine Substituted Heterocycles as Selective α1a Adrenergic Antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2443</span>– <span class="NLM_lpage">2446</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00436-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2FS0960-894X%2802%2900436-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2443-2446&issue=17&author=H.+Khatuyaauthor=R.+H.+Hutchingsauthor=G.-H.+Kuoauthor=V.+L.+Pulitoauthor=L.+K.+Jolliffeauthor=X.+Liauthor=W.+V.+Murray&title=Arylpiperazine+Substituted+Heterocycles+as+Selective+%CE%B11a+Adrenergic+Antagonists&doi=10.1016%2FS0960-894X%2802%2900436-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900436-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900436-5%26sid%3Dliteratum%253Aachs%26aulast%3DKhatuya%26aufirst%3DH.%26aulast%3DHutchings%26aufirst%3DR.%2BH.%26aulast%3DKuo%26aufirst%3DG.-H.%26aulast%3DPulito%26aufirst%3DV.%2BL.%26aulast%3DJolliffe%26aufirst%3DL.%2BK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26atitle%3DArylpiperazine%2520Substituted%2520Heterocycles%2520as%2520Selective%2520%25CE%25B11a%2520Adrenergic%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D17%26spage%3D2443%26epage%3D2446%26doi%3D10.1016%2FS0960-894X%2802%2900436-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodroofe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwinn, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Méndez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkland, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span> <span> </span><span class="NLM_article-title">NanoBRET - A Novel BRET Platform for the Analysis of Protein-Protein Interactions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1797</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1797-1804&issue=8&author=T.+Machleidtauthor=C.+C.+Woodroofeauthor=M.+K.+Schwinnauthor=J.+M%C3%A9ndezauthor=M.+B.+Robersauthor=K.+Zimmermanauthor=P.+Ottoauthor=D.+L.+Danielsauthor=T.+A.+Kirklandauthor=K.+V.+Wood&title=NanoBRET+-+A+Novel+BRET+Platform+for+the+Analysis+of+Protein-Protein+Interactions&doi=10.1021%2Facschembio.5b00143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00143%26sid%3Dliteratum%253Aachs%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DWoodroofe%26aufirst%3DC.%2BC.%26aulast%3DSchwinn%26aufirst%3DM.%2BK.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DOtto%26aufirst%3DP.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DKirkland%26aufirst%3DT.%2BA.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DNanoBRET%2520-%2520A%2520Novel%2520BRET%2520Platform%2520for%2520the%2520Analysis%2520of%2520Protein-Protein%2520Interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3D1797%26epage%3D1804%26doi%3D10.1021%2Facschembio.5b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4849</span>– <span class="NLM_lpage">4858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00202</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00202" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4849-4858&issue=10&author=E.+Christiansenauthor=B.+D.+Hudsonauthor=A.+H.+Hansenauthor=G.+Milliganauthor=T.+Ulven&title=Development+and+Characterization+of+a+Potent+Free+Fatty+Acid+Receptor+1+%28FFA1%29+Fluorescent+Tracer&doi=10.1021%2Facs.jmedchem.6b00202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00202%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DHansen%26aufirst%3DA.%2BH.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDevelopment%2520and%2520Characterization%2520of%2520a%2520Potent%2520Free%2520Fatty%2520Acid%2520Receptor%25201%2520%2528FFA1%2529%2520Fluorescent%2520Tracer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D10%26spage%3D4849%26epage%3D4858%26doi%3D10.1021%2Facs.jmedchem.6b00202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, C.</span></span> <span> </span><span class="NLM_article-title">Fluorescence/Bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1124/pr.110.004309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1124%2Fpr.110.004309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=22407612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=299-336&issue=2&author=M.+J.+Lohseauthor=S.+Nuberauthor=C.+Hoffmann&title=Fluorescence%2FBioluminescence+Resonance+Energy+Transfer+Techniques+to+Study+G-Protein-Coupled+Receptor+Activation+and+Signaling&doi=10.1124%2Fpr.110.004309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling</span></div><div class="casAuthors">Lohse, Martin J.; Nuber, Susanne; Hoffmann, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-336</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Fluorescence and bioluminescence resonance energy transfer (FRET and BRETT) techniques allow the sensitive monitoring of distances between two labels at the nanometer scale.  Depending on the placement of the labels, this permits the anal. of conformational changes within a single protein (for example of a receptor) or the monitoring of protein-protein interactions (for example, between receptors and G-protein subunits).  Over the past decade, numerous such techniques have been developed to monitor the activation and signaling of G-protein-coupled receptors (GPCRs) in both the purified, reconstituted state and in intact cells.  These techniques span the entire spectrum from ligand binding to the receptors down to intracellular second messengers.  They allow the detn. and the visualization of signaling processes with high temporal and spatial resoln.  With these techniques, it has been demonstrated that GPCR signals may show spatial and temporal patterning.  In particular, evidence has been provided for spatial compartmentalization of GPCRs and their signals in intact cells and for distinct physiol. consequences of such spatial patterning.  We review here the FRET and BRET technologies that have been developed for G-protein-coupled receptors and their signaling proteins (G-proteins, effectors) and the concepts that result from such expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzZxuO8ZQ_D7Vg90H21EOLACvtfcHk0ljHSmSZI6Tb7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslKktr8%253D&md5=76146f70e0e0776aa1d10dae884462aa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.004309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.004309%26sid%3Dliteratum%253Aachs%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DNuber%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DC.%26atitle%3DFluorescence%252FBioluminescence%2520Resonance%2520Energy%2520Transfer%2520Techniques%2520to%2520Study%2520G-Protein-Coupled%2520Receptor%2520Activation%2520and%2520Signaling%26jtitle%3DPharmacol.%2520Rev.%26date%3D2012%26volume%3D64%26issue%3D2%26spage%3D299%26epage%3D336%26doi%3D10.1124%2Fpr.110.004309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vernall, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briddon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doughty, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellam, B.</span></span> <span> </span><span class="NLM_article-title">Conversion of a Non-Selective Adenosine Receptor Antagonist into A3-Selective High Affinity Fluorescent Probes Using Peptide-Based Linkers</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">5673</span>, <span class="refDoi"> DOI: 10.1039/c3ob41221k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1039%2Fc3ob41221k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=23881285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1els73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=5673&issue=34&author=A.+J.+Vernallauthor=L.+A.+Stoddartauthor=S.+J.+Briddonauthor=H.+W.+Ngauthor=C.+A.+Laughtonauthor=S.+W.+Doughtyauthor=S.+J.+Hillauthor=B.+Kellam&title=Conversion+of+a+Non-Selective+Adenosine+Receptor+Antagonist+into+A3-Selective+High+Affinity+Fluorescent+Probes+Using+Peptide-Based+Linkers&doi=10.1039%2Fc3ob41221k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers</span></div><div class="casAuthors">Vernall, Andrea J.; Stoddart, Leigh A.; Briddon, Stephen J.; Ng, Hui Wen; Laughton, Charles A.; Doughty, Stephen W.; Hill, Stephen J.; Kellam, Barrie</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5673-5682</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Advances in fluorescence-based imaging technologies have helped propel the study of real-time biol. readouts and anal. across many different areas.  In particular the use of fluorescent ligands as chem. tools to study proteins such as G protein-coupled receptors (GPCRs) has received ongoing interest.  Methods to improve the efficient chem. synthesis of fluorescent ligands remain of paramount importance to ensure this area of bioanal. continues to advance.  Here we report conversion of the non-selective GPCR adenosine receptor antagonist Xanthine Amine Congener into higher affinity and more receptor subtype-selective fluorescent antagonists.  This was achieved through insertion and optimization of a dipeptide linker between the adenosine receptor pharmacophore and the fluorophore.  Fluorescent probe 27 contg. BODIPY 630/650 (pKD = 9.12 ± 0.05 [hA3AR]), and BODIPY FL-contg. 28 (pKD = 7.96 ± 0.09 [hA3AR]) demonstrated clear, displaceable membrane binding using fluorescent confocal microscopy.  From in silico anal. of the docked ligand-receptor complexes of 27, we suggest regions of mol. interaction that could account for the obsd. selectivity of these peptide-linker based fluorescent conjugates.  This general approach of converting a non-selective ligand to a selective biol. tool could be applied to other ligands of interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdIBs1bmWol7Vg90H21EOLACvtfcHk0ljHSmSZI6Tb7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1els73F&md5=213e61289058406b1fddc734377ec287</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc3ob41221k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob41221k%26sid%3Dliteratum%253Aachs%26aulast%3DVernall%26aufirst%3DA.%2BJ.%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DBriddon%26aufirst%3DS.%2BJ.%26aulast%3DNg%26aufirst%3DH.%2BW.%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26aulast%3DDoughty%26aufirst%3DS.%2BW.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DKellam%26aufirst%3DB.%26atitle%3DConversion%2520of%2520a%2520Non-Selective%2520Adenosine%2520Receptor%2520Antagonist%2520into%2520A3-Selective%2520High%2520Affinity%2520Fluorescent%2520Probes%2520Using%2520Peptide-Based%2520Linkers%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26issue%3D34%26spage%3D5673%26doi%3D10.1039%2Fc3ob41221k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="patent1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'patent1'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="patent1_1"><span><span> </span><span class="NLM_article-title">2,4-Dithi(oxo)-pyrimidin-5-yl
compounds bearing a tricyclic substituent
useful as P2 purinoceptor antagonists</span>. <span class="NLM_patent">US6107297</span>, Aug 22, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2%2C4-Dithi%28oxo%29-pyrimidin-5-yl%0Acompounds+bearing+a+tricyclic+substituent%0Auseful+as+P2+purinoceptor+antagonists.+US6107297%2C+Aug+22%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=patent1_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26atitle%3D2%252C4-Dithi%2528oxo%2529-pyrimidin-5-yl%250Acompounds%2520bearing%2520a%2520tricyclic%2520substituent%250Auseful%2520as%2520P2%2520purinoceptor%2520antagonists%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'patent1':['patent1_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Eleonora Comeo, Phuc Trinh, Anh T. Nguyen, Cameron J. Nowell, Nicholas D. Kindon, Mark Soave, Leigh A. Stoddart, Jonathan M. White, Stephen J. Hill, Barrie Kellam, Michelle L. Halls, Lauren T. May, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6670-6695. <a href="https://doi.org/10.1021/acs.jmedchem.0c02067" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02067%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252BApplication%252Bof%252BSubtype-Selective%252BFluorescent%252BAntagonists%252Bfor%252Bthe%252BStudy%252Bof%252Bthe%252BHuman%252BAdenosine%252BA1%252BReceptor%252Bin%252BLiving%252BCells%26aulast%3DComeo%26aufirst%3DEleonora%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D27112020%26date%3D16032021%26volume%3D64%26issue%3D10%26spage%3D6670%26epage%3D6695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yujie Zhang, Shufeng Li, Hang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Haiwei Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Application of Receptor-Targeted Fluorescent Probes Based on Small Molecular Fluorescent Dyes. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (1)
                                     , 4-24. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00606" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00606%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDesign%252Band%252BApplication%252Bof%252BReceptor-Targeted%252BFluorescent%252BProbes%252BBased%252Bon%252BSmall%252BMolecular%252BFluorescent%252BDyes%26aulast%3DZhang%26aufirst%3DYujie%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D05112020%26date%3D09122020%26date%3D07012021%26volume%3D32%26issue%3D1%26spage%3D4%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eleonora Comeo, Nicholas D. Kindon, Mark Soave, Leigh A. Stoddart, Laura E. Kilpatrick, Peter J. Scammells, Stephen J. Hill, <span class="NLM_string-name hlFld-ContribAuthor">Barrie Kellam</span>. </span><span class="cited-content_cbyCitation_article-title">Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A2A Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2656-2672. <a href="https://doi.org/10.1021/acs.jmedchem.9b01856" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01856%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSubtype-Selective%252BFluorescent%252BLigands%252Bas%252BPharmacological%252BResearch%252BTools%252Bfor%252Bthe%252BHuman%252BAdenosine%252BA2A%252BReceptor%26aulast%3DComeo%26aufirst%3DEleonora%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D08112019%26date%3D09012020%26date%3D30122019%26volume%3D63%26issue%3D5%26spage%3D2656%26epage%3D2672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlotta  Borgarelli</span>, <span class="hlFld-ContribAuthor ">Yvonne E.  Klingl</span>, <span class="hlFld-ContribAuthor ">Abril  Escamilla‐Ayala</span>, <span class="hlFld-ContribAuthor ">Sebastian  Munck</span>, <span class="hlFld-ContribAuthor ">Ludo  Van Den Bosch</span>, <span class="hlFld-ContribAuthor ">Wim M.  De Borggraeve</span>, <span class="hlFld-ContribAuthor ">Ermal  Ismalaj</span>. </span><span class="cited-content_cbyCitation_article-title">Lighting Up the Plasma Membrane: Development and Applications of Fluorescent Ligands for Transmembrane Proteins. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.1002/chem.202100296" title="DOI URL">https://doi.org/10.1002/chem.202100296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202100296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202100296%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DLighting%252BUp%252Bthe%252BPlasma%252BMembrane%25253A%252BDevelopment%252Band%252BApplications%252Bof%252BFluorescent%252BLigands%252Bfor%252BTransmembrane%252BProteins%26aulast%3DBorgarelli%26aufirst%3DCarlotta%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivar  von Kügelgen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular pharmacology of P2Y receptor subtypes. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>187 </em>, 114361. <a href="https://doi.org/10.1016/j.bcp.2020.114361" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114361%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DMolecular%252Bpharmacology%252Bof%252BP2Y%252Breceptor%252Bsubtypes%26aulast%3Dvon%2BK%25C3%25BCgelgen%26aufirst%3DIvar%26date%3D2021%26volume%3D187%26spage%3D114361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joëlle  Goulding</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Mistry</span>, <span class="hlFld-ContribAuthor ">Mark  Soave</span>, <span class="hlFld-ContribAuthor ">Jeanette  Woolard</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Briddon</span>, <span class="hlFld-ContribAuthor ">Carl W.  White</span>, <span class="hlFld-ContribAuthor ">Barrie  Kellam</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Hill</span>. </span><span class="cited-content_cbyCitation_article-title">Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2021,</strong> <em>9 </em>
                                    (3)
                                     <a href="https://doi.org/10.1002/prp2.779" title="DOI URL">https://doi.org/10.1002/prp2.779</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.779%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DSubtype%252Bselective%252Bfluorescent%252Bligands%252Bbased%252Bon%252BICI%252B118%25252C551%252Bto%252Bstudy%252Bthe%252Bhuman%252B%2525CE%2525B22%2525E2%252580%252590adrenoceptor%252Bin%252BCRISPR%25252FCas9%252Bgenome%2525E2%252580%252590edited%252BHEK293T%252Bcells%252Bat%252Blow%252Bexpression%252Blevels%26aulast%3DGoulding%26aufirst%3DJo%25C3%25ABlle%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua W  Conner</span>, <span class="hlFld-ContribAuthor ">Daniel P  Poole</span>, <span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Nicholas A  Veldhuis</span>. </span><span class="cited-content_cbyCitation_article-title">New small molecule fluorescent probes for G protein-coupled receptors: valuable tools for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (1)
                                     , 63-90. <a href="https://doi.org/10.4155/fmc-2019-0327" title="DOI URL">https://doi.org/10.4155/fmc-2019-0327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0327%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bsmall%252Bmolecule%252Bfluorescent%252Bprobes%252Bfor%252BG%252Bprotein-coupled%252Breceptors%25253A%252Bvaluable%252Btools%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DConner%26aufirst%3DJoshua%2BW%26date%3D2021%26volume%3D13%26issue%3D1%26spage%3D63%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lukas  Grätz</span>, <span class="hlFld-ContribAuthor ">Katharina  Tropmann</span>, <span class="hlFld-ContribAuthor ">Merlin  Bresinsky</span>, <span class="hlFld-ContribAuthor ">Christoph  Müller</span>, <span class="hlFld-ContribAuthor ">Günther  Bernhardt</span>, <span class="hlFld-ContribAuthor ">Steffen  Pockes</span>. </span><span class="cited-content_cbyCitation_article-title">NanoBRET binding assay for histamine H2 receptor ligands using live recombinant HEK293T cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-70332-3" title="DOI URL">https://doi.org/10.1038/s41598-020-70332-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-70332-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-70332-3%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DNanoBRET%252Bbinding%252Bassay%252Bfor%252Bhistamine%252BH2%252Breceptor%252Bligands%252Busing%252Blive%252Brecombinant%252BHEK293T%252Bcells%26aulast%3DGr%25C3%25A4tz%26aufirst%3DLukas%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.B.  Robers</span>, <span class="hlFld-ContribAuthor ">R.  Friedman-Ohana</span>, <span class="hlFld-ContribAuthor ">K.V.M.  Huber</span>, <span class="hlFld-ContribAuthor ">L.  Kilpatrick</span>, <span class="hlFld-ContribAuthor ">J.D.  Vasta</span>, <span class="hlFld-ContribAuthor ">B.-T.  Berger</span>, <span class="hlFld-ContribAuthor ">C.  Chaudhry</span>, <span class="hlFld-ContribAuthor ">S.  Hill</span>, <span class="hlFld-ContribAuthor ">S.  Müller</span>, <span class="hlFld-ContribAuthor ">S.  Knapp</span>, <span class="hlFld-ContribAuthor ">K.V.  Wood</span>. </span><span class="cited-content_cbyCitation_article-title">Quantifying Target Occupancy of Small Molecules Within Living Cells. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Biochemistry</span><span> <strong>2020,</strong> <em>89 </em>
                                    (1)
                                     , 557-581. <a href="https://doi.org/10.1146/annurev-biochem-011420-092302" title="DOI URL">https://doi.org/10.1146/annurev-biochem-011420-092302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-biochem-011420-092302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-biochem-011420-092302%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Biochemistry%26atitle%3DQuantifying%252BTarget%252BOccupancy%252Bof%252BSmall%252BMolecules%252BWithin%252BLiving%252BCells%26aulast%3DRobers%26aufirst%3DM.B.%26date%3D2020%26volume%3D89%26issue%3D1%26spage%3D557%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Soave</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Briddon</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Hill</span>, <span class="hlFld-ContribAuthor ">Leigh A.  Stoddart</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent ligands: Bringing light to emerging GPCR paradigms. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (5)
                                     , 978-991. <a href="https://doi.org/10.1111/bph.14953" title="DOI URL">https://doi.org/10.1111/bph.14953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14953%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DFluorescent%252Bligands%25253A%252BBringing%252Blight%252Bto%252Bemerging%252BGPCR%252Bparadigms%26aulast%3DSoave%26aufirst%3DMark%26date%3D2020%26date%3D2020%26volume%3D177%26issue%3D5%26spage%3D978%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Soave</span>, <span class="hlFld-ContribAuthor ">Joëlle  Goulding</span>, <span class="hlFld-ContribAuthor ">Robert  Markus</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Hill</span>, <span class="hlFld-ContribAuthor ">Leigh A.  Stoddart</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Fluorescent Purinoceptor Antagonists for Bioluminescence Resonance Energy Transfer Assays and Fluorescent Microscopy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 163-181. <a href="https://doi.org/10.1007/978-1-4939-9717-6_12" title="DOI URL">https://doi.org/10.1007/978-1-4939-9717-6_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-9717-6_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-9717-6_12%26sid%3Dliteratum%253Aachs%26atitle%3DApplication%252Bof%252BFluorescent%252BPurinoceptor%252BAntagonists%252Bfor%252BBioluminescence%252BResonance%252BEnergy%252BTransfer%252BAssays%252Band%252BFluorescent%252BMicroscopy%26aulast%3DSoave%26aufirst%3DMark%26date%3D2020%26date%3D2019%26spage%3D163%26epage%3D181%26pub%3DSpringer%2520New%2520York%26atitle%3DPurinergic%252BSignaling%26aulast%3DPelegr%25C3%25ADn%26aufirst%3DPablo%26date%3D2020%26volume%3D2041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natasha C.  Dale</span>, <span class="hlFld-ContribAuthor ">Elizabeth K. M.  Johnstone</span>, <span class="hlFld-ContribAuthor ">Carl W.  White</span>, <span class="hlFld-ContribAuthor ">Kevin D. G.  Pfleger</span>. </span><span class="cited-content_cbyCitation_article-title">NanoBRET: The Bright Future of Proximity-Based Assays. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Bioengineering and Biotechnology</span><span> <strong>2019,</strong> <em>7 </em><a href="https://doi.org/10.3389/fbioe.2019.00056" title="DOI URL">https://doi.org/10.3389/fbioe.2019.00056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fbioe.2019.00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffbioe.2019.00056%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Bioengineering%2520and%2520Biotechnology%26atitle%3DNanoBRET%25253A%252BThe%252BBright%252BFuture%252Bof%252BProximity-Based%252BAssays%26aulast%3DDale%26aufirst%3DNatasha%2BC.%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carl W.  White</span>, <span class="hlFld-ContribAuthor ">Elizabeth K.M.  Johnstone</span>, <span class="hlFld-ContribAuthor ">Heng B.  See</span>, <span class="hlFld-ContribAuthor ">Kevin D.G.  Pfleger</span>. </span><span class="cited-content_cbyCitation_article-title">NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2019,</strong> <em>54 </em>, 27-34. <a href="https://doi.org/10.1016/j.cellsig.2018.11.018" title="DOI URL">https://doi.org/10.1016/j.cellsig.2018.11.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2018.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2018.11.018%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DNanoBRET%252Bligand%252Bbinding%252Bat%252Ba%252BGPCR%252Bunder%252Bendogenous%252Bpromotion%252Bfacilitated%252Bby%252BCRISPR%25252FCas9%252Bgenome%252Bediting%26aulast%3DWhite%26aufirst%3DCarl%2BW.%26date%3D2019%26volume%3D54%26spage%3D27%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SARs for the P2Y<sub>2</sub>R antagonists showing the change from the furan in <b>1</b> to thiazole (reduced lipophilicity) and the change from 2,8-dimethyl-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>][7]annulene to the 7-chloro-4<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>d</i>]thiazole tricyclic ring system.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chiral resolution of <b>16</b> and structural assignment made by vibrational circular dichroism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>–<b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) ethyl 2-(bromomethyl)thiazole-4-carboxylate, 50 °C, 24 h (55%). (b) Lawesson’s reagent, <b>1</b>, 4-dioxane, 100 °C, 18 h (85%). (c) NaOH, methanol/H<sub>2</sub>O, reflux, 1 h (91%). (d) 5-Aminotetrazole, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, DIPEA, rt, 1 h (49%). (e) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) iodomethane, 50 °C, 24 h (61%). (f) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (40%).</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Allyl alcohol, tetrabutylammonium chloride, DMF, 3 mol % palladium(II)acetate, NaHCO<sub>3</sub>, 50 °C, 18 h (92%). (b) (i) Ethyl dichloroacetate, sodium ethoxide, diethyl ether, 30 min, 0–40 °C; (ii) thioacetamide, ethanol, reflux, 3 h (30% over two steps). (c) NaOH, H<sub>2</sub>O/THF (1:1), rt, 18 h (99%). (d) (i) Oxalyl chloride, catalytic DMF, DCM, rt, 3 h; (ii) aluminum(III)chloride, DCM, rt, 18 h (39% over two steps). (e) Sodium <i>tert</i>-butoxide, THF, 0 °C to rt, 18 h (61%). (f) (i) <i>n</i>-Butyllithium, THF, −78 °C, 30 min; (ii) <b>29</b>, −78 °C to rt, 1 h (65%). (g) Trifluoroacetic acid, reflux, 72 h (36%). (h) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) iodomethane, 50 °C, 24 h (61%). (i) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (40%). (j) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) ethyl 2-(bromomethyl)thiazole-4-carboxylate, 50 °C, 24 h (57%). (k) Lawesson’s reagent, 1,4-dioxane, 100 °C, 18 h (89%). (l) (i) NaOH, methanol/H<sub>2</sub>O, reflux, 1 h (91%); (ii) 5-aminotetrazole, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, DIPEA, rt, 1 h (30%).</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0015.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) Ethyl dichloroacetate, sodium ethoxide, diethyl ether, 30 min, 0–40 °C; (ii) thiourea, ethanol, reflux, 2.5 h (46% over two steps). (b) Copper(II)chloride, <i>tert</i>-butyl nitrite, acetonitrile, rt, 2 h (65%). (c) NaOH, H<sub>2</sub>O/THF (1:1), rt, 18 h (quant). (d) (i) Oxalyl chloride, catalytic DMF, DCM, rt, 3 h; (ii) AlCl<sub>3</sub>, DCM, rt, 18 h (83% over two steps). (e) (i) <b>31</b>, <i>n</i>-butyllithium, THF, −78 °C, 30 min; (ii) <b>82</b>, −78 °C to rt, 1 h (79%). (f) Acetic acid/1,4-dioxane (1:1), 140 °C, 10 min (58%). (g) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, DCM, reflux, 18 h; (ii) iodomethane, 50 °C, 24 h (61%). (h) Phenylboronic acid, Na<sub>2</sub>CO<sub>3</sub>, 1 mol % bis(triphenylphosphine) palladium(II)chloride, 1,4-dioxane, water, microwave irradiation, 150 °C, 5 min (68%). (i) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (76%). (j) R<sub>1</sub>R<sub>2</sub>NH, 1,4-dioxane, microwave irradiation, 100 °C, 4 h (51–92%). (k) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (44–88%). (l) (i) <i>N</i>,<i>O</i>-Bis(trimethylsilyl)trifluoroacetamide, 1,2-dichloroethane, reflux, 18 h; (ii) ethyl 2-(bromomethyl)thiazole-4-carboxylate, reflux, 48 h (91%). (m) 2-Methoxyethyl amine, triethylamine, 1,4-dioxane, reflux, 72 h (59%). (n) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (81%). (o) (i) NaOH, methanol/H<sub>2</sub>O, reflux, 1 h (91%); (ii) 5-aminotetrazole, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, DIPEA, rt, 2 h (34%).</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design of the fluorescent P2Y<sub>2</sub>R antagonists based on the SARs of <b>1</b>. The figure shows the potential attachment points to which either BODIPY A or BODIPY B could be attached via a suitable linking group. The asterisks (*) represent the attachment points for the fluorophore linkage via a suitable linking group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0016.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthetic Route for the First-Generation P2Y<sub>2</sub>R Fluorescent Antagonists<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Dimethyl 5-(bromomethyl)isophthalate, BSTFA, 1,2-dichloroethane, reflux, 16 h. (b) Lawesson’s reagent, 1,4-dioxane, reflux, 16 h. (c) NaOH (2 equiv), MeOH, toluene, H<sub>2</sub>O, 4 h, 65% (three steps). (d) <i>tert</i>-Butyl (2-(2-aminoethoxy)ethyl)carbamate (53%) or <i>tert</i>-butyl (2-aminoethyl)carbamate (63%), <i>N</i>Et<sub>3</sub>, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, rt, 0.5 h. (e) LiOH, MeOH, H<sub>2</sub>O, 16 h, rt, 14–30%. (f) 4-Aminotetrazole, <i>N</i>Et<sub>3</sub>, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, 1 h, rt. (g) HCl (4 M) in 1,4-dioxane, 1 h. (h) BODIPY-SE, DIPEA, DMF, rt, 1–4 h, 15–45%.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0017.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. General Synthetic Route for the Second-Generation P2Y<sub>2</sub>R Fluorescent Antagonists<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Amine, <i>N</i>Et<sub>3</sub>, 1,4-dioxane, reflux, 72 h, 96–97%. (b) Lawesson’s reagent, 1,4-dioxane, 100 °C, 18 h, 39–74%. (c) TFA, DCM, rt, 30 min. (d) Amine, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DMF, DIPEA, rt, 1 h, 36–58% (two steps). (e) TFA, DCM, rt, 30 min. (f) BODIPY-SE, DIPEA, DMF, rt, 1–4 h, 10–54% (two steps).</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. NanoBRET saturation binding isotherms, determined in 1321N1 astrocytoma cells expressing recombinant NLuc-P2Y<sub>2</sub>R, for (a) <b>80</b>, (b) <b>85</b>, (c) <b>86</b>, and (d) <b>87</b> in the absence and presence of 10 μM <b>1</b>. The data points are the mean values ± SEM (<i>n</i> = 3 or 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0018.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. General Synthetic Route for the Third-Generation P2Y<sub>2</sub>R Fluorescent Antagonists<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Amine, <i>N</i>Et<sub>3</sub>, 1,4-dioxane, reflux, 72 h (89%). (b) Lawesson’s reagent, 1,4-dioxane, reflux, 18 h (48%). (c) TFA, DCM, rt, 30 min (55%). (d) <i>tert</i>-Butyl (2-aminoethyl)carbamate, HATU, DCM, DIPEA, rt, 24 h (63%). (e) (i) NaOH, MeOH, reflux, 4 h; (ii) 5-aminotetrazole, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, DIPEA, DMF, rt, 4 h (28% over two steps). (f) (i) TFA, DCM, rt, 30 min; (ii) BODIPY-SE, DIPEA, DMF, rt, 1–4 h (11–18% over two steps). The structures of compounds <b>95</b>–<b>98</b> are assigned in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</p></p></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacological evaluations of <b>97</b> and <b>98</b> showing the effects on Ca<sup>2+</sup> mobilization in <i>h</i>P2Y<sub>2</sub>R-1321N1 cells induced by 0.1 μM UTPγS (<i>n</i> = 7 or 8).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacological evaluations of (a) <b>97</b> and (b) <b>98</b> showing BRET saturation binding (<i>n</i> = 7). Displacement of (c) <b>97</b> (100 nM, <i>n</i> = 9) and (d) <b>98</b> (1 μM, <i>n</i> = 6) binding in NLuc-P2Y<sub>2</sub> 1321N1 cells by <b>1</b>. The values shown are the means ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/medium/jm-2018-00139e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Visualization of the binding of (a,b) <b>97</b> and (c,d) <b>98</b> on astrocytoma cells expressing <i>h</i>P2Y<sub>2</sub>R. The images in the left-hand column (a,c) are confocal image with 100 nM concentrations of the fluorescent ligands, whereas the right-hand column (b,d) shows images of the cells with the fluorescent ligands and 10 μM <b>1</b>. In all of the conditions, the cells were incubated for 30 min at 37 °C in the presence or absence of 10 μM <b>1</b>. Single-equatorial confocal images were then obtained in the continued presence of the fluorescent ligand (<b>97</b> or <b>98</b>) and the unlabeled antagonist. The images shown are from a single experiment representative of the four performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00139/20180503/images/large/jm-2018-00139e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00139&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i133">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbracchio, M. P.</span></span> <span> </span><span class="NLM_article-title">International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1124/pr.58.3.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1124%2Fpr.58.3.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=16968944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=281-341&issue=3&author=M.+P.+Abbracchio&title=International+Union+of+Pharmacology+LVIII%3A+Update+on+the+P2Y+G+Protein-Coupled+Nucleotide+Receptors%3A+From+Molecular+Mechanisms+and+Pathophysiology+to+Therapy&doi=10.1124%2Fpr.58.3.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy</span></div><div class="casAuthors">Abbracchio, Maria P.; Burnstock, Geoffrey; Boeynaems, Jean-Marie; Barnard, Eric A.; Boyer, Jose L.; Kennedy, Charles; Knight, Gillian E.; Fumagalli, Marta; Gachet, Christian; Jacobson, Kenneth A.; Weisman, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-341</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  There have been many advances in our knowledge about different aspects of P2Y receptor signaling since the last review published by our International Union of Pharmacol. subcommittee.  More receptor subtypes have been cloned and characterized and most orphan receptors deorphanized, so that it is now possible to provide a basis for a future subdivision of P2Y receptor subtypes.  More is known about the functional elements of the P2Y receptor mols. and the signaling pathways involved, including interactions with ion channels.  There have been substantial developments in the design of selective agonists and antagonists to some of the P2Y receptor subtypes.  There are new findings about the mechanisms underlying nucleotide release and ectoenzymic nucleotide breakdown.  Interactions between P2Y receptors and receptors to other signaling mols. have been explored as well as P2Y-mediated control of gene transcription.  The distribution and roles of P2Y receptor subtypes in many different cell types are better understood and P2Y receptor-related compds. are being explored for therapeutic purposes.  These and other advances are discussed in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3-m5Cf-JzaLVg90H21EOLACvtfcHk0lgRj8aloqrTAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLbF&md5=b302ee34857a5f45d740e4f2e962ed42</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.3%26sid%3Dliteratum%253Aachs%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology%2520LVIII%253A%2520Update%2520on%2520the%2520P2Y%2520G%2520Protein-Coupled%2520Nucleotide%2520Receptors%253A%2520From%2520Molecular%2520Mechanisms%2520and%2520Pathophysiology%2520to%2520Therapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26issue%3D3%26spage%3D281%26epage%3D341%26doi%3D10.1124%2Fpr.58.3.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C.</span></span> <span> </span><span class="NLM_article-title">Is There a Basis for Distinguishing Two Types of P2-Purinoceptor?</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">433</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1016/0306-3623(85)90001-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2F0306-3623%2885%2990001-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=2996968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADyaL2MXlsFChtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1985&pages=433-440&issue=5&author=G.+Burnstockauthor=C.+Kennedy&title=Is+There+a+Basis+for+Distinguishing+Two+Types+of+P2-Purinoceptor%3F&doi=10.1016%2F0306-3623%2885%2990001-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a basis for distinguishing two types of P2-purinoceptor?</span></div><div class="casAuthors">Burnstock, G.; Kennedy, C.</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">433-40</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    </div><div class="casAbstract">A review with approx. 70 refs. of studies indicating that the P2-purinergic receptors may be sepd. into 2 subtypes largely on the basis of the rank order of agonist potency of structural analogs of ATP and also on the activity of antagonists at the P2-purinoceptor.  Differences in the structure of P2-purinoceptors in various tissues may be useful in the development of drugs for the treatment of vascular, gastrointestinal, and urinogenital disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpejfAeAGiLzrVg90H21EOLACvtfcHk0liT8i0DbDxIoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsFChtr0%253D&md5=0edabb89502eb887e0cfabc936e06601</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2885%2990001-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252885%252990001-1%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DKennedy%26aufirst%3DC.%26atitle%3DIs%2520There%2520a%2520Basis%2520for%2520Distinguishing%2520Two%2520Types%2520of%2520P2-Purinoceptor%253F%26jtitle%3DGen.%2520Pharmacol.%26date%3D1985%26volume%3D16%26issue%3D5%26spage%3D433%26epage%3D440%26doi%3D10.1016%2F0306-3623%2885%2990001-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazarowski, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutts, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, T. K.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Selectivity of the Cloned Human P2U-Purinoceptor: Potent Activation by Diadenosine Tetraphosphate</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1619</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1995.tb16382.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1111%2Fj.1476-5381.1995.tb16382.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=8564228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVKktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1995&pages=1619-1627&issue=1&author=E.+R.+Lazarowskiauthor=W.+C.+Wattauthor=M.+J.+Stuttsauthor=R.+C.+Boucherauthor=T.+K.+Harden&title=Pharmacological+Selectivity+of+the+Cloned+Human+P2U-Purinoceptor%3A+Potent+Activation+by+Diadenosine+Tetraphosphate&doi=10.1111%2Fj.1476-5381.1995.tb16382.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate</span></div><div class="casAuthors">Lazarowski, Eduardo R.; Watt, William C.; Stutts, M. Jackson; Boucher, Richard C.; Harden, T. Kendall</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1619-27</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">The human P2U-purinoceptor was stably expressed in 1321N1 human astrocytoma cells and the pharmacol. selectivity of the expressed receptor was studied by measurement of inositol lipid hydrolysis.  High basal levels of inositol phosphates occurred in P2U-purinoceptor-expressing cells.  This phenomenon was shown to be due to release of large amts. of ATP from 1321N1 cells, and could be circumvented by adoption of an assay protocol that did not involve medium changes.  UTP, ATP and ATPγS were full and potent agonists for activation of phospholipase C with EC50 values of 140 nM, 230 nM, and 1.72 μM, resp.  5BrUTP, 2C1ATP and 8BrATP were also full agonists although less potent than their natural congeners.  Little or no effect was obsd. with the selective P2y-, P2X-, and P2T-purinoceptor agonists, 2MeSATP, α,β-MeATP, and 2MeSADP, resp.  Diadenosine tetraphosphate, Ap4A, was a surprisingly potent agonist at the expressed P2U-purinoceptor with an EC50 (720 nM) in the range of the most potent P2U-purinoceptor agonists.  Ap4A may be a physiol. important activator of P2U-purinoceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdomI8KI4cx7Vg90H21EOLACvtfcHk0liT8i0DbDxIoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVKktLY%253D&md5=f5f4f71d7f0df38f26e501094e3373f5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb16382.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb16382.x%26sid%3Dliteratum%253Aachs%26aulast%3DLazarowski%26aufirst%3DE.%2BR.%26aulast%3DWatt%26aufirst%3DW.%2BC.%26aulast%3DStutts%26aufirst%3DM.%2BJ.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DHarden%26aufirst%3DT.%2BK.%26atitle%3DPharmacological%2520Selectivity%2520of%2520the%2520Cloned%2520Human%2520P2U-Purinoceptor%253A%2520Potent%2520Activation%2520by%2520Diadenosine%2520Tetraphosphate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D116%26issue%3D1%26spage%3D1619%26epage%3D1627%26doi%3D10.1111%2Fj.1476-5381.1995.tb16382.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocks, M. J.</span></span> <span> </span><span class="NLM_article-title">Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9981</span>– <span class="NLM_lpage">10005</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01972</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01972" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9981-10005&issue=22&author=S.+Conroyauthor=N.+Kindonauthor=B.+Kellamauthor=M.+J.+Stocks&title=Drug-like+Antagonists+of+P2Y+Receptors-From+Lead+Identification+to+Drug+Development&doi=10.1021%2Facs.jmedchem.5b01972"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01972%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DS.%26aulast%3DKindon%26aufirst%3DN.%26aulast%3DKellam%26aufirst%3DB.%26aulast%3DStocks%26aufirst%3DM.%2BJ.%26atitle%3DDrug-like%2520Antagonists%2520of%2520P2Y%2520Receptors-From%2520Lead%2520Identification%2520to%2520Drug%2520Development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D22%26spage%3D9981%26epage%3D10005%26doi%3D10.1021%2Facs.jmedchem.5b01972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strilic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraj, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettschureck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">Platelet-Derived Nucleotides Promote Tumor-Cell Transendothelial Migration and Metastasis <i>via</i> P2Y<sub>2</sub> Receptor</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">130</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2Fj.ccr.2013.05.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=130-137&issue=1&author=D.+Schumacherauthor=B.+Strilicauthor=K.+K.+Sivarajauthor=N.+Wettschureckauthor=S.+Offermanns&title=Platelet-Derived+Nucleotides+Promote+Tumor-Cell+Transendothelial+Migration+and+Metastasis+via+P2Y2+Receptor&doi=10.1016%2Fj.ccr.2013.05.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DD.%26aulast%3DStrilic%26aufirst%3DB.%26aulast%3DSivaraj%26aufirst%3DK.%2BK.%26aulast%3DWettschureck%26aufirst%3DN.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DPlatelet-Derived%2520Nucleotides%2520Promote%2520Tumor-Cell%2520Transendothelial%2520Migration%2520and%2520Metastasis%2520via%2520P2Y2%2520Receptor%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26issue%3D1%26spage%3D130%26epage%3D137%26doi%3D10.1016%2Fj.ccr.2013.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Virgilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliani, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adinolfi, E.</span></span> <span> </span><span class="NLM_article-title">P2 Receptors in Cancer Progression and Metastatic Spreading</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2016.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2Fj.coph.2016.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=27262778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC28XotF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=17-25&author=F.+Di%0AVirgilioauthor=S.+Falzoniauthor=A.+L.+Giulianiauthor=E.+Adinolfi&title=P2+Receptors+in+Cancer+Progression+and+Metastatic+Spreading&doi=10.1016%2Fj.coph.2016.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">P2 receptors in cancer progression and metastatic spreading</span></div><div class="casAuthors">Di Virgilio, Francesco; Falzoni, Simonetta; Giuliani, Anna Lisa; Adinolfi, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-25</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor microenvironment is nucleoside and nucleotide rich.  Adenosine is a key determinant of the highly immunosuppressive tumor interstitium.  Extracellular ATP also affects anti-tumor immunity, albeit its effects on host-tumor interaction are incompletely understood.  We give here an overview of recent literature covering the role of nucleotide-selective (P2) plasma membrane receptors in tumor growth and progression.  P2 receptors are expressed on both host and cancer cells, where depending on the receptor subtype, the inflammatory infiltrate and the tumor cell type they may drive an anti-tumor response or promote tumor progression.  It is anticipated that knowledge of the pharmacol., biochem. and functional activity of the P2 receptors will allow a better understanding of host-tumor interaction and the development of innovative anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxdlW1FuqvubVg90H21EOLACvtfcHk0lgPt65rBwwaHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotF2rtbY%253D&md5=7caad662c50efbf79cea14fc42fdc8b2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2016.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2016.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26aulast%3DFalzoni%26aufirst%3DS.%26aulast%3DGiuliani%26aufirst%3DA.%2BL.%26aulast%3DAdinolfi%26aufirst%3DE.%26atitle%3DP2%2520Receptors%2520in%2520Cancer%2520Progression%2520and%2520Metastatic%2520Spreading%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2016%26volume%3D29%26spage%3D17%26epage%3D25%26doi%3D10.1016%2Fj.coph.2016.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmouty-Quintana, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zissel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lungarella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Virgilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeynaems, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idzko, M.</span></span> <span> </span><span class="NLM_article-title">The Purinergic Receptor Subtype P2Y<sub>2</sub> Mediates Chemotaxis of Neutrophils and Fibroblasts in Fibrotic Lung Disease</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">35962</span>– <span class="NLM_lpage">35972</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.16414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.18632%2Foncotarget.16414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=35962-35972&issue=22&author=T.+M%C3%BCllerauthor=S.+Fayauthor=R.+P.+Vieiraauthor=H.+Karmouty-Quintanaauthor=S.+Cickoauthor=K.+Ayataauthor=G.+Zisselauthor=T.+Goldmannauthor=G.+Lungarellaauthor=D.+Ferrariauthor=F.+Di+Virgilioauthor=B.+Robayeauthor=J.-M.+Boeynaemsauthor=M.+R.+Blackburnauthor=M.+Idzko&title=The+Purinergic+Receptor+Subtype+P2Y2+Mediates+Chemotaxis+of+Neutrophils+and+Fibroblasts+in+Fibrotic+Lung+Disease&doi=10.18632%2Foncotarget.16414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.16414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.16414%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%26aulast%3DFay%26aufirst%3DS.%26aulast%3DVieira%26aufirst%3DR.%2BP.%26aulast%3DKarmouty-Quintana%26aufirst%3DH.%26aulast%3DCicko%26aufirst%3DS.%26aulast%3DAyata%26aufirst%3DK.%26aulast%3DZissel%26aufirst%3DG.%26aulast%3DGoldmann%26aufirst%3DT.%26aulast%3DLungarella%26aufirst%3DG.%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26aulast%3DRobaye%26aufirst%3DB.%26aulast%3DBoeynaems%26aufirst%3DJ.-M.%26aulast%3DBlackburn%26aufirst%3DM.%2BR.%26aulast%3DIdzko%26aufirst%3DM.%26atitle%3DThe%2520Purinergic%2520Receptor%2520Subtype%2520P2Y2%2520Mediates%2520Chemotaxis%2520of%2520Neutrophils%2520and%2520Fibroblasts%2520in%2520Fibrotic%2520Lung%2520Disease%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26issue%3D22%26spage%3D35962%26epage%3D35972%26doi%3D10.18632%2Foncotarget.16414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougall, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKechnie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meghani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocks, M. J.</span></span> <span> </span><span class="NLM_article-title">From UTP to AR-C118925, the Discovery of a Potent Non Nucleotide Antagonist of the P2Y<sub>2</sub> Receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4849</span>– <span class="NLM_lpage">4853</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2Fj.bmcl.2017.09.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4849-4853&issue=21&author=N.+Kindonauthor=A.+Davisauthor=I.+Dougallauthor=J.+Dixonauthor=T.+Johnsonauthor=I.+Waltersauthor=S.+Thomauthor=K.+McKechnieauthor=P.+Meghaniauthor=M.+J.+Stocks&title=From+UTP+to+AR-C118925%2C+the+Discovery+of+a+Potent+Non+Nucleotide+Antagonist+of+the+P2Y2+Receptor&doi=10.1016%2Fj.bmcl.2017.09.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DKindon%26aufirst%3DN.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DDougall%26aufirst%3DI.%26aulast%3DDixon%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DWalters%26aufirst%3DI.%26aulast%3DThom%26aufirst%3DS.%26aulast%3DMcKechnie%26aufirst%3DK.%26aulast%3DMeghani%26aufirst%3DP.%26aulast%3DStocks%26aufirst%3DM.%2BJ.%26atitle%3DFrom%2520UTP%2520to%2520AR-C118925%252C%2520the%2520Discovery%2520of%2520a%2520Potent%2520Non%2520Nucleotide%2520Antagonist%2520of%2520the%2520P2Y2%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D21%26spage%3D4849%26epage%3D4853%26doi%3D10.1016%2Fj.bmcl.2017.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindon, N. D.</span>; <span class="NLM_string-name">Meghani, P.</span>; <span class="NLM_string-name">Thom, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-oxo-4-thioxopyrimidin-1-ylmethylheterocyclylcarboxylates as P2-purinoceptor 7-transmembrane G-protein Coupled Receptor Antagonists</span>. <span class="NLM_patent">WO9854180</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=N.+D.+Kindon&author=P.+Meghani&author=S.+Thom&title=Preparation+of+2-oxo-4-thioxopyrimidin-1-ylmethylheterocyclylcarboxylates+as+P2-purinoceptor+7-transmembrane+G-protein+Coupled+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKindon%26aufirst%3DN.%2BD.%26atitle%3DPreparation%2520of%25202-oxo-4-thioxopyrimidin-1-ylmethylheterocyclylcarboxylates%2520as%2520P2-purinoceptor%25207-transmembrane%2520G-protein%2520Coupled%2520Receptor%2520Antagonists%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugar, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, A. D.</span></span> <span> </span><span class="NLM_article-title">Nucleotide-Mediated Mucin Secretion from Differentiated Human Bronchial Epithelial Cells</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2003-0211OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1165%2Frcmb.2003-0211OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=15231488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot12ntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=446-455&issue=4&author=P.+A.+Kempauthor=R.+A.+Sugarauthor=A.+D.+Jackson&title=Nucleotide-Mediated+Mucin+Secretion+from+Differentiated+Human+Bronchial+Epithelial+Cells&doi=10.1165%2Frcmb.2003-0211OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide-mediated mucin secretion from differentiated human bronchial epithelial cells</span></div><div class="casAuthors">Kemp, Philip A.; Sugar, Rosemary A.; Jackson, Alan D.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">446-455</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Most current cell-based models for examg. the regulation of mucin secretion demonstrate low signal-to-noise ratios, making exptl. manipulation and data interpretation difficult.  Using ATP (ATP) as a mucin secretagogue, we have developed a model of agonist-induced mucin secretion in differentiated human bronchial epithelial cells.  Mucin secretory signals were estd. using enzyme-linked lectin assay, and typical signals of 300-400% of baseline were obsd. in response to a 30-min exposure to ATP (100 μM).  ATP and uridine triphosphate equipotently stimulated mucin secretion consistent with mediation via P2Y2 receptor activation.  Suramin and AR-C118925XX, a competitive P2Y2 receptor antagonist, inhibited adenosine 5'-o-(3-thiotriphosphate) (ATP-γS)-induced mucin secretion.  A selective Gq G-protein antagonist (GP-ANT)-2A completely abrogated ATP-γS-induced mucin secretion.  Pertussis toxin and the Gi/o-specific, GP-ANT-2, had no effect.  The phospholipase C inhibitor, D609, and the protein kinase C inhibitor, calphostin C, substantially inhibited ATP-γS-induced mucin secretion.  Phorbol myristate acetate also stimulated mucin secretion in a calphostin C-sensitive manner.  ATP-γS-induced mucin secretion was inhibited by the Ca2+ chelator, 1,2-bis(o-aminophenoxy) ethane-N,N,N',N'-tetra-acetic acid tetra (acetoxymethyl) ester.  Ionomycin and thapsigargin both stimulated mucin secretion.  Our data are broadly consistent with known G-protein-coupling and downstream signaling events assocd. with the P2Y2 receptor.  The exceptional signal-to-noise ratios obtained using this model have permitted clear evaluation of the involvement of these mechanisms in agonist-induced mucin secretion from differentiated human bronchial epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj6XFmsXBGVrVg90H21EOLACvtfcHk0lhn1jjYkMqYmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot12ntLg%253D&md5=05567b0a6b6f4c1f88e45bc44ae82392</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2003-0211OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2003-0211OC%26sid%3Dliteratum%253Aachs%26aulast%3DKemp%26aufirst%3DP.%2BA.%26aulast%3DSugar%26aufirst%3DR.%2BA.%26aulast%3DJackson%26aufirst%3DA.%2BD.%26atitle%3DNucleotide-Mediated%2520Mucin%2520Secretion%2520from%2520Differentiated%2520Human%2520Bronchial%2520Epithelial%2520Cells%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2004%26volume%3D31%26issue%3D4%26spage%3D446%26epage%3D455%26doi%3D10.1165%2Frcmb.2003-0211OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rafehi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbiel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attah, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Characterization, and in Vitro Evaluation of the Selective P2Y<sub>2</sub> Receptor Antagonist AR-C118925</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1007/s11302-016-9542-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1007%2Fs11302-016-9542-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=89-103&issue=1&author=M.+Rafehiauthor=J.+C.+Burbielauthor=I.+Y.+Attahauthor=A.+Abdelrahmanauthor=C.+E.+M%C3%BCller&title=Synthesis%2C+Characterization%2C+and+in+Vitro+Evaluation+of+the+Selective+P2Y2+Receptor+Antagonist+AR-C118925&doi=10.1007%2Fs11302-016-9542-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs11302-016-9542-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-016-9542-3%26sid%3Dliteratum%253Aachs%26aulast%3DRafehi%26aufirst%3DM.%26aulast%3DBurbiel%26aufirst%3DJ.%2BC.%26aulast%3DAttah%26aufirst%3DI.%2BY.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DSynthesis%252C%2520Characterization%252C%2520and%2520in%2520Vitro%2520Evaluation%2520of%2520the%2520Selective%2520P2Y2%2520Receptor%2520Antagonist%2520AR-C118925%26jtitle%3DPurinergic%2520Signalling%26date%3D2017%26volume%3D13%26issue%3D1%26spage%3D89%26epage%3D103%26doi%3D10.1007%2Fs11302-016-9542-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, H.</span></span> <span> </span><span class="NLM_article-title">Development of Selective Agonists and Antagonists of P2Y Receptors</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1007/s11302-008-9106-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1007%2Fs11302-008-9106-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=75-89&issue=1&author=K.+A.+Jacobsonauthor=A.+A.+Ivanovauthor=S.+de+Castroauthor=T.+K.+Hardenauthor=H.+Ko&title=Development+of+Selective+Agonists+and+Antagonists+of+P2Y+Receptors&doi=10.1007%2Fs11302-008-9106-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs11302-008-9106-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-008-9106-2%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DHarden%26aufirst%3DT.%2BK.%26aulast%3DKo%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520Selective%2520Agonists%2520and%2520Antagonists%2520of%2520P2Y%2520Receptors%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26issue%3D1%26spage%3D75%26epage%3D89%26doi%3D10.1007%2Fs11302-008-9106-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jayasekara, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">4-Alkyloxyimino Derivatives of Uridine-5′-Triphosphate: Distal Modification of Potent Agonists as a Strategy for Molecular Probes of P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub> Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3874</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1021/jm500367e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500367e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3874-3883&issue=9&author=P.+S.+Jayasekaraauthor=M.+O.+Barrettauthor=C.+B.+Ballauthor=K.+A.+Brownauthor=E.+Hammesauthor=R.+Balasubramanianauthor=T.+K.+Hardenauthor=K.+A.+Jacobson&title=4-Alkyloxyimino+Derivatives+of+Uridine-5%E2%80%B2-Triphosphate%3A+Distal+Modification+of+Potent+Agonists+as+a+Strategy+for+Molecular+Probes+of+P2Y2%2C+P2Y4%2C+and+P2Y6+Receptors&doi=10.1021%2Fjm500367e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm500367e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500367e%26sid%3Dliteratum%253Aachs%26aulast%3DJayasekara%26aufirst%3DP.%2BS.%26aulast%3DBarrett%26aufirst%3DM.%2BO.%26aulast%3DBall%26aufirst%3DC.%2BB.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DHammes%26aufirst%3DE.%26aulast%3DBalasubramanian%26aufirst%3DR.%26aulast%3DHarden%26aufirst%3DT.%2BK.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3D4-Alkyloxyimino%2520Derivatives%2520of%2520Uridine-5%25E2%2580%25B2-Triphosphate%253A%2520Distal%2520Modification%2520of%2520Potent%2520Agonists%2520as%2520a%2520Strategy%2520for%2520Molecular%2520Probes%2520of%2520P2Y2%252C%2520P2Y4%252C%2520and%2520P2Y6%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D9%26spage%3D3874%26epage%3D3883%26doi%3D10.1021%2Fjm500367e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Böhme, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Illuminating the Life of GPCRs</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.1186/1478-811X-7-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1186%2F1478-811X-7-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=19602276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A280%3ADC%252BD1MrltVKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=16&issue=1&author=I.+B%C3%B6hmeauthor=A.+G.+Beck-Sickinger&title=Illuminating+the+Life+of+GPCRs&doi=10.1186%2F1478-811X-7-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating the life of GPCRs</span></div><div class="casAuthors">Bohme Ilka; Beck-Sickinger Annette G</div><div class="citationInfo"><span class="NLM_cas:title">Cell communication and signaling : CCS</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> The investigation of biological systems highly depends on the possibilities that allow scientists to visualize and quantify biomolecules and their related activities in real-time and non-invasively.  G-protein coupled receptors represent a family of very dynamic and highly regulated transmembrane proteins that are involved in various important physiological processes.  Since their localization is not confined to the cell surface they have been a very attractive "moving target" and the understanding of their intracellular pathways as well as the identified protein-protein-interactions has had implications for therapeutic interventions.  Recent and ongoing advances in both the establishment of a variety of labeling methods and the improvement of measuring and analyzing instrumentation, have made fluorescence techniques to an indispensable tool for GPCR imaging.  The illumination of their complex life cycle, which includes receptor biosynthesis, membrane targeting, ligand binding, signaling, internalization, recycling and degradation, will provide new insights into the relationship between spatial receptor distribution and function.  This review covers the existing technologies to track GPCRs in living cells.  Fluorescent ligands, antibodies, auto-fluorescent proteins as well as the evolving technologies for chemical labeling with peptide- and protein-tags are described and their major applications concerning the GPCR life cycle are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuNF2niqBaepVVjGoY74BafW6udTcc2eaVU58BjtD62Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrltVKhug%253D%253D&md5=246281fd5b3c42b28bc56c1f9d01f156</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-7-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-7-16%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6hme%26aufirst%3DI.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DIlluminating%2520the%2520Life%2520of%2520GPCRs%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2009%26volume%3D7%26issue%3D1%26spage%3D16%26doi%3D10.1186%2F1478-811X-7-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span> <span> </span><span class="NLM_article-title">Toward Fluorescent Probes for G-Protein-Coupled Receptors (GPCRs)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8187</span>– <span class="NLM_lpage">8203</span>, <span class="refDoi"> DOI: 10.1021/jm401823z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401823z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8187-8203&issue=20&author=Z.+Maauthor=L.+Duauthor=M.+Li&title=Toward+Fluorescent+Probes+for+G-Protein-Coupled+Receptors+%28GPCRs%29&doi=10.1021%2Fjm401823z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401823z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401823z%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DToward%2520Fluorescent%2520Probes%2520for%2520G-Protein-Coupled%2520Receptors%2520%2528GPCRs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8187%26epage%3D8203%26doi%3D10.1021%2Fjm401823z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, M. E.</span></span> <span> </span><span class="NLM_article-title">Fluorescent Approaches for Understanding Interactions of Ligands with G Protein Coupled Receptors</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1838</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2013.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2Fj.bbamem.2013.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=24055822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOgsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=15-33&issue=1&author=R.+Sridharanauthor=J.+Zuberauthor=S.+M.+Connellyauthor=E.+Mathewauthor=M.+E.+Dumont&title=Fluorescent+Approaches+for+Understanding+Interactions+of+Ligands+with+G+Protein+Coupled+Receptors&doi=10.1016%2Fj.bbamem.2013.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors</span></div><div class="casAuthors">Sridharan, Rajashri; Zuber, Jeffrey; Connelly, Sara M.; Mathew, Elizabeth; Dumont, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">1PA</span>),
    <span class="NLM_cas:pages">15-33</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are responsible for a wide variety of signaling responses in diverse cell types.  Despite major advances in the detn. of structures of this class of receptors, the underlying mechanisms by which binding of different types of ligands specifically elicits particular signaling responses remain unclear.  The use of fluorescence spectroscopy can provide important information about the process of ligand binding and ligand-dependent conformational changes in receptors, esp. kinetic aspects of these processes that can be difficult to ext. from x-ray structures.  Here, the authors present an overview of the extensive array of fluorescent ligands that have been used in studies of GPCRs and describe spectroscopic approaches for assaying binding and probing the environment of receptor-bound ligands with particular attention to examples involving yeast pheromone receptors.  In addn., the authors discuss the use of fluorescence spectroscopy for detecting and characterizing conformational changes in receptors induced by the binding of ligands.  Such studies have provided strong evidence for diversity of receptor conformations elicited by different ligands, consistent with the idea that GPCRs are not simple on and off switches.  This diversity of states constitutes an underlying mechanistic basis for biased agonism, the observation that different stimuli can produce different responses from a single receptor.  It is likely that continued tech. advances will allow fluorescence spectroscopy to play an important role in continued probing of structural transitions in GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_MCI4Gleo1rVg90H21EOLACvtfcHk0lgTCZVHDimfgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOgsbjP&md5=c6958b3b707da56efb8a2e6513c3b579</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DSridharan%26aufirst%3DR.%26aulast%3DZuber%26aufirst%3DJ.%26aulast%3DConnelly%26aufirst%3DS.%2BM.%26aulast%3DMathew%26aufirst%3DE.%26aulast%3DDumont%26aufirst%3DM.%2BE.%26atitle%3DFluorescent%2520Approaches%2520for%2520Understanding%2520Interactions%2520of%2520Ligands%2520with%2520G%2520Protein%2520Coupled%2520Receptors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26issue%3D1%26spage%3D15%26epage%3D33%26doi%3D10.1016%2Fj.bbamem.2013.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cottet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faklaris, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durroux, T.</span></span> <span> </span><span class="NLM_article-title">Original Fluorescent Ligand-Based Assays Open New Perspectives in G-Protein Coupled Receptor Drug Screening</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.3390/ph4010202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.3390%2Fph4010202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=202-214&issue=12&author=M.+Cottetauthor=O.+Faklarisauthor=J.+M.+Zwierauthor=E.+Trinquetauthor=J.-P.+Pinauthor=T.+Durroux&title=Original+Fluorescent+Ligand-Based+Assays+Open+New+Perspectives+in+G-Protein+Coupled+Receptor+Drug+Screening&doi=10.3390%2Fph4010202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3390%2Fph4010202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph4010202%26sid%3Dliteratum%253Aachs%26aulast%3DCottet%26aufirst%3DM.%26aulast%3DFaklaris%26aufirst%3DO.%26aulast%3DZwier%26aufirst%3DJ.%2BM.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DOriginal%2520Fluorescent%2520Ligand-Based%2520Assays%2520Open%2520New%2520Perspectives%2520in%2520G-Protein%2520Coupled%2520Receptor%2520Drug%2520Screening%26jtitle%3DPharmaceuticals%26date%3D2011%26volume%3D4%26issue%3D12%26spage%3D202%26epage%3D214%26doi%3D10.3390%2Fph4010202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, E. K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheal, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfleger, K. D. G.</span></span> <span> </span><span class="NLM_article-title">Application of BRET to Monitor Ligand Binding to GPCRs</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1038/nmeth.3398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1038%2Fnmeth.3398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=26030448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=661-663&issue=7&author=L.+A.+Stoddartauthor=E.+K.+M.+Johnstoneauthor=A.+J.+Whealauthor=J.+Gouldingauthor=M.+B.+Robersauthor=T.+Machleidtauthor=K.+V.+Woodauthor=S.+J.+Hillauthor=K.+D.+G.+Pfleger&title=Application+of+BRET+to+Monitor+Ligand+Binding+to+GPCRs&doi=10.1038%2Fnmeth.3398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Application of BRET to monitor ligand binding to GPCRs</span></div><div class="casAuthors">Stoddart, Leigh A.; Johnstone, Elizabeth K. M.; Wheal, Amanda J.; Goulding, Joelle; Robers, Matthew B.; Machleidt, Thomas; Wood, Keith V.; Hill, Stephen J.; Pfleger, Kevin D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-663</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bioluminescence resonance energy transfer (BRET) is a well-established method for investigating protein-protein interactions.  Here we present a BRET approach to monitor ligand binding to G protein-coupled receptors (GPCRs) on the surface of living cells made possible by the use of fluorescent ligands in combination with a bioluminescent protein (NanoLuc) that can be readily expressed on the N terminus of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKCGBtnUo25LVg90H21EOLACvtfcHk0lgTCZVHDimfgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbbI&md5=b829c12d21f0079ceb4222be2ebf6f32</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.3398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.3398%26sid%3Dliteratum%253Aachs%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DJohnstone%26aufirst%3DE.%2BK.%2BM.%26aulast%3DWheal%26aufirst%3DA.%2BJ.%26aulast%3DGoulding%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DK.%2BV.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DPfleger%26aufirst%3DK.%2BD.%2BG.%26atitle%3DApplication%2520of%2520BRET%2520to%2520Monitor%2520Ligand%2520Binding%2520to%2520GPCRs%26jtitle%3DNat.%2520Methods%26date%3D2015%26volume%3D12%26issue%3D7%26spage%3D661%26epage%3D663%26doi%3D10.1038%2Fnmeth.3398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5638</span>– <span class="NLM_lpage">5645</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00338</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Shsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5638-5645&issue=13&author=A.+H.+Hansenauthor=E.+Sergeevauthor=S.+K.+Pandeyauthor=B.+D.+Hudsonauthor=E.+Christiansenauthor=G.+Milliganauthor=T.+Ulven&title=Development+and+Characterization+of+a+Fluorescent+Tracer+for+the+Free+Fatty+Acid+Receptor+2+%28FFA2%2FGPR43%29&doi=10.1021%2Facs.jmedchem.7b00338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43)</span></div><div class="casAuthors">Hansen, Anders Hoejgaard; Sergeev, Eugenia; Pandey, Sunil K.; Hudson, Brian D.; Christiansen, Elisabeth; Milligan, Graeme; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5638-5645</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The free fatty acid receptor 2 (FFA2/GPR43) is considered a potential target for treatment of metabolic and inflammatory diseases.  Here we describe the development of the first fluorescent tracer for FFA2 intended as a tool for assessment of thermodn. and kinetic binding parameters of unlabeled ligands.  Starting with a known azetidine FFA2 antagonist, we used a carboxylic acid moiety known not to be crit. for receptor interaction as attachment point for a nitrobenzoxadiazole (NBD) fluorophore.  This led to the development of 4 (TUG-1609), a fluorescent tracer for FFA2 with favorable spectroscopic properties and high affinity, as detd. by bioluminescence resonance energy transfer (BRET)-based satn. and kinetic binding expts., as well as a high specific to nonspecific BRET binding signal.  A BRET-based competition binding assay with 4 was also established and used to det. binding consts. and kinetics of unlabeled ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdOUn9oB6w8LVg90H21EOLACvtfcHk0liZl3vJRbVwlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Shsro%253D&md5=23b6686e714c04768bf89723bd6a84ee</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00338%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DA.%2BH.%26aulast%3DSergeev%26aufirst%3DE.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDevelopment%2520and%2520Characterization%2520of%2520a%2520Fluorescent%2520Tracer%2520for%2520the%2520Free%2520Fatty%2520Acid%2520Receptor%25202%2520%2528FFA2%252FGPR43%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5638%26epage%3D5645%26doi%3D10.1021%2Facs.jmedchem.7b00338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span> <i>Instant JChem</i>, 16.2.15.0 2016; <span class="NLM_publisher-name">ChemAxon</span>: <span class="NLM_publisher-loc">Budapest</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Instant+JChem%2C+16.2.15.0+2016%3B+ChemAxon%3A+Budapest%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DInstant%2520JChem%26pub%3DChemAxon%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindon, N. D.</span>; <span class="NLM_string-name">Meghani, P.</span>; <span class="NLM_string-name">Thom, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Pyrimidinediones and Thioxopyrimidinones as P2-purinoceptor 7-transmembrane (TM) G-protein Coupled Receptor Antagonists</span>. <span class="NLM_patent">WO9926944</span>, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=N.+D.+Kindon&author=P.+Meghani&author=S.+Thom&title=Preparation+of+Pyrimidinediones+and+Thioxopyrimidinones+as+P2-purinoceptor+7-transmembrane+%28TM%29+G-protein+Coupled+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKindon%26aufirst%3DN.%2BD.%26atitle%3DPreparation%2520of%2520Pyrimidinediones%2520and%2520Thioxopyrimidinones%2520as%2520P2-purinoceptor%25207-transmembrane%2520%2528TM%2529%2520G-protein%2520Coupled%2520Receptor%2520Antagonists%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukor, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nafie, L. A.</span></span> <span> </span><span class="NLM_article-title">Determination of Absolute Configuration of Chiral Molecules Using Vibrational Optical Activity: A Review</span>. <i>Appl. Spectrosc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1366/11-06321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1366%2F11-06321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=21740631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovV2jtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=699-723&issue=7&author=Y.+Heauthor=W.+Boauthor=R.+K.+Dukorauthor=L.+A.+Nafie&title=Determination+of+Absolute+Configuration+of+Chiral+Molecules+Using+Vibrational+Optical+Activity%3A+A+Review&doi=10.1366%2F11-06321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of absolute configuration of chiral molecules using vibrational optical activity: a review</span></div><div class="casAuthors">He, Yanan; Wang, Bo; Dukor, Rina K.; Nafie, Laurence A.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Spectroscopy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">699-723</span>CODEN:
                <span class="NLM_cas:coden">APSPA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-7028</span>.
    
            (<span class="NLM_cas:orgname">Society for Applied Spectroscopy</span>)
        </div><div class="casAbstract">A review.  Detn. of the abs. handedness, known as abs. configuration (AC), of chiral mols. is an important step in any field related to chirality, esp. in the pharmaceutical industry.  Vibrational optical activity (VOA) has become a powerful tool for the detn. of the AC of chiral mols. in the soln. state after nearly forty years of evolution.  VOA offers a novel alternative, or supplement, to X-ray crystallog., permitting AC detns. on neat liq., oil, and soln. samples without the need to grow single crystals of the pure chiral sample mols. as required for X-ray anal.  By comparing the sign and intensity of the measured VOA spectrum with the corresponding ab initio d. functional theory (DFT) calcd. VOA spectrum of a chosen configuration, one can unambiguously assign the AC of a chiral mol.  Comparing measured VOA spectra with calcd. VOA spectra of all the conformers can also provide soln.-state conformational populations.  VOA consists of IR vibrational CD (VCD) and vibrational Raman optical activity (ROA).  Currently, VCD is used routinely by researchers in a variety of backgrounds, including mol. chirality, asym. synthesis, chiral catalysis, drug screening, pharmacol., and natural products.  Although the application of ROA in AC detn. lags behind that of VCD, with the recent implementation of ROA subroutines in com. quantum chem. software, ROA will in the future complement VCD for AC detn.  In this review, the basic principles of the application of VCD to the detn. of abs. configuration in chiral mols. are described.  The steps required for VCD spectral measurement and calcn. are outlined, followed by brief descriptions of recently published papers reporting the detn. of AC in small org., pharmaceutical, and natural product mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBwQY6usjp5rVg90H21EOLACvtfcHk0liZl3vJRbVwlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovV2jtL0%253D&md5=cd48886d271835460a76afd1d016dc2c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1366%2F11-06321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1366%252F11-06321%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DBo%26aufirst%3DW.%26aulast%3DDukor%26aufirst%3DR.%2BK.%26aulast%3DNafie%26aufirst%3DL.%2BA.%26atitle%3DDetermination%2520of%2520Absolute%2520Configuration%2520of%2520Chiral%2520Molecules%2520Using%2520Vibrational%2520Optical%2520Activity%253A%2520A%2520Review%26jtitle%3DAppl.%2520Spectrosc.%26date%3D2011%26volume%3D65%26issue%3D7%26spage%3D699%26epage%3D723%26doi%3D10.1366%2F11-06321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaizen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monde, K.</span></span> <span> </span><span class="NLM_article-title">Vibrational CD (VCD) Spectroscopy as a Powerful Tool for Chiral Analysis of Flavor Compounds</span>. <i>ACS Symp. Ser.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1212</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1021/bk-2015-1212.ch003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bk-2015-1212.ch003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1212&publication_year=2015&pages=35-56&author=Y.+Yaguchiauthor=A.+Nakahashiauthor=N.+Miuraauthor=T.+Taniguchiauthor=D.+Sugimotoauthor=M.+Emuraauthor=K.+Zaizenauthor=Y.+Kusanoauthor=K.+Monde&title=Vibrational+CD+%28VCD%29+Spectroscopy+as+a+Powerful+Tool+for+Chiral+Analysis+of+Flavor+Compounds&doi=10.1021%2Fbk-2015-1212.ch003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbk-2015-1212.ch003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbk-2015-1212.ch003%26sid%3Dliteratum%253Aachs%26aulast%3DYaguchi%26aufirst%3DY.%26aulast%3DNakahashi%26aufirst%3DA.%26aulast%3DMiura%26aufirst%3DN.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DD.%26aulast%3DEmura%26aufirst%3DM.%26aulast%3DZaizen%26aufirst%3DK.%26aulast%3DKusano%26aufirst%3DY.%26aulast%3DMonde%26aufirst%3DK.%26atitle%3DVibrational%2520CD%2520%2528VCD%2529%2520Spectroscopy%2520as%2520a%2520Powerful%2520Tool%2520for%2520Chiral%2520Analysis%2520of%2520Flavor%2520Compounds%26jtitle%3DACS%2520Symp.%2520Ser.%26date%3D2015%26volume%3D1212%26spage%3D35%26epage%3D56%26doi%3D10.1021%2Fbk-2015-1212.ch003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nafie, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukor, R. K.</span></span> <span> </span><span class="NLM_article-title">Structural Determination of Molecular Stereochemistry Using VCD Spectroscopy and a Conformational Code: Absolute Configuration and Solution Conformation of a Chiral Liquid Pesticide, (R)-(+)-Malathion</span>. <i>Chirality</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1E</span>),  <span class="NLM_fpage">E172</span>– <span class="NLM_lpage">E180</span>, <span class="refDoi"> DOI: 10.1002/chir.20793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1002%2Fchir.20793" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=E172-E180&issue=1E&author=H.+Izumiauthor=A.+Ogataauthor=L.+A.+Nafieauthor=R.+K.+Dukor&title=Structural+Determination+of+Molecular+Stereochemistry+Using+VCD+Spectroscopy+and+a+Conformational+Code%3A+Absolute+Configuration+and+Solution+Conformation+of+a+Chiral+Liquid+Pesticide%2C+%28R%29-%28%2B%29-Malathion&doi=10.1002%2Fchir.20793"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fchir.20793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchir.20793%26sid%3Dliteratum%253Aachs%26aulast%3DIzumi%26aufirst%3DH.%26aulast%3DOgata%26aufirst%3DA.%26aulast%3DNafie%26aufirst%3DL.%2BA.%26aulast%3DDukor%26aufirst%3DR.%2BK.%26atitle%3DStructural%2520Determination%2520of%2520Molecular%2520Stereochemistry%2520Using%2520VCD%2520Spectroscopy%2520and%2520a%2520Conformational%2520Code%253A%2520Absolute%2520Configuration%2520and%2520Solution%2520Conformation%2520of%2520a%2520Chiral%2520Liquid%2520Pesticide%252C%2520%2528R%2529-%2528%252B%2529-Malathion%26jtitle%3DChirality%26date%3D2009%26volume%3D21%26issue%3D1E%26spage%3DE172%26epage%3DE180%26doi%3D10.1002%2Fchir.20793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillet, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span> <span> </span><span class="NLM_article-title">Assessment of Additive/Nonadditive Effects in Structure–Activity Relationships: Implications for Iterative Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">7552</span>– <span class="NLM_lpage">7562</span>, <span class="refDoi"> DOI: 10.1021/jm801070q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801070q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7552-7562&issue=23&author=Y.+Patelauthor=V.+J.+Gilletauthor=T.+Howeauthor=J.+Pastorauthor=J.+Oyarzabalauthor=P.+Willett&title=Assessment+of+Additive%2FNonadditive+Effects+in+Structure%E2%80%93Activity+Relationships%3A+Implications+for+Iterative+Drug+Design&doi=10.1021%2Fjm801070q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm801070q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801070q%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DY.%26aulast%3DGillet%26aufirst%3DV.%2BJ.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DWillett%26aufirst%3DP.%26atitle%3DAssessment%2520of%2520Additive%252FNonadditive%2520Effects%2520in%2520Structure%25E2%2580%2593Activity%2520Relationships%253A%2520Implications%2520for%2520Iterative%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D23%26spage%3D7552%26epage%3D7562%26doi%3D10.1021%2Fjm801070q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchings, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulito, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolliffe, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, W. V.</span></span> <span> </span><span class="NLM_article-title">Arylpiperazine Substituted Heterocycles as Selective α1a Adrenergic Antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2443</span>– <span class="NLM_lpage">2446</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00436-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1016%2FS0960-894X%2802%2900436-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2443-2446&issue=17&author=H.+Khatuyaauthor=R.+H.+Hutchingsauthor=G.-H.+Kuoauthor=V.+L.+Pulitoauthor=L.+K.+Jolliffeauthor=X.+Liauthor=W.+V.+Murray&title=Arylpiperazine+Substituted+Heterocycles+as+Selective+%CE%B11a+Adrenergic+Antagonists&doi=10.1016%2FS0960-894X%2802%2900436-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900436-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900436-5%26sid%3Dliteratum%253Aachs%26aulast%3DKhatuya%26aufirst%3DH.%26aulast%3DHutchings%26aufirst%3DR.%2BH.%26aulast%3DKuo%26aufirst%3DG.-H.%26aulast%3DPulito%26aufirst%3DV.%2BL.%26aulast%3DJolliffe%26aufirst%3DL.%2BK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26atitle%3DArylpiperazine%2520Substituted%2520Heterocycles%2520as%2520Selective%2520%25CE%25B11a%2520Adrenergic%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D17%26spage%3D2443%26epage%3D2446%26doi%3D10.1016%2FS0960-894X%2802%2900436-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodroofe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwinn, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Méndez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkland, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span> <span> </span><span class="NLM_article-title">NanoBRET - A Novel BRET Platform for the Analysis of Protein-Protein Interactions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1797</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1797-1804&issue=8&author=T.+Machleidtauthor=C.+C.+Woodroofeauthor=M.+K.+Schwinnauthor=J.+M%C3%A9ndezauthor=M.+B.+Robersauthor=K.+Zimmermanauthor=P.+Ottoauthor=D.+L.+Danielsauthor=T.+A.+Kirklandauthor=K.+V.+Wood&title=NanoBRET+-+A+Novel+BRET+Platform+for+the+Analysis+of+Protein-Protein+Interactions&doi=10.1021%2Facschembio.5b00143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00143%26sid%3Dliteratum%253Aachs%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DWoodroofe%26aufirst%3DC.%2BC.%26aulast%3DSchwinn%26aufirst%3DM.%2BK.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DOtto%26aufirst%3DP.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DKirkland%26aufirst%3DT.%2BA.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DNanoBRET%2520-%2520A%2520Novel%2520BRET%2520Platform%2520for%2520the%2520Analysis%2520of%2520Protein-Protein%2520Interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3D1797%26epage%3D1804%26doi%3D10.1021%2Facschembio.5b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4849</span>– <span class="NLM_lpage">4858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00202</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00202" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4849-4858&issue=10&author=E.+Christiansenauthor=B.+D.+Hudsonauthor=A.+H.+Hansenauthor=G.+Milliganauthor=T.+Ulven&title=Development+and+Characterization+of+a+Potent+Free+Fatty+Acid+Receptor+1+%28FFA1%29+Fluorescent+Tracer&doi=10.1021%2Facs.jmedchem.6b00202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00202%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DHansen%26aufirst%3DA.%2BH.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDevelopment%2520and%2520Characterization%2520of%2520a%2520Potent%2520Free%2520Fatty%2520Acid%2520Receptor%25201%2520%2528FFA1%2529%2520Fluorescent%2520Tracer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D10%26spage%3D4849%26epage%3D4858%26doi%3D10.1021%2Facs.jmedchem.6b00202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, C.</span></span> <span> </span><span class="NLM_article-title">Fluorescence/Bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1124/pr.110.004309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1124%2Fpr.110.004309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=22407612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=299-336&issue=2&author=M.+J.+Lohseauthor=S.+Nuberauthor=C.+Hoffmann&title=Fluorescence%2FBioluminescence+Resonance+Energy+Transfer+Techniques+to+Study+G-Protein-Coupled+Receptor+Activation+and+Signaling&doi=10.1124%2Fpr.110.004309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling</span></div><div class="casAuthors">Lohse, Martin J.; Nuber, Susanne; Hoffmann, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-336</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Fluorescence and bioluminescence resonance energy transfer (FRET and BRETT) techniques allow the sensitive monitoring of distances between two labels at the nanometer scale.  Depending on the placement of the labels, this permits the anal. of conformational changes within a single protein (for example of a receptor) or the monitoring of protein-protein interactions (for example, between receptors and G-protein subunits).  Over the past decade, numerous such techniques have been developed to monitor the activation and signaling of G-protein-coupled receptors (GPCRs) in both the purified, reconstituted state and in intact cells.  These techniques span the entire spectrum from ligand binding to the receptors down to intracellular second messengers.  They allow the detn. and the visualization of signaling processes with high temporal and spatial resoln.  With these techniques, it has been demonstrated that GPCR signals may show spatial and temporal patterning.  In particular, evidence has been provided for spatial compartmentalization of GPCRs and their signals in intact cells and for distinct physiol. consequences of such spatial patterning.  We review here the FRET and BRET technologies that have been developed for G-protein-coupled receptors and their signaling proteins (G-proteins, effectors) and the concepts that result from such expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzZxuO8ZQ_D7Vg90H21EOLACvtfcHk0ljHSulPFafJbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslKktr8%253D&md5=76146f70e0e0776aa1d10dae884462aa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.004309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.004309%26sid%3Dliteratum%253Aachs%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DNuber%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DC.%26atitle%3DFluorescence%252FBioluminescence%2520Resonance%2520Energy%2520Transfer%2520Techniques%2520to%2520Study%2520G-Protein-Coupled%2520Receptor%2520Activation%2520and%2520Signaling%26jtitle%3DPharmacol.%2520Rev.%26date%3D2012%26volume%3D64%26issue%3D2%26spage%3D299%26epage%3D336%26doi%3D10.1124%2Fpr.110.004309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vernall, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briddon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doughty, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellam, B.</span></span> <span> </span><span class="NLM_article-title">Conversion of a Non-Selective Adenosine Receptor Antagonist into A3-Selective High Affinity Fluorescent Probes Using Peptide-Based Linkers</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">5673</span>, <span class="refDoi"> DOI: 10.1039/c3ob41221k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=10.1039%2Fc3ob41221k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=23881285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1els73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=5673&issue=34&author=A.+J.+Vernallauthor=L.+A.+Stoddartauthor=S.+J.+Briddonauthor=H.+W.+Ngauthor=C.+A.+Laughtonauthor=S.+W.+Doughtyauthor=S.+J.+Hillauthor=B.+Kellam&title=Conversion+of+a+Non-Selective+Adenosine+Receptor+Antagonist+into+A3-Selective+High+Affinity+Fluorescent+Probes+Using+Peptide-Based+Linkers&doi=10.1039%2Fc3ob41221k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers</span></div><div class="casAuthors">Vernall, Andrea J.; Stoddart, Leigh A.; Briddon, Stephen J.; Ng, Hui Wen; Laughton, Charles A.; Doughty, Stephen W.; Hill, Stephen J.; Kellam, Barrie</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5673-5682</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Advances in fluorescence-based imaging technologies have helped propel the study of real-time biol. readouts and anal. across many different areas.  In particular the use of fluorescent ligands as chem. tools to study proteins such as G protein-coupled receptors (GPCRs) has received ongoing interest.  Methods to improve the efficient chem. synthesis of fluorescent ligands remain of paramount importance to ensure this area of bioanal. continues to advance.  Here we report conversion of the non-selective GPCR adenosine receptor antagonist Xanthine Amine Congener into higher affinity and more receptor subtype-selective fluorescent antagonists.  This was achieved through insertion and optimization of a dipeptide linker between the adenosine receptor pharmacophore and the fluorophore.  Fluorescent probe 27 contg. BODIPY 630/650 (pKD = 9.12 ± 0.05 [hA3AR]), and BODIPY FL-contg. 28 (pKD = 7.96 ± 0.09 [hA3AR]) demonstrated clear, displaceable membrane binding using fluorescent confocal microscopy.  From in silico anal. of the docked ligand-receptor complexes of 27, we suggest regions of mol. interaction that could account for the obsd. selectivity of these peptide-linker based fluorescent conjugates.  This general approach of converting a non-selective ligand to a selective biol. tool could be applied to other ligands of interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdIBs1bmWol7Vg90H21EOLACvtfcHk0ljHSulPFafJbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1els73F&md5=213e61289058406b1fddc734377ec287</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc3ob41221k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob41221k%26sid%3Dliteratum%253Aachs%26aulast%3DVernall%26aufirst%3DA.%2BJ.%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DBriddon%26aufirst%3DS.%2BJ.%26aulast%3DNg%26aufirst%3DH.%2BW.%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26aulast%3DDoughty%26aufirst%3DS.%2BW.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DKellam%26aufirst%3DB.%26atitle%3DConversion%2520of%2520a%2520Non-Selective%2520Adenosine%2520Receptor%2520Antagonist%2520into%2520A3-Selective%2520High%2520Affinity%2520Fluorescent%2520Probes%2520Using%2520Peptide-Based%2520Linkers%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26issue%3D34%26spage%3D5673%26doi%3D10.1039%2Fc3ob41221k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-patent1"><div class="reference"><strong class="refLabel"><a href="#patent1" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-patent1_1"><span><span> </span><span class="NLM_article-title">2,4-Dithi(oxo)-pyrimidin-5-yl
compounds bearing a tricyclic substituent
useful as P2 purinoceptor antagonists</span>. <span class="NLM_patent">US6107297</span>, Aug 22, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2%2C4-Dithi%28oxo%29-pyrimidin-5-yl%0Acompounds+bearing+a+tricyclic+substituent%0Auseful+as+P2+purinoceptor+antagonists.+US6107297%2C+Aug+22%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=patent1_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26atitle%3D2%252C4-Dithi%2528oxo%2529-pyrimidin-5-yl%250Acompounds%2520bearing%2520a%2520tricyclic%2520substituent%250Auseful%2520as%2520P2%2520purinoceptor%2520antagonists%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i129"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00139">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57846"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00139">10.1021/acs.jmedchem.8b00139</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular-formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_001.csv">CSV</a>)</p></li><li><p class="inline">Description of the VCD structure determination and figure showing the binding of the BODIPY630/650-labeled (<b>78</b>–<b>84</b>) and BODIPYFL-labeled (<b>85</b>–<b>91</b>) ligands in NLuc-P2Y<sub>2</sub>-1321N1 cells using the NanoBRET assay (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_001.csv">jm8b00139_si_001.csv (4.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00139/suppl_file/jm8b00139_si_002.pdf">jm8b00139_si_002.pdf (884.04 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00139&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00139%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00139" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799dde85fa81964","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
